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The subject of this thesis lies at the interface of microfabrication technology and advanced
biomaterials synthesis and processing for use in designing and fabricating novel tissue
engineered constructs. The unifying theme is to use micron and sub-micron fabrication
strategies to form advanced tissue engineering scaffolds which are able to precisely control the
microenvironment of cells. These efforts are organized into two thrusts; (1) materials synthesis
and process development for microfluidic scaffold fabrication and (2) micro- and nanofabricated
synthetic substratum for controlling cell function. In the first thrust, materials-specific processes
for the fabrication of poly(glycerol-co-sebacate), a synthetic elastomeric biodegradable polyester,
into three-dimensional, hepatocyte-seeded microfluidic constructs is discussed. Material
advantages of natural proteins motivated the fabrication of next-generation microfluidic scaffolds
using silk fibroin from the Bombyx mori as a bulk material. The need to combine the advantages
of both natural proteins and synthetic polyesters motivated the synthesis and characterization of a
new class of biodegradable elastomers termed poly(1,3-diamino-2-hydroxypropane-co-polyol
sebacate) (APS). APS polymers are tunable and possess the advantages of both natural and
synthetic polymers. APS polymers induce a favorable biomaterial-tissue response including
reduced fibrous capsule formation and macrophage recruitment compared to PLGA. In vivo
degradation half lives could be controlled to between approximately 6 and 100 wks by adjusting
polymer composition and processing. The second thrust focuses on the interaction with cells and
synthetically fabricated nanotopographic substrates for potential in vascularized tissue
engineering applications. The contact guidance response of human embryonic stem cells to
poly(dimethylsiloxane) (PDMS) substrates with 600 nm ridge-groove geometry and 600 ± 150
nm feature height was characterized. This motivated the study of endothelial progenitor cell
function and morphology on nanofabricated PDMS substrates. Endothelial progenitor cells
(EPCs) were found to exhibit increased doubling time from 16.2 ± 0.8 to 20.9 ± 1.9 h for cells
grown on flat and nanotopographic substrates, respectively. EPCs cultured on nanotopographic
substrates had a faster velocity and enhanced directed migration. The average velocity of EPCs
on nanotopographic and flat substrates was 0.80 ± 0.45 and 0.54 ± 0.27 pm-min -1, respectively,
while the effective displacement due to migration was 23.6 + 12.1 and 15.6 ± 10.1 jPm. Lastly,
an in vitro capillary tube formation assay induced the formation of larger, more organized
vascular structures in EPCs cultured on nanotopographic (411 ± 209 pm) versus flat substrates
(140 + 35.6 jpm). This work has validated the potential impact of microfabricated scaffolds in
tissue engineering by modulating cell function and controlling microenvironmental parameters.
Thesis Supervisor: Professor Robert Langer
Title: Institute Professor, Massachusetts Institute of Technology
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Preface
The topic of this dissertation lies principally at the interface of microfabrication technology,
biomaterials, and tissue engineering. More specifically, this work describes materials and
methods for the fabrication of advanced scaffolds, which are able to provide additional
functionality beyond traditional porous tissue engineering scaffolds. The fabrication of
microfluidic scaffolds from a variety of biodegradable materials in order to enable rapid
perfusion of cell-seeded constructs is discussed. The use of synthetic topography in a wide
variety of polymers to control cell function is also discussed. The work described herein is
organized into two thrusts. The first thrust is dedicated to the application of modified materials
processing strategies for the design and fabrication of microfluidic biodegradable scaffolds.
After a brief introduction to the clinically relevant problem of the shortage of vital organs,
various strategies to implement tissue engineering and the complimentary role of biomaterials
microfabrication are outlined in Chapter 1. The fabrication of three-dimensional microfluidic
scaffolds using synthetic elastomeric biodegradable polyester is described in Chapter 2. The
advantages of natural proteins as biomaterials for use in microfluidic scaffolds were pursued in
Chapter 3, which described the fabrication of a microfluidic scaffold device using silk fibroin.
The subsequent advantages of these polymers inspired the synthesis and characterization of
poly(1,3-diamino-2-hydroxypropane-co-polyol sebacate), a new class of biodegradable
elastomer. Synthesis, characterization, and comprehensive biocompatibility studies are
described in Chapter 4. These materials can exhibit a wide range of tunable physical properties
including biodegradation rate. A wide parameter space was explored with respect to
composition and processing on properties. An in-depth study on the mechanism and
performance during in vitro and in vivo biodegradation is outlined in Chapter 5. The
commentary in Chapter 6 discusses these results in the greater context of tissue engineering.
Further work and applications are also discussed in this chapter. The second thrust describes the
work done regarding the use of synthetic nanotopographic substrates for the controlling cell
function for applications in tissue engineering. Chapter 7 provides a brief introduction to the
subject of nanotopography, both in nature and in synthetic systems. Various micro- and
nanofabrication methods for translating these structural features in synthetic biomaterials
systems are discussed. The contact guidance response of human embryonic stem cells to
nanofabricated poly(dimethylsiloxane) (PDMS) was characterized and is described in Chapter 8.
The effect of contact guidance was also characterized in the presence of actin disrupting agents
to investiagate the critical role of the cytoskeleton in cell-substrate interactions with synthetic
nanotopography. Given the favorable results in human embryonic stem cells, the contact
guidance response of endothelial progenitor cells was also characterized on nanofabricated
PDMS. This effort, described in Chapter 9, led to the ability to organize and control in vitro
capillary tube formation using substrate nanotopography. These efforts were produced using
replica molded substrates from PDMS, an inorganic elastomer. A modified replica molding
technique was devised to form nanotopographic structures in biodegradable elastomeric
substrates using poly(glycercol-co-sebacate). These efforts are described in Chapter 10. The
potential for biodegradable elastomers with synthetic nanotopography is further investigated in
Chapter 11. Specifically, these efforts were aimed at investigating the possibility of using replica
molded poly(1,3-diamino-2-hydroxypropane-co-polyol sebacate) nanotopographic substrates as
synthetic collagen analogues for primary hepacotye culture. Chapter 12 puts the collective
previous results into greater context with additional commentary on the future application of
synthetic substrate nanotopography in tissue engineering.
Chapter 1: Introduction to Microfabrication of
Biomaterials for Tissue Engineering Applications
I. Clinical Problem of Vital Organ Shortages
Tissue loss and organ failure are problems that have plagued health care throughout the world
and in the United States. The financial burden of treating these patients have totaled more than
$400BB USD annually.[] Standard treatments for organ loss include transplantation, surgical
reconstruction, and the incorporation of artificial organs and systems. Although these techniques
can save lives, they each carry significant drawbacks, which can negatively affect the patients'
quality of life. Reconstruction of lost or damaged tissue can often leave a patient with long-term
problems. For example, colon cancer becomes prevalent in patients that undergo a treatment to
redirect urine from the bladder to the colon. [2] Transplantation is limited by the amount of organ
donors coupled with a rapidly increasing waiting list for organ recipients. At the beginning of
2008, there were approximately 100,000 on the organ recipient waiting list (Table 1).J31
Table 1. Organ Recipient Waiting List Breakdown by Organ.
Organ Patients on Waiting List
Total 97,889
Kidney 73,921
Liver 16,647
Pancreas 1,642
Kidney-Pancreas 2,293
Intestine 229
Heart 2,679
Heart-Lung 107
Lung 2,268
aFigures from 2008.
The inadequacies of current treatments of organ failure and tissue loss have prompted the
creation of the tissue engineering. The field of tissue engineering, more broadly termed
regenerative medicine, is an interdisciplinary effort that combines the disciplines of medicine,
engineering, and science in growing, repairing, and improving tissue structure and function.
There are three basic strategies that have been studied to create new tissue.[4]
1. Isolated cells and cell substitutes. This treatment allows for an infusion of specific cells
into the patient without the complications of surgery. Although the cells may be
manipulated prior to injection, the possible loss of cell function and immunological
response are imminent.
2. Tissue growth factors. High, localized concentrations of signaling molecules could lead
to organ regeneration. Success with this approach hinges not only upon the ability to
produce massive quantities of these biomolecules, but also targeted delivery. Another
strategy to utilize tissue growth factors for tissue engineering is the use of gene delivery
systems to upregulate the local production of these growth factors.
3. Cell-matrix interactions with scaffolds. Matrices constructed out of natural or
synthetic materials can induce cell migration, act as immunoisolation barriers, and
provide structural support for the cells to grow and proliferate. The ultimate goal is for
the cells to grow and eventual replace a biodegradable scaffold. thereby forming tissue
that is functionally equivalent to the desired tissue.
These strategies have been pursued in attempts to grow a variety of tissues including nerve, skin,
cardiac and bone. More recent efforts have focused on developing strategies to engineer more
complex organs such as the pancreas, kidney, and liver. The field of vascular tissue engineering
has been born out of the demand for blood vessels of various dimensions for treatment of
coronary artery and peripheral vascular diseases, the leading causes of mortality in the United
States.1s ] A more recent demand for vascular tissue engineering approaches has also matured to
support parallel advances in tissue engineering of vital organs that contain highly metabolic
tissue, which requires rapid supply of nutrients and simultaneous removal of waste by-products.
General tissue engineering strategies have relied on the natural in-growth of local blood vessels
within tissue engineering devices to achieve permanent vascularization after the construct has
been implanted. Although vascularization and blood vessel in-growth is known to be an
convenient compononent of the foreign body response, this natural response is not sufficient to
create the extensive vascular networks that are present in native tissues such as the liver. The in
vivo vascularization of tissues can be supplemented using a variety of strategies to enhance
vasculargenesis including drug delivery, gene therapy, and cell-based therapies.
II. Strategies for Enhancing the Vascularization of Tissue
Engineering Constructs in vivo
A. Controlled Release of Tissue Growth Factors
As previously mentioned, the precise spatio-temporal concentration of specific growth factors is
critical to growth and maturation of blood vessels. The rapidly advancing fields of biomaterials
and biopolymers have made controlled release of therapeutic agents a reality. Gene therapy
techniques can also be applied to facilitate desirable in vivo responses.
1. Feedback Response Delivery Systems
Most of the previously developed polymer-based drug delivery systems are used in static
conditions where the drug is released at a predetermined rate. Although changing the polymer
formulation can alter the release pattern, these devices typically aren't designed to respond to
peripheral stimuli. However, a recent improvement upon this class of systems allows for the
modulation of release kinetics by external mechanical signals. One alginate hydrogel system can
upregulate the release of vascular endothelial growth factor (VEGF) in response to mechanical
stimuli.16] The properties of the material in this system are critical. Namely, the material must be
able to withstand repeated deformation and also permit the reversible binding of VEGF protein.
When programmed to release VEGF, this engineered ECM has been shown to increase both the
blood vessel number and blood vessel density in severe combined immunodeficiency (SCID)
mouse models in response to mechanical stimulation. These systems could have a dramatic
impact on both in vivo vascular therapies and in vitro vascular tissue engineering applications.
The biocompatibility and biodegradability of the hydrogel serves to increase the number of
applications of this system.
2. Temporal Control of Delivery of Multiple Signaling Molecules
Another unique type of drug delivery system accommodates the necessary time-dependent
exposure of nascent blood vessels to various types of growth factors. This can be accomplished
by using a heterogeneous polymer system that can control the release of multiple cytokines
(Figure 1). Furthermore, the release of these signaling molecules can occur at different,
predetermined rates. 7] The variable kinetics of the system is achieved by imbedding polymer
microspheres within a larger polymer scaffold. This system can be used to deliver VEGF and
platelet-derived growth factor (PDGF) to a specific location in temporal sequence. The VEGF-
infused scaffold slowly degrades by hydrolysis, releasing the VEGF molecule at a controlled rate.
When this polymer system has degraded sufficiently, the PDGF-containing microspheres are
exposed. The subsequent rapid hydrolysis of the microspheres then releases PDGF-B in a timely
manner. In vivo studies of this technology have resulted in a high degree of neovascularization
and stabilization of mature blood vessels.
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Figure 1. Heterogenous Polymer Controlled Drug Release System
The controlled release kinetics of two angiogenic factors aids in the engineering of mature vessels. Intially,VEGF is released which induces endothelial cell proliferation and angiogenesis. In the second phase, PDGF-
BB is released to recruit SMCs, which are necessary for blood vessel maturation.
B. Gene Transfer for Use in Therapeutic Vascular Growth
Gene therapy provides a possible alternative for in vivo vascular growth. Therapeutic vascular
growth using gene transfer uses the standard strategies and exhibits near-identical characteristics
and benefits as traditional gene therapy procedures. Adenoviruses are the standard vector for
gene delivery and insertion. However, gene therapy for vascular growth aims to produce
increased amount of cytokines and chemokines such as various types of VEGF, placental growth
factor (PLGF), fibroblast growth factor (FGF), and angiopoiteins.[8] Therapeutic vascular growth
has also focused on both the constitutive and inducible expression of other factors involved in
vascular growth including the multifunctional protein, hepatocyte growth factor (HGF). Another
potential strategy is to induce cellular genes that, in turn, stimulate angiogenesis via a number of
signal transduction proteins or transcription factors. This goal can be accomplished through the
·r!
targeted insertion of genes that code for transcription factors such as nitric oxide synthetase
(eNOS), inducible NOS (iNOS) and hypoxia-induced transcription factor (HIF-1). One potential
benefit of using gene transfection is the selectivity towards inducing angio- and ateriogenesis,
but not lymphangiogenesis. As with most gene therapy applications, there are significant
limitations in gene transfer efficiency in large mammals.193 Nonetheless, gene therapy for
vascular therapies has been able to overcome other traditional barriers of treating monogenetic
disorders and, as a result, has shown positive results in some animal models. For example,
preclinical wound healing models have shown the enlargement and proliferation of the
capillaries when treated with adenovirus-mediated delivery of VEGF for more than 4 wks. If the
treatment were stopped before this critical time period, the vessels would regress.
C. Cell-Based Strategies for Vascularized Tissue Engineering
1. Blood Vessels Derived From Stem Cells
Traditional tissue engineering strategies have focused on utilizing differentiated cell types for
regeneration of specific organs and tissues. For example, chondracytes are used for cartilage and
hepatocytes are used for liver engineering applications, respectively. However, the recent
developments of human embryonic stem cells (hESCs) have opened the door for new, exciting
tissue engineering strategies. hESCs have the potential to differentiate into various types of cells.
Therefore, they may be a useful source of cells for tissue engineering applications. A procedure
that isolated hESCs using an antibody for platelet-endothelial cell adhesion molecule-1
(PECAM1) was recently reported.o'0 ] In vitro techniques have induced the newly differentiated
stem cells to produce conformal geometries as well as cellular markers that similar to endothelial
cells. Stem cells have also differentiated controllably to produce blood-containing vascular
microstructures in vivo. This discovery may prove to be effective in engineering new blood
vessels and treatment of regional ischemia. However, this advancement may also set the
groundwork for engineering mature blood vessels by selectively differentiating hESCs thereby
creating a co-culture environment. By precisely controlling the delivery concentration of
cytokines and chemokines in the cellular microenvironment using previously detailed methods, a
single population of hESCs cells could selectively differentiate into both endothelial cells and
mesenchymal cells, which are necessary for blood vessel maturation, in close spatial proximity
to each other, which could ultimately promote the formation of stable blood vessels.
2. Optimizing Cell-Matrix and Cell-Cell Interactions for Vascularized Tissue
Engineering
Controlling cell-matrix interactions with synthetic biomaterials can induce desirable in vitro
cellular responses. This approach exhibits often-significant advantages over the in vivo delivery
of growth factors and cytokines. For example, more recent work with stem cells has focused on
the formation and organization of hESCs into more complex three-dimensional vessel networks
using porous biodegradable scaffolds. ["11 These scaffolds, which were fabricated out of poly(L-
lactic acid) (PLA), poly(glycolic acid), and their copolymers, poly(L-lactic-co-glycolic acid)
(PLGA), provide physical cues for stem cell differentiation while also allowing sufficient void
volume for proliferation and remodeling activities in cells. After seeding the polymer constructs
with actively differentiating hESCs, they were cultured in the presence of various growth factors
for several weeks. Depending on the growth factor, the cells exhibited properties similar to
various developing tissues types including neuronal, cartilage, and liver. Furthermore, the
hESCs were also shown to differentiate and organize into 3D vascular networks, which was
supported by CD34+ staining. When the cell-seeded construct was implanted into SCID mice,
not only did the cells remain viable, but they were recruited by the host vascular system as they
continued the in vitro progression and differentiation.
Controlling cell-cell interaction is another critical strategy for engineering vascular tissue in vivo.
The formation and stabilization of nascent blood vessels can be accomplished through the use of
co-culture systems in the drive to create vascularized skeletal muscle. [121 Combining the
appropriate ratio of endothelial cells, smooth muscle cells, and fibroblasts led to the
vascularization of skeletal muscle in mice. The vascular structures throughout the tissue were
found to be connected to the host vascularture as well. The formation of stable blood vessels
was also contingent upon a variety of other factors including maintaining the appropriate level of
co-culture and medium composition.
D. In vitro Tissue Engineering Using Perfused Constructs
1. Blood Vessel Engineering
Inducing the growth and maturation of blood vessels can be accomplished in vivo as a direct
therapeutic approach or in vitro using both traditional and non-traditional tissue-engineering
methods. Presumably, the goal of in vitro tissue engineering is to successfully culture vessels for
eventual implantation into a host. There are wide ranges of general strategies that can be used
for creating viable microvasculature. One traditional approach is to culture multiple cell types
on a porous biodegradable polymeric scaffold that can be perfused with medium to create more
native live morphologies for blood vessel xenografts. This strategy has proven to be successful
in the growth of functional arteries.[ 13 ] In this system, endothelial cells
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Figure 2. Perfused Scaffolds for Blood Vessel Tissue Engineering.
Bioreactors consisting of poly(glycolic acid) scaffolds seeded with endothelial cells and smooth muscle cells
were cultured under perfusion conditions for up to 8 wks. Tissue morphology of constructs cultured under
perfusion condictions exhibited a more native morphology relative to those cultured in static conditions.
Image reproduced from L E Niklason, J Gao, et al. Functional Arteries Grown in vitro. Science 284: 489(1999).
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and smooth muscle cells were cultured on poly(glycolic acid) (PGA) polymers in a biomimetic
bioreactor under both static and pulsatile flow conditions (Figure 2). After 8 wks of perfusion,
the gross appearance of the cultured vessels was identical to that of native vessels. The wall
thickness for vessels grown under pulsatile flow conditions was also significantly larger than
those grown under static conditions. Blood vessels engineering using this approach were then
implanted into a miniature swine modeled and observed for up to 24 d. The engineered blood
vesssels cultured with pulsatile flow had showed a highly ordered structure, which was similar to
that of autologous nerve grafts. Again, the function of the blood vessel was highly-dependent
upon the combination of cells and perfusion. This result illustrates the importance of creating a
biomimetic mechanical microenvironment for in vitro culture of vessels. These studies, in
support of previous in vivo work,[12] have demonstrated the potential of co-culturing smooth
muscle and endothelial cells directly rather than inciting the recruitment in vivo. Therefore,
these vessels may not exhibit the ideal characteristics of a native, mature blood vessel. Tissue
engineering bioreactor technology is sufficient for culturing single blood vessels with diameters
on the order of 1 mm or greater. These systems lack the spatial resolution and features for
culturing complex networks of highly metabolic cells such as hepatocytes, which are required for
vital organs such the liver. However, the rapidly growing field of BioMEMS enables the
creation of microfabricated devices that are able to control many aspects of the surrounding
cellular microenvironment and produce the next generation of cell-seeded tissue engineering
scaffolds.
2. Perfused Contruct Approach for Tissue Engineering of Vital Organs
Previously described work in the area of blood vessel engineering constructs has demonstrated
the advantage of the perfusion of cell-seeded constructs in vitro to obtain a more native
morphology. The perfused construct can then be integrated into the vascularture of the host to
enahble perfusion through cardiovascular circulation. Host perfusion through circulation serves
to supply the tissue engineered construct with fresh nutrients and simultaneously remove waste
products. The notion of in vitro perfusion of cell-seeded constructs is also a potentially viable
method for use in tissue engineered systems for vital organs in which a similar strategy can be
employed. Consider the example of utilizing this method for liver tissue engineering. The
scaffold could be fabricated from a desirable material and then seeded with hepatocytes in vitro.
The scaffold could then be cultured under perfusion to support cell proliferation and function in
vitro. The cell-seeded construct could then be implanted and attached to host vasculature to
facilitate perfusion in vivo. The hepatocyte-construct can be engineered to provide hepatic
function for the host, promote integration with host tissue, or both. This strategy can be alikened
to a hydbrid strategy based on the bioartificial liver (BAL),[14-16] in which the BAL is implatanble
and can eventually become integrated to fulfill the demands of liver function in vivo.
3. Advantages of Microfluidic Scaffolds for Hepatic Tissue Engineering
Microfabrication technologies, specifically microfluidics, provide a technology platform that
enables advanced scaffold formation for hepatic tissue engineering. Assuming appropriate
material selection and processing capabilities, microfluidic scaffolds provide at least three key
advantages for hepatic tissue engineering:
1. Control of scaffold microarchitecture. The length scale of the structures within the
liver approaches the order of 10 microns with precise spatial arrangement of multiple
cells types. Microfluidic scaffolds enable the precise control of scaffold architecture,
device geometry, and cell placement.
2. High cell density per volume. The surface-to-volume ratio of geometries is greatly
enhanced as the length scale approaches that of microns or smaller. Microfluidic
scaffolds enable a high cell density of cells to be cultured per unit volume. This is an
important asset when engineering large-volume vital organs that perform critical, live-
sustaining function.
3. Rapid scaffold perfusion. Hepatocytes are known to have a high demand for oxygen
and nutrients. Microfluidic structures are able to sequester and deliver a steady supply of
nutrient supply and waste removal through perfusion. Microfluidic scaffolds could also
be beneficial for the tissue engineering of other highly metabolic tissue.
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Figure 3. Microarchitecture of Native Liver.
Reproduced from Encyclopedia Brittanica, Inc (2003).
Given the viable strategy of utilizing perfusable hepatocyte-seeded constructs for hepatic tissue
engineering applications, there are numerous parameters that can be engineered to optimize
aspects of the scaffold function. Bulk biomaterials selection, scaffold geometry, and perfusion
conditions must be carefully selected. Porous scaffolds have been used extensively in tissue
engineering applications. [17
-
221 Although bulk parameters such as average pore size, porosity,
and average strut length can be engineering by carefully controlling the processing, there is
generally a lack of control in fabricating spatially specific features on the micron scale. It is well
known that the liver contains a micron scale architecture in which the relative placement of
different cells plays an essential role in optimizing heterotypic cell-cell interactions. Therefore
controlling the distributions of cells within a construct is crucial to maintaining appropriate cell
function. Furthermore, the perfusion of porous scaffolds can lead to spatial distribuations of
microenvironmental parameters that are difficult to predict including localized shear stress and
oxygen concentration. These shortcomings of traditional porous scaffolds can be addressed by
utilizing microfabrication strategies for tissue engineering; specifically fabricating microfluidic
scaffolds that can enable facile, precise microscale geometry fabrication and efficient perfusion
of the construct. The generalized topic of the application of microfabrication to tissue
engineering will now be introduced.
III. Introduction to Microfabrication Techniques for Tissue
Engineering Applications
The advent of the semiconductor industry throughout the 2 0th century has provided the secondary
benefit of advanced manufacturing processes including the increased precision of the
microfabrication of modem engineering materials such as metals and polymers. Advances in
microfabrication techniques including micromachining and photolithography-aided processes
such as dry and wet etching, metal deposition, and thin film growth have led to the ability to
engineer systems and materials with well-defined features on the micron and sub-micron scale.
Other more advanced techniques such as electron-beam (e-beam) photolithography and
nanomanipulation have enabled the fabrication of structures with nanometer scale precision.
Although initially designed to support the rapid development demands associated with the
integrated circuits industry, the application of micron and nanometer scale fabrication techniques
has demonstrated invaluable utility in the design and development of engineered systems for
biological and bioengineering applications.
The increasing precision of microfabricated devices has systematically enabled the manipulation
of biological systems on a wide variety of length scales ranging from whole tissues and organs of
centimeters in length, to individual cells on the micron scale, to individual biomolecules on the
nanometer scale. One particularly promising application lies in the field of tissue engineering, a
subset of bioengineering where micron and nanometer systems have, and will continue to be of
paramount importance. The application of these microfabricated systems have proven to be
useful not only in the development and engineering of next-generation tissue engineered systems,
but also in aiding basic research efforts. Instrumentation that operates at the micron and sub-
micron length scale is able to probe cells and tissues at biologically relevant length scales, which
has led to the elucidation of some of the fundamental parameters of the cellular
microenvironment that influence various fundamental biological processes such as
differentiation, [23] migration, [24 ] embryonic development,12 5] and apoptosis.[26]  Applying
microfabricated systems towards the study and engineering of cell-matrix interactions is also of
extreme importance. While the chemistry and biology of cell-matrix interactions has been
studied extensively, the topography of this interface also plays an important role in regulating
cell functions. The extracellular matrix (ECM) is composed of numerous structural proteins that
are known to contain features at length scales from millimeters to nanometers. While larger
structures are designed to provide macroscopic support, nanoscale features within the ECM are
known to provide cues that influence essential cell functions such as proliferation, migration,
spreading, contractility, tension, and traction forces. Numerous synthetic systems with a variety
of sub-micron scale feature sizes and geometries have been used to study the behavior of cells in
response to substrates rich in topographical cues.[27]
In addition to well-defined substrates, cells have also been known to respond to randomly
oriented topography such as nanometer scale roughness. Topographic features on the order of 1
micron or smaller can influence cell functions that may be critical for tissue engineered systems
including cell attachment, morphology, and directed migration, which are all critical cellular
processes for controlling cell phenotype in cell-scaffold constructs. Cell alignment, for example,
has been shown to play an important role in developing stronger tissues in the cases of smooth
muscle cells, skeletal muscle, and fibroblasts. Topography has also been shown to influence the
genotype and phenotype [28] including the upregulation of fibronectin mRNA levels in
fibroblasts. [291 The generalized reaction of cell to topography has been extensively reviewed
elsewhere[27, 30, 31] including other chapters within this text. Understanding of the fundamental
processes related to cell-cell and cell-matrix interactions based on chemical, physical,
topographical, and spatial microenvironmental cues is only one key aspect for the rational design
of tissue engineering systems. It is also important to be able to apply these scientific discoveries
through engineering both materials and material fabrication techniques for to further realize the
potential for use in tissue engineering and regenerative medicine.
The evolution of increasingly sophisticated microfabricated systems will continue to play an
important role in the advancement of tissue engineering and regenerative medicine. Although
the current paradigm for the design and fabrication of tissue engineering scaffolds is biomimicry,
advances in genomics, cell biology, and developmental biology will mandate proportional
advances in the toolset for tissue engineering scaffold fabrication including the ability to control
the spatial and temporal cellular environments on a micron and sub-micron level. There
currently exists a wide range of "top-down" and "bottom-up" processes that have been
developed to meet the corresponding increase in demand of micron and nanometer scale
precision in engineering biomaterials for tissue and organ regeneration systems.[3 2' 33] However,
there are multitudes of engineering challenges that remain to be addressed including the efficient
incorporation of cells into scaffolds with sufficient spatial precision and the translation of the
fundamentally two-dimensional photolithographic-based processes into three dimensions. This
chapter focuses on the design and fabrication of tissue engineering scaffolds with micron and
sub-micron scale features. The current state of the art in materials and materials processing for
tissue engineering is surveyed with a specific focus at the interface of these disciplines with
micro- and nanofabrication techniques.
IV. Application of Traditional Microfabrication Techniques
A. Soft Lithography of Biomaterials
Photolithographic patterning processes lie at the cornerstone of micron scale systems as one of
the most widely implemented tools for producing microfabricated structures. The principles of
traditional photolithography have been translated directly to biomedical applications for the use
of selective patterning of proteins, synthetic biomaterials, and cell-seeded biomaterials. One
such technique involves the use of photoactivation to produce locally active regions that can
readily immobilize proteins and other biomolecules. Though effective, alternatives to
photografting of biomolecules would prove to be beneficial to promote rapid, scalable,
inexpensive processing while retaining biological activity of the species. Microcontact printing
(pCP), which was originally developed to for patterning of chemical species,1 34] has since been
modified to for patterning biomolecules.[35] ptCP and related processes are grouped together in a
general technique known as soft lithography. Soft lithographic patterning of biological materials
through various techniques has led to advanced tissue engineering scaffolds. A summary of the
processes using soft-lithography and related techniques is shown in Table 2.
Table 2. Comparison of Techniques for Micropatterning of Biomaterials for Use in Tissue Engineering
Scaffold Fabrication and Development.
Patterning Compatible
Technique Modality Materials Minimum Feature Resolution References
Replica Molding Silicon / PDMS Natural and 30 nm [36-40]
(RM) master synthetic polymers
Small molecules, . 35) (41)PDMS stamp Small molecules, 35 nm (small molecules, proteins) 3 (41]Microcontact polymers, proteins
Printing (jiCP)
Agarose stamp Cells 10-15 plm (single cells) [42]
Capillary Force PDMS stamp Polymers, 100 nm (43-45)
Lithography (CFL) biopolymers
Microfluidic 3D PDMS Small molecules, 3-10 [pm (proteins) (46-50]
patterning microfluidics proteins, cells
15-50 jim (cells)
Stencil (51, 52]
micropatteni PDMS stencil Cells 100 pmmicropatterning
Dip-Pen Small molecules, 530 n7]Nanolithography AFM tip proteins10 nm
(DPN)
1. Microcontact Printing
pCP is the direct deposition of molecules using a replica molded, elastomeric stamp, typically
fabrication from PDMS. Although 1iCP has been utilized for patterning molecules since the mid-
1990s, this technique has only recently been applied to tissue engineering applications. pCP has
typically been employed in this regard via the micropatterning of adhesion-promoting ECM
proteins for selective adhesion of cells. tCP has been demonstrated on a variety of biomaterials
including PLA, PLGA,t58] and even human tissue.[59] Proteins patterned in this manner have
been shown to control cell morphology, spreading, geometry,[60 ] spatial arrangement, and
relative orientation. 61] pCP of multiple proteins have also been demonstrated. Multi-step
protein patterning using iCP followed by backfilling with additional proteins in layer-by-layer
techniques has led to the ability to precisely develop co-culture systems with well-defined
hetereotypic cell-cell interactions.[ 44]  The ability to control individual cell morphology,
orientation, and cell-cell interactions may prove to be critical in engineering biomimetic
microenvironments within tissue engineering scaffolds. Therefore, the advancement giCP
printing has also been adopted for the use of direct cell patterning. [421 Stevens et al demonstrated
the use of replica molded, elastomeric agarose stamps for the direct deposition of human
osteoblasts on to porous hydroxyapatite scaffolds for applications in bone tissue engineering.
This work highlights the benefits of using "cell-friendly" materials in itCP that allows for rapid,
one-step patterning of mammalian cells. The subject of direct-cell patterning will be further
addressed in subsequent sections of this chapter.
2. Capillary Force Lithography and Other Soft Lithography Techniques
There are also a number of derivative techniques that are related to gtCP designed to fabricated
polymeric structues with high fidelity using elastomeric molds, stencils, and substrates. These
techniques include micromolding in microcapillaries (MIMIC),[ 62] solvent-assisted microcontact
molding (SAMIM) [63], and microtransfer molding (ýLTM).[ 641 However, one technique that is
especially useful for scaffold development is capillary force lithography (CFL), a soft
lithographic technique that is complimentary to tCP.143] Like gtCP, CFL can be used for
patterning structures with minimum feature sizes down to 100 nm in a variety of polymeric
materials. CFL utilizes elastomeric molds for the sequestration of polymers in the voids of the
mold, which results in microstructures when then mold is removed. CFL is especially useful in
scaffold fabrication because of the large feature heights that can be achieved in additional to the
large array of compatible biomaterials[ 45] For example, this technique has been utilized for the
micropatterning of repellant biomaterials such as poly(ethylene glycol) (PEG) and hyaluronic
acid (HA), which, when used in combination with adhesion proteins, can be used to selectively
pattern cells (Figure 4).[65]
Figure 4. Scheme for Fabrication of Co-culture Systems Using Capillary Force Lithography and Layer-by-
layer Deposition.
Multiple types of soft lithographic techniques can be combined to form a variety of co-culture systems. This
schematic demonstrates one such example, in which capillary force lithography patterning of hyaluronic acid
(HA) and layer-by-layer deposition of ECM proteins are combined to create a co-culture of 3T3 fibroblasts
and murine embryonic stem cells. Briefly, a few drops of HA solution were spun coated onto a glass slide,
and a PDMS mold was immediately placed on the thin layer of HA. HA under the void space of the PDMS
mold receded until the glass surface became exposed. The exposed region of a glass substrate was coated with
fibronectin, where primary cells could be selectively adhered. Subsequently, the HA surface was complexed
with collagen, allowing for the subsequent adhesion of secondary cells. This procedure is general and can be
adapted for virtually any pair of cell types. Used with kind permission from J. Fukuda, A. Khademhosseini,
et al. Micropatterned cell co-cultures using layer-by-layer deposition of extracellular matrix components.
Biomaterials 27 (8): 1479-1486 (2006). Copyright Elsevier Ltd. All rights reserved. Reproduced with
permission.
The prevalence of microfabrication and microtechnology laboratories and low-cost of materials
has led to many variations of soft lithography. Soft lithography has expanded beyond simple
stamping techniques for the direct patterning of proteins and cells. Folch et al. have developed
microfabricated elastomeric stencils using PDMS for patterning of mammalian cells on two-
dimensional substrates. [511 After overcoming technical challenges associated with the
incompatible hydrophobic nature of PDMS and the aqueous environment for biomaterials, cells
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were patterned on a variety of substrate materials with various curvatures including gold,
polystyrene, and collagen gels. Micropatterning using elastomeric stencils has been used in the
co-culture of hepatocytes with Kupffer cells to improve hepatocyte function in vitro.[52 ] Chiu et
al used complex microfluidic devices for the micropatterning of multiple proteins and cells. [47]
This technique utilized complex three-dimensional microfluidic circuits that were mounted on
the substrate to be patterned. Multiple protein solutions were then pumped throughout the
network, selectively adsorbing to the substrate only at regions defined by the microfluidic
structures. The structure can then be removed to reveal the final patterned substrate. This
method had been previously developed by Delamarche et al for the patterning of
immunoglobulins.[46]
3. Applications of Soft Lithography in Scaffold Development
Soft lithography will continue to play an important role in fundamental and applied biomedical
engineering applications. For example, protein patterning has aided in elucidating fundamentals
of cell biology through the use of designer microenvironments. Soft lithography will also serve
to aid high-throughput screening assays for drug development or biomaterial deposition for cell
differentiation studies. [66' 67] Although soft lithography has been used to lay the groundwork for
fundamental studies in cell biology, the direct application of soft lithography in tissue
engineering through advanced scaffold development has been somewhat limited. The reason for
this is primarily due to the previously mentioned inherent two-dimensional nature of these
techniques. As that paradigm for tissue engineering complex organs continues to evolve into
three-dimensions, soft lithography will need to follow suit if it is to command a significant role
in the next generation of scaffolds.
B. Electrodeposition of Biomaterials
Electrodeposition processes combined with photolithography has been used extensively in
traditional microfabrication in a process termed LIGA. LIGA is an acronym for the German
words Llthographie, Galvanoformung, Abformung, which translate into "Lithography,
Electroplating, and Molding" in English. LIGA is generally used in the fabrication of structures
with feature sizes that fall between surface silicon micromachining and precision
micromachining. LIGA is used to fabricated structures with lateral dimensions on the order of a
few microns wide and several millimeters, which results in extremely high-aspect ratio structures.
A wide variety of materials can be fabricated using LIGA including metals, metal alloys, plastics
and ceramics. LIGA and related processes for high-precision micromachining using traditional
engineering materials have been reviewed extensively elsewhere. [68 ] There has been recent
interest in the use of biodegradable eclectically conducting polymers in tissue engineering,[69, 70]
with specific interest for applications in neuronal tissue regeneration.[ 7 1  LIGA presents a
suitable method for the microfabrication of electrically conducting polymers for use as either
neural prosthetics or scaffolds to help direct nerve growth for applications in peripheral nerve
regeneration. In work by Lavan et al, poly(pyrrole) (PPy), an electrically conducting polymer
used extensively in biomedical applications, [72' 73] is electrodeposited on micropatterned gold
islands to form micron scale structures of PPy on a silicon substrate [74]. This process is also
amenable to electroforming three-dimensional structures with varying feature heights by
designing the appropriate spacing of conductive features on the insulating substrate. The
microfabrication of electrically conducting material could have a variety of applications
including micropatterning and contact guidance of neurons. Although there are currently a wide
variety of conducting polymers available for biomedical applications, there are significant
limitations that preclude widespread use in tissue engineering including slow biodegradation
rates, brittle mechanical properties, and poor cell attachment in some cases. These material
deficiencies and the drive for implantable conducting biomaterials will also drive the
development of novel conducting materials for a similar set of neuronal tissue engineering
applications. As with other material processes, the drive materials development must be
accompanied by a parallel pursuit of novel material processing capabilities.
C. Advanced Micropatterning Techniques
RM and soft lithography can collectively recapitulate features with resolutions that are suitable
for cell and tissue engineering applications. There are other techniques that can reproduce sub-
micron scale features without the need for photolithographic processes. Instead, these techniques
employ other precision instrumentation to achieve micron and sub-micron scale feature
resolution. However, like photolithographic processes, these technologies are primarily limited
to patterning two-dimensional surfaces.
1. Laser Micromachining
Laser micromachining is a "top down" process for rapid production of micron scale features.
Laser ablation of polymers is typically performed using UV laser types such as excimer, argon-
ion, fluorine, helium-cadmium, metal vapor, and nitrogen. Polymers are etched when the energy
of the incident photoelectron is large enough to dissociate chemical bonds directly while
imparting little thermal damage to the non-machined regions. Microfabrication of polymers
using laser ablation can be performed by either exposing the entire polymer substrate to UV
irradiation through a photomask or by using a direct writing process. The minimum feature
resolution of laser ablation is approximately 100 nm, [751 which is an acceptable length scale for
microfabricated structures for tissue engineering applications. The advantages of each method
are scalability and elimination of the photolithographic patterns, respectively. Laser ablation has
been used to fabricate a number of microsystems that would otherwise be difficult to produce
using polymer RM techniques. For example, geometries such as through holes and trenches can
be produced in biodegradable substrates with minimum feature sizes of approximately 10
microns in polymers such as poly(ether-ether-ketone) (PEEK),[76] poly(methyl methacrylate)
(PMMA), [771 poly(vinyl alcohol) (PVA), PCL, PLA. 78 1 Laser ablation has also been used in
combination with lamination techniques such as thermal or solvent lamination techniques to
fabricate microfluidic prototypes.[ 77' 79] Laser ablation, while proven directly useful for
micromachining, can simultaneously functionalize surfaces that have undergone laser treatment.
Laser irradiation can lead to the incorporation of nitrogen or oxygen molecules thereby creating
functional groups such as amines or carboxylic acids. These functionalities can serve as pre-
cursors for surface modifications such as covalent linkages of peptides or non-bio-fouling agents.
These surface modifications can also lead to a number of deleterious effects on materials used in
microfluidics for certain applications. For example, it has been shown that laser ablation does
not significantly impact the surface properties of PMMA, it does effect the electroosmotic
mobility of polymer microchannels in materials such as poly(ethylene terephthalate glycol),
poly(vinyl chloride), and poly(carbonate).,8 01 As previously suggested, one potential limitation
of laser ablation is the material selection, depending upon the intended final application. The
ideal organic polymer for laser ablation is thermally and mechanically stable, yet susceptible to
bond dissociation upon UV irradiation. Furthermore, the laser ablation process would ideally
result in desirable surface modification to facilitate downstream material processing such as
chemical modification, protein adsorption, or appropriate physical properties for use in
microfluidics systems.
V. Microfabrication of Bulk Biomaterials
D. Replica Molding of Biomaterials
Replica molding (RM) is the general term that encompasses a wide range of molding processes
including hot embossing, solvent casting, and injection molding. Although RM has traditionally
been used to create molded structures in a variety of engineering materials, [81] the RM of
biomaterials is the most straightforward technique toward creating microfabricated structures for
tissue engineering applications. Photolithography remains a keystone technology in the
fabrication of molds for use in RM processes. The advantages of RM include; (1) feature
resolutions down to 30 nm using polymeric materials, (2) the rapid and scalable production of
microstructures across large surface areas, (3) the inherent simplicity of the process. However,
these advantages also result in limitations including the two-dimensional nature of molds for RM
using photolithographic processes. RM of inorganic materials such as poly(di-methylsiloxane)
(PDMS) has been used extensively for biomedical applications including biosensors and
microfluidic networks for cell culture. [39, 82-84] However, the RM of biomaterials requires the
adaptation of traditional processes to accommodate the chemical and physical properties of both
synthetic and natural biomaterials.
Synthetic biodegradable polymers and natural biomaterials alike can be cast onto
microfabricated molds to produce structures on substrates with feature resolutions as small as 30
nm. Synthetic thermoplastic biopolymers such as poly(s-caprolactone) (PCL), poly(L-lactic acid)
(PLA), and poly(L-lactic-co-glycolic acid) (PLGA) have been processed in this manner for
various biomedical applications including tissue engineering scaffolds and devices for controlled
drug release. [32, 851] Melt casting, solvent-casting, injection molding, and hot-embossing can all be
employed to attain well-defined feature geometries in polycrystalline or amorphous
thermoplastic synthetic biomaterials. Similar processes can be adapted for fabricating tissue
engineering scaffolds with conductive polymers for potential in nerve regeneration applications.
[71, 72] Thermoset biomaterials including crosslinked elastomeric networks such as poly(glycerol-
co-sebacic acid) (PGS)186] and poly(1,8-octanediol-co-citric acid) (POC)[87' require that the
material be set into a given shape when initially molded followed by a chemical or physical
crosslinking process. Therefore, processing of such materials may require the use of a sacrificial
mold release layer consisting of a biologically benign material to prevent adhesion of these
aggressive materials to the mold used during the final polymerization. Dilute sucrose solutions,
which are typically used to prevent flocculation and coagulation in microparticle formulations,
can be used to create thin films for aid in mold release of films while maintaining the fidelity of
sub-micron sized features.[88 ]
RM has also been used to produce micron scale and sub-micron scale features in natural
biomaterials including structural proteins such as collagen, Matrigel, and sugar-based molecules
including agarose. [40, 89-91] A method reported by Tang et al. is also capable of incorporating
cells within microfabricated gel constructs produced by micromolding. However, there are
significantly more stringent processing limitations imparted on the processing of natural proteins,
especially those that also incorporate cells within the structures. The potential for loss of
function via protein denaturation limits processing conditions to generally low temperature
processes using aqueous conditions. The inability to use elevated temperatures or organic
solvents limits the suite of potential techniques, however, there are potential chemical methods
that can be implemented including chemical crosslinking through established bioconjugation
methods such as 1-ethyl-3-[3-dimehtylaminopropyl]carbodiimide hydrochloride (EDC) and N-
hydroxysuccinimide (NHS), an established chemical route for bioconjugation of amines to
carboxylates. Photopolymerization is another method for fabrication of replica molded polymer
sheets using mild processing conditions such as low temperatures and aqueous solvents.
E. Micro- and Nanomolding of Biomaterials for Scaffold Topography
The ECM contains nanometer scale features, which provide cues that mediate essential cell
functions such as proliferation, migration, cytoskeleton remodeling, and differentiation.
Synthetic systems with various sub-micron scale feature sizes and geometries have been used to
study the behavior of cells in response to substrates rich in nanometer scale topographical cues
[27]. Cells also have been reported to respond to randomly oriented topography such as
nanometer scale roughness in addition to well-defined substrates with sub-micron features.
Topographic features on the order of 1 micron or smaller in size and pitch can influence a
number of cell functions including cell attachment, adhesion, morphology, and migration.
Topography has also been shown to influence the gene profile[2 8] including the upregulation of
fibronectin mRNA levels in fibroblasts.[291 The generalized reaction of cell to topography has
been extensively reviewed elsewhere, E27, 30, 31] including other sections within this book.
Given the demonstrated utility of being able to control cell function using nanotopography, this
technology may also continue to play an important role in scaffold development as
nanotopography is applied to natural and synthetic biomaterials. As previously mentioned, RM
can reproduce features down to 30 nm, which is more than sufficient for inducing alterations in
cell function. RM processes have been adapted to fabricate substrate nanotopography using a
variety of biomaterials.[ 89' 92, 93] Some biomaterials require the addition of a sacrificial release
layers, which promote mold release.[ 881 The materials used in mold release agents should be
non-toxic, inexpensive, and soluble in aqueous agents to facilitate dissolution and release under
mild conditions.
Although RM is a rapid, scalable, and facile method for producing ordered nanotopographic
substrates, there are other processes available for producing nanotopographic features, which
will be reviewed later in this chapter. One of the obvious limitations with nanotopographic
substrates using traditional RM is the restriction to engineering principally two-dimensional
systems. This restriction is not limiting in the design and fabrication of tissue engineered
systems that are primarily two-dimensional structures such as the epidermis and epithelium of
various organs. For example, laser micromachined wafers were used to fabricate PDMS masters
for RM of collagen I sponges.[ 94] These sponges contained features on the order of 40 to 310
microns, which were designed to mimic the structures of native epidermis. RM microfabricated
sponges formed a basal lamina analogue when seeded with human epidermal keratinocytes.
Another potential application for two-dimensional systems is in the retina of the eye. Corneal
epithelium have been shown to respond to well-defined ling-grating substrate nanotopography
with features as small as 40 nm using silicon.[ 951 However, further work must be performed in
novel materials to allow for the potential for implantation. Two-dimensional RM could be
expanded to other applications where the predominant structure is monolayer in nature. For
example, RM of substrates using suitable biomaterials could also be envisioned for vascular
implant applications [96], where the orientation of cells may prove to be important in inducing the
appropriate phenotype. Two-dimensional sheets could be formed into tubes for applications in
peripheral nerve regeneration as well.[97 ]
The engineering of vital organs with complex microarchitecture requires the expansion from a
two-dimensional platform. To address these unmet needs, tissue engineering strategies and
scaffold fabrication techniques are continually moving towards development of three-
dimensional systems. Subsequent nanotopography fabrication methods will also eventually have
to expand to three-dimensional systems to accommodate advanced tissue engineering scaffold
systems. One route towards pursuing this end is eliminating the use of photolithographic
processing and instead utilizing physical properties of materials to produce cell-reactive
nanotopographic materials.198 ] These techniques will be described in detail elsewhere in this
chapter.
F. Micromolding and Bonding of Biomaterials for Microfluidic Tissue
Engineering Scaffolds
The development of microfluidics for biomedical engineering applications is extensive and
permeates fields of study such as drug discovery, high throughput screening, picoliter-scale
diagnostics, and more recently, tissue engineering. RM has been interfaced with non-degradable
polymeric materials for the fabrication of microfluidic device.[ 99] Silicon etching has been used
recently in the fabrication of microfluidic bioreactors for engineering tissues of various types. [1
00]
Endothelial cells were cultured in silicon microchannels that were capped with pyrex glass
(Figure 5). Viable cell monolayers were successfully removed from the microreactor and
implanted into rat omentum. This process was also demonstrated in the culture of
hepatocytes.•'00] Silicon etching is also applicable to the fabrication of microfluidic masters for
use in replica molding. Poly(dimethyl siloxane) (PDMS) is an inexpensive elastomer that is
often used in the fabrication of microfluidic devices for a variety of applications including tissue
engineering. 1821 PDMS-based microfluidic systems have been designed to mimic microvascular
structures and flow geometries for use a vascular tissue engineering bioreactor.[82]  The
microchannels in the device were coated with synthetic extracellular matrix peptides to aid in
cell adhesion of cells and provide an angiogenic cue. The device is seeded with endothelial cells
and perfused in a continuous fluidic circuit. After several weeks in culture, the endothelial cells
tend to proliferate and form junctions as the channels become confluent. Microfluidic devices
have also been fabricated from PLGA.[ 37 ' 101' However, this material is not desirable for a tissue
engineering scaffold for reasons outlined later in the text. Nonetheless, the advantages of using
such a microfluidic system are immediately obvious. The channel geometries can be constructed
in such a way to mimic physiological geometries and length scales of blood vessels.
Consequently, the fluid mechanic microenvironment can be controlled with great precision.
Manipulating geometries on the sub-micron can lead to new abilities in guiding tissue formation
and regeneration by inducing selected cellular responses. This newfound control can be
expanded to other types of tissue engineering including the culture of hepatocytes. Complex
methods and devices have also been developed more recently using PDMS microfluidic systems.
Three-dimensional PDMS microfluidic devices have been fabricated for the perfusion culture of
a liver cell model.?83' 84] The high gas permeability of PDMS allowed for high-volume tissue
engineering constructs while maintaining sufficient oxygen concentrations.
Figure 5. Perfusion Culture of Endothelial Cells in Silicon Micromachined Networks.
Image reproduced from S Kaihara, J T Borenestein et al. Silicon Micromachining to Tissue Engineer
Branched Vascular Channels for Liver Fabrication. Tissue Eng 6: 105 (2000).
However, the appropriate processes must be tailored to establish efficient processes that utilize
biodegradable materials. RM of biomaterials has proven to be useful in a variety of biomedical
applications including drug delivery. RM coupled with appropriate lamination processes has led
to the nascent sub-field of microfluidic scaffold fabrication. This branch of tissue engineering is
designed to address the issue of facile nutrient transport and waste removal within cell-seeded
scaffolds. There have been a wide range of both synthetic and natural biomaterials, each of
which requires material-specific processes that have been pursued to meet this demand for
microfluidic, biodegradable scaffolds.
1. Microfluidic Scaffolds Using Synthetic Polymers
The primary advantage of synthetic polymers is the wide range of properties and processes that
are available for use in design and fabrication. PLGA is among the first biomaterials to be used
in biodegradable microfluidic systems. 37] Using a modified hot embossing technique, PLGA
layers are molded with micron scale features using a PDMS mold. Heating PLGA to
temperatures close to the melting point combined with appropriate amounts of mechanical
pressure resulted in the fusion of polymer at the interface. Multiple PLGA layers are then
laminated together using this precise thermal fusion bonding process to form enclosed
microfluidic channels. Solvent bonding and embossing processes have also been developed for
microfluidic scaffolds comprised of PLA, PGA, and corresponding PLGA copolymers. 10 2' 1031
RM and lamination processes have also been developed for the fabrication of cell-seeded
microfluidic scaffolds from elastomeric, thermoset biodegradable polymers. Single layer and
multi-layer constructs have been fabricated using PLGA. These systems have been shown to
support multiple cells types including both endothelial cells and hepatocytes.
2. Microfluidic Scaffolds Using Natural Biomaterials
Natural biomaterials offer many advantages over synthetic polymers as a material platform for
microfluidic scaffolds. Natural biomaterials are typically composed proteins, which can usually
support rapid cell attachment and have desirable degradation kinetics including long degradation
times and non-toxic by-products. Similar to synthetic polymers, the fabrication of microfluidic
scaffolds using natural biomaterials requires the adaptation of innovative soft-lithography
techniques for molding and lamination of protein films. Microfluidic devices have been
fabricated from gelatin, a protein composed primarily of collagen, and seeded with normal
murine mammary epithelial cells (NMuMG). The observed cell morphology of NMuMGs in
gelatin-based microfluidic device culture and static culture was similar. Although the motivation
for fabricating these devices was to create a more native microenvironment for in vitro cell
culture assays, the materials-specific processes developed for this purpose could also be used for
the development of advanced scaffolds.
Microfluidic devices fabricated from gelatin and silk fibroin have been demonstrated to support
cell culture within the lumen of the devices. The relative lack of permeability of liquids within
these biomaterials enables the precise control of liquids within these device modalities.
Sequestering fluid to the lumen alone provides sufficient nutrient supply and waste removal for
cells seeded within the microchannels of the devices. However, one of the promising
applications of microfluidic scaffolds is the use of convection-aided mass transfer for large-
volume tissue engineering scaffolds. The realization of this concept requires the fabrication of
microfluidic scaffolds using highly water-permeable biomaterials. Towards this end,
microfluidic devices have been fabricated using alginate,[91] a naturally occurring polysaccharide
that has been used extensively in tissue engineering applications.[ '04 105] One particularly useful
property of alginate-based biomaterials is the ability to reversable crosslink this material using
calcium-containing solutions to control the material properties. •'06 ] Alginate microfluidic
scaffolds were fabricated by replica molding alginate films followed by bonding by calcium ion-
induced crosslinking. The channels are sealed via chemical crosslinking by first chelating
calcium from each of the faces to remove crosslinks, laminating the hydrogel slabs together, and
then inducing chemical linkages via the addition of calcium chloride. Perfusion of the network
(Figure 6) with solutions of both low and high molecular weight compounds results in a variety
of possibilities of transient concentration profiles throughout the hydrogel network. Parameters
such as flow geometry, volumetric flow rate, solute concentration, molecular weight of solute,
and crosslinking density of hydrogel can be adjusted to control the spatial and temporal
coordinates of concentration. The utility of such a system lies in the ability to potentially perfuse
the ambient hydrogel network, which would presumably be housing seeded cells, to enhance
nutrient supply and waste removal. This application would be especially useful for highly
metabolically active cells such as hepatocytes. The development of convection aided diffusion
of biomolecules through microfluidic networks using natural biomaterials is a key development
in advancing the field of tissue engineered scaffolds that are able to exceed spatial limitations
that are defined by the diffusion limits. Rapid diffusion through networks will support the
growth of encapsulated cells throughout the network. Microfluidic networks have also been
fabricated using agarose, [1°0 7 a naturally occurring unbranched polysaccharide that is present in
the cell wall of some microorganisms. Like alginate, agarose is a natural polymer that can be
cast into permeable gels. Microfluidic networks have been fabricated using a replica molding
processes combined with physical lamination techniques. This mild, aqueous processing is an
enabling feature that facilitates encapsulation of cells with adequate viability. Agarose
microfluidic networks were fabricated with encapsulated murine hepatocytes (AML-12) and
perfused with medium. The viability of cells in perfused networks was 58% while viabilities of
static networks remained below 20% at 3 d post seeding. The work outlined in this section, as
well as other work not mentioned here, demonstrates the potential benefit of utilizing perfused
microfluidic scaffolds as a tool for the next generation of tissue engineering scaffolds that are
aimed at overcoming long-standing limitations.
E
0.1
Figure 6. Characterization of Mass Transfer in a Microfluidic Biomaterial Fabricated from Alginate
Microfluidic Devices.
A) Fluorescence micrographs of a microfluidic biomaterial (mFBM) during assisted delivery (i-iii) and
assisted extraction (iv-vi) of RITC-dextran. Assisted delivery refers to the operational mode of the device in
which the solute is perfused through the microchannels and dissolves throughout the network. Assisted
extraction refers to the operational mode where solute loaded within the alignate network is removed by
perfusion of the microchannel network with an aqueous solution. These modes correspond to the cases of
nutrient supply and waste removal respectively. The rate of diffusion is primarily a function of the molecular
weight of the solute, the crosslinking density of the network, the concentration of the solute in the perfused
solution, and the flow rate of the perfused medium. B,C) Temporal evolution of the normalized total intensity
from fluorescence images, such as those in (A), during delivery and extraction of solutes (fluorescein, MW =
376 Da; RITC-dextran, MW = 70 kDa). Diamonds represent intensities during assisted delivery and assisted
extraction. Crosses represent intensities during unassisted extraction from the same initial condition (i.e.,
achieved by delivery via the channels) as the assisted extraction experiment. The starting time of the
unassisted evacuation has been shifted to match that of the assisted extraction. The dimensions of the
construct as as follows; the height of the gel H = 0.29 cm, the lateral dimension of the gel L = 1 cm, the height
of the microchannels h = 200 mm, the width of the channels is w = 100 mm. The linear flow velocities of the
fluid on the exterior of the construct is ur = 1 cm/s while the velocity of the fluid within the microchannels is
uc = 0.6 cm/s. The solute concentrations are cO = 20 mmol/L for fluorescein and 10 mmol/L for RITC-
dextran. Used with kind permission from M. Caboodi, N. W. Choi, et al. A Microfluidic Biomaterial. J
Amer Chem Soc 127: 13788 (2005). Copyright Elsevier Ltd. All rights reserved. Reproduced with
permission.
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3. The Future of Microfluidic Systems in Tissue Engineering
The explosion of the use of microfluidics as engineering systems has largely focused on
miniaturization of molecular analysis and genomics, portable devices for field-deployable
biosensors, and interfacing fluid handling with microelectromechanical systems (MEMS) for
improved automation [108]. However, the field of tissue engineering can also benefit significantly
from advances in microfluidics technology, given that the appropriate biomaterials and
biocompatible processes are interfaced with traditional microfabrication methods. The
challenges that face the applications of microfluidics for advanced scaffold fabrication parallel
those challenges faced by the microelectronic industry in the middle of the 20th century. There
are traditional issues that face any field of study based on microfabrication including increasing
device yield and packaging, the term for seamlessly interfacing macroscopic instrumentation
with devices that operate at micron length scales. Another essential cornerstone of developing
the next generation of microfluidic scaffolds is the design, synthesis, and validation of novel
materials and processing capabilities. The implementation of PDMS as a material for fabrication
microfluidic devices[391 intended for analytical and diagnostic applications was essential because
PDMS satisfied the material selection criteria set forth by the collective needs of the end user.
The intermediate stage of the implementation of microfluidics for tissue engineering applications
is the design and fabrication of complex microarchitecture for cell culture using traditional
engineering materials, such as the aforementioned PDMS. For example, much work has been
performed in creating designer microenvironments for hepatocytes within microfluidic
devices.1'6', 09 These systems, though ultimately limited by their inorganic, non-biodegradable
material, are useful for the study of optimal conditions including microenvironmental effects
such as shear stress, mass transport, and co-culture. Lee et al. have moved beyond traditional
microfluidic geometries to fabricate a device that mimics the in vivo geometry and mass
transport characteristics of a liver sinusoid.1El ]0 Although these and other systems are not directly
applicable to tissue engineering and organ regeneration applications, the technological
developments surrounding the design, fabrication, cell culture techniques of these devices
continue to lay the groundwork for future directly applicable tissue engineered systems.
However, utilizing microfluidics for tissue engineering applications requires a more stringent set
of material requirements. Materials used for microfluidic tissue engineering applications would
ideally be resorbable, promote cell attachment, allow surface modification, and be amenable to
facile processing. These unmet needs will continue to drive active research in synthetic
biomaterial synthesis and development as well as natural biomaterial purification and
characterization. In addition to material development, advances in materials processes must also
be pursued to allow for efficient microfabrication strategies of novel materials. For example,
advanced three-dimensional microfluidic systems using PDMSE'111 must be expanded to facilitate
similar strategies using biodegradable materials. In general, developing parallel strategies for
novel, cell compatible biomaterial synthesis and processing will result in advanced microfluidic
scaffolds to further scaffold development and ultimately tissue engineering.
V. Biomaterial Selection for Microfabrication Applications
Selecting appropriate biomaterials for tissue engineering is of paramount importance for tissue
engineering applications. There exists a wide range of optimal chemical, physical, and
mechanical properties, which varies greatly upon the specific intended application. The
performance of biomaterials for tissue engineering is greatly dependent upon the composition of
the material as well as material processing. The performance of a biomaterial for tissue
engineering applications is based on measurable parameters such as cytotoxicity, cell attachment,
mechanical compliance, degradation kinetics. An ideal polymer would exhibit low toxicity and
promote rapid attachment and spreading in a wide range of cell phenotypes. The mechanical
properties of such a material would be stiff to ensure proper cell matrix tensegrity, [112, 113] yet
compliant enough to limit irritation and recruitment of macrophages upon implantation. In
addition to these goals for tissue engineering biomaterials in general, biomaterials must exhibit
additional properties that make them amenable for use in microfabrication processes. For
example, polymers that are soluble in common solvents can be spin cast into thin films. Also,
materials for use in replica molding processes should ideally be suitable for rapid successive
steps of casting and delamination using microfabricated masters.
A. Synthetic Polymeric Elastomers
Synthetic biomaterials have played an important role in the advancement of tissue engineering as
they have been used in the fabrication of complex scaffolds for a wide range of tissues.[4]
Poly(L-lactic acid) (PLA), poly(glycolic acid) (PGA), and their co-polymer poly(L-lactic-co-
glycolic acid) (PLGA) has been used extensively for tissue applications because of the
convenience associated with FDA approval for various surgical applications and tunable
degradation rate. Although these materials are generally regarded as being biocompatibility in
vitro, the physicochemical nature of the surface is non-native. Furthermore, there is a lack of
chemical functionality in these materials, which limits the possibility for covalent surface
modification with native biomolecules to control cell functions such as adhesion and spreading.
These materials have an undesirable degradation profile in which the polymer implant; 1)
becomes swollen with water, 2) undergoes significant geometry deformation; 3) degrades in a
non-linear manner. Furthermore, the high modulus of these materials often leads to mechanical
irritation at the implant site, which exacerbates the immune response. Upon degradation, these
materials produce acidic byproducts which can also negatively influence the in vivo
microenvironment immediately surrounding the implant.
B. Extracellular Matrix Proteins
There exist a wide range of proteins that serve as suitable biomaterials for tissue engineering
applications including ECM proteins such as collagen I, gelatin, elastin and structural
carbohydrates such as hyaluronic acid and chitosan.[114] Another natural biomaterial used for the
fabrication of tissue engineering scaffolds is silk fibroin, a 391 kD protein that is produced by the
silkworm Bombyx mori. Silk fibroin is a biodegradable material["15 that has shown potential for
use as a biomaterial for many biomedical applications [116] including use as a scaffold
biomaterial. 1 7,' 118] Natural proteins such as silk fibroin offer many advantages including a wide
range of mechanical properties including moduli that can span several orders of magnitude.
ECM proteins also provide appropriate substrate chemistry and topography for rapid cell
attachment and proliferation. However, there are a number of significant disadvantages that
limit the use of natural proteins. Isolating large amounts of native protein is a costly batch
process that may not be able to meet demand if the material is used in widespread medical
procedures. Perhaps the most critical limitation with respect to medical applications is the
known immunogenic response that is attributed to these materials. For example, there has been a
significant, documented human immune response to implanted bovine collagen matrices.["119
Therefore, this limits the potential application for xenografts, yet allows for the potential use of
allografts. However, the intricate processes to isolate and implant an allograft implant are
arduous, expensive, and time consuming and not readily scalable to industrial scale. The limited
quantity of material may also limit application to porous devices such as scaffolds, while
eliminating potential use as a bulk material for biomedical device applications.
VI. Motivation and Summary of Results
Microfluidic scaffolds present a viable opportunity to overcome many issues with current tissue
engineering scaffolds including the problem of active transport of nutrients and removal of waste
products. Therefore, it is important to develop appropriate material specific processes in order to
enable the potential for microfluidic scaffold fabrication. In this section of the work, two
examples of material-specific designs will be described that result in the production of
biodegradable microfluidic scaffolds. Chapter 2 describes the fabrication of hepatocyte-seeded
three-dimensional microfluidic networks fabricated using poly(glycerol-co-sebacate) a
biodegradable elastomeric polyester. The significant advantages of this microfluidic scaffold
material closely mirror the advantages of synthetic biodegradable polyesters for use in tissue
engineering in general. Namely, large batches can be synthesized rapidly and facile processing
produces tunable properties, which can lead to enhanced control over the final material
properties. However, this material degrades extremely rapidly with a reported half life on the
order of 3 wks, which would be incompatible with the notion of implantable microfluidic
scaffolds This rapid degradation rate drove the design and synthesis of material-specific
processing of native silk fibroin for use in microfluidic scaffolds, which is the subject of Chapter
3. This section describes the fabrication of single-layer hepatocyte-seeded silk fibroin
microfluidic scaffolds. Again, the disadvantages with silk fibroin for use in microfluidic devices
are a microcosm of the disadvantages with natural proteins in general. These disadvantages,
with respect to microfluidic processing, include inefficient raw material production and difficulty
in material processing. Ultimately, these result in poor device yield and limited device
functionality, which will be described more in depth in subsequent sections. The disadvantages
of these two materials drove the need to develop a hybrid material with properties that bridge
synthetic and natural classes of materials. This lead to the development of poly(ester amide)
elastomers, which is the subject of Chapter 4. This class of materials exhibits a variety of
favorable properties including in vitro and in vivo biocompatibility. Poly(ester amide)
elastomers also exhibit tunable properties by varying stoichiometric feed ratios and processing
conditions, which will be described in Chapter 5.
Chapter 2: Three-Dimensional Microfluidic Tissue
Engineering Scaffolds Using a Flexible Biodegradable
Polymer
The content of this chapter has been published in whole or in part in the following journal article:
C J Bettinger, E Weinberg, K Kulig, J Vacanti, Y Wang, J T Borenstein, R Langer. Three-
dimensional microfluidic tissue engineering scaffolds using a flexible biodegradable polymer.
Advanced Materials 2006, 18, 165-69.
I. Introduction
A. Microfluidic Scaffolds
Organ loss and failure is one of the most critical issues facing the healthcare industry in
developed nations. The shortage of available organ donors has driven the growth and expansion
of the field of tissue engineering as a means of developing replacement tissues and organs [4, 120]
including the liver.[121] Microfabrication and BioMEMS technology is an attractive tool for
developing tissue engineering systems because of the improved spatial resolutions over
traditional scaffold fabrication techniques such as casting/porogen leaching, 122 ] gas foaming, 123 ]
and three-dimensional printing. [124] Polymer scaffolds replica molded on micromachined silicon
substrates can achieve feature resolutions of less than 10 microns,[8 21 the same length scale of
mammalian cells. Microfluidic bioreactors have been fabricated and seeded both with a variety
of cell types including endothelial cells [821 and hepatocytes. [83' 84, 125] However, one limiting
factor in previous studies of microfluidic scaffolds has been the choice of material.
Microfabricated silicon and replica molded poly(dimethyl siloxane) (PDMS), although
ubiquitous and inexpensive, are not biodegradable, have limited biocompatibility, and therefore
are not suitable biomaterials for a tissue engineering scaffold. Microfluidic scaffolds fabricated
from poly(L-lactic-glycolic acid), [37] while biodegradable, exhibits sub-optimal properties for an
implant material such as rigid mechanical properties, 1 261 bulk degradation kinetics,[8 6' and
limited biocompatibility in some cases. [1271 High concentrations of PLGA by-products has also
been shown to be cytotoxic,[128] which is a major limitation in the prospect of fabricating large,
organ-size scaffolds.
B. Poly(glycerol-co-sebacate)
Poly(glycerol-co-sebacate) (PGS), a recently synthesized biocompatible and biodegradable
elastomer with superior mechanical properties, serves as a promising alternative material for
fabricating microfluidic vascular scaffolds [86] as well as other microscale tissue engineering
systems. PGS is a tough, biodegradable, elastomer that is biocompatible, inexpensive, and easy
to synthesize from glycerol and sebacic acid. Glycerol and polymers containing sebacic acid
have already been approved for use in medical applications. Biocompatibility studies [86' 127]
suggest improved cellular response and morphology of PGS when compared to PLGA. PGS is
also a suitable material for microfluidic scaffolds from a processing perspective. PGS pre-
polymer can be replica molded and cured on silicon masters to form layers as thin as 100
microns in a process that is analogous to replica molding of PDMS.[3 91
C. Summary of Results
Controlling the cellular microenvironment within scaffolds is critical for eliciting desirable
biological responses such as proliferation, migration, and maturation. Maintaining suitable
oxygen concentrations is of paramount importance in the culture of highly metabolic cells such
as hepatocytes in microfluidic devices. [1291  Therefore, elucidating the relevant transport
properties of oxygen and carbon dioxide in PGS is essential in the determination of gas
concentrations in the cell microenvironment. The mechanical microenvironment has also been
shown to be critical in cellular function[ 13 0] in various cell types including endothelial cells.1131'
132] Fluid shear stresses imposed on cells within microfluidic devices can lead to detachment and
death. Therefore, it is important to consider the effect of shear stress that cells might experience
within the microfluidic scaffold. In this work, we have developed microfabrication and replica
molding techniques specific to PGS. Single-layer microfluidic networks designed to promote
hepatocyte adhesion and proliferation were stacked and bonded to create three-dimensional
scaffold networks with high spatial densities of microchannels. Chemical and mechanical
aspects of the cellular microenvironment were predicted using known device and material
properties, and suitable operating conditions were implemented using this information. These
networks were seeded with hepatocytes and grown to form confluent layers in perfusion culture
using adequate microenvironment parameters.
II. Materials and Methods
A. PGS Membrane Synthesis
PGS pre-polymerl861 was cured into flat sheets of approximately 1 mm in thickness for 15 h at
150 oC at 50 mTorr. The membrane was placed in an aluminum machined diffusion chamber
and evacuated for at least 120 h by applying vacuum to both sides across the membrane. After
the evacuation procedure, the sample gas was supplied at a pressure of 1 atm to the topside of the
membrane as the pressure was continuously measured and recorded on the bottom side using a
digital pressure transducer (MKS Instruments, Wilmington, MA) and LabVIEW software. Each
experiment produced. a time evolution of pressure, which was used to calculate the solubility,
diffusivity, and permeability.[133]
B. Computational Fluid Dynamics
Flow modeling was performed using the FEMLAB 3.0a finite-element simulation software
(COMSOL Inc, Los Angeles, CA). A two-dimensional model for incompressible flow was used
to determine the flow rates throughout the reactor using device symmetry arguments.
Appropriate boundary conditions were imposed consisting of a volumetric flow rate at the inlet,
a neutral condition at the outlet, and a combination of slip and no-slip boundary conditions
throughout the interior boundaries of the model geometry.
C. Device Design and Fabrication
Microfluidic networks were simulated using a finite element simulation. The finalized mask
layouts were converted to DXF files using AutoCAD 2000 and printed onto 1/20-mil
transparencies (International Phototool, Colorado Springs, CO). Standard photolithographic and
plasma etching techniques were utilized to produce "negative mold" silicon masters for use in
replica molding just as PDMS is used to fabricate microfluidic devices quickly and easily.[39]
Briefly, patterns printed on high-resolution transparency films were transferred to chrome-on-
glass masks to be used in the photolithography step. 100 mm diameter wafers were patterned
with photoresist using one photolithography cycle. Features were etched using an STS etcher
(Surface Technology Systems, Newport, South Wales, UK) using etch-passivation cycles to
yield a constant feature height of 50 ± 2 microns across the wafer. The remaining photoresist
was stripped in a series of acetone, isopropanol, and methanol rinses. Prior to replica molding of
PGS, a sacrificial sucrose release layer was spin-coated on the silicon master. Micromachined
silicon masters were cleaned using piranha solution (Mallinckrodt, St. Louis, MO) and plasma
cleaned (March, St. Petersburg, FL) at 250 mTorr and 200W for 180 sec. A 90% (w/w) solution
of sucrose (Sigma, St. Louis, MO) in water was spin-coated at 3000 RPM for 30 sec. The
sucrose layer was pre-baked on hot plate at 95 TC for 120 sec and post-baked in an oven at 120
oC for 24 h. 1.7 ± 0.05 g of PGS pre-polymer was melted at 160 oC and applied to the wafers for
replica molding and smooth sheet formation. The thickness of the final PGS film can be
adjusted simply by varying the mass of pre-polymer used. The pre-polymer was cured at
temperatures ranging from 135 oC to 140 oC for 18 h under 50 mTorr of vacuum, which
produced a crosslinked sheet in which a portion of the hydroxyl and carboxylic acid functional
groups remain. The PGS sheets were delaminated by statically incubating the polymer-master
system into ddH20 at 24 OC for 24 h beginning immediately after polymer curing. Diffusion of
water between the polymer-silicon interface led to sucrose dissolution and eventual delamination.
The sheets were trimmed and punched to achieve appropriate fluidic connections between layers.
The microfluidic layers were stacked, aligned at 24 OC and bonded together simultaneously by
curing the polymer at 120 oC for 15 h under 50 mTorr of vacuum. Once the final curing step was
completed, silicone tubing (1/16" ID, 1/8" OD, Cole-Parmer) was inserted into the devices in a
sterile environment. Luer-Lok connections were inserted into the tubing and the base of the
connections was sealed with epoxy (McMaster-Carr). In some cases, additional PDMS
structures were added to the inlet and outlet to prevent dissociation of the tubing from the device.
Samples used from SEM were sputter-coated with Gold/Palladium using a Cressington 108 Auto
sputter coater (Cressington Scientific Instruments Inc, Cranberry Twp, PA). Scanning electron
micrographs were taken using a Hitachi S-3500N at 5kV. Fluorescent micrographs were
obtained by flowing 100 gg/mL rhodamine and 100 jtg/mL DAPI solutions in PBS (Sigma).
D. Cell Culture
All cell culture products were obtained from Invitrogen Inc, Carlsbad, CA unless otherwise
noted. Hepatocyte carcinoma cells (HepG2, ATCC, Manassas, VA) were cultured with Eagle's
Modified Essential Medium supplemented with 10% fetal bovine serum, 25 mM HEPES, 100
gig/mL streptomycin, 100 U/mL penicilin, at 370C and 5% CO 2 . Cells were harvested using
trypsin 0.025%/EDTA 0.01% and quenched with an equal volume of medium to re-suspend the
cells. PGS devices were prepared for seeding by incubating with medium for 24 h and with
0.1% collagen solution (Sigma) for 2 h at 37 oC immediately prior to cell seeding. The devices
were statically seeded for 2 h to allow for cell attachment using cellular concentrations of
approximately 5 x 108 cells/mL. After this period, the devices were set up in a linear perfusion
circuit consisting of a syringe pump (New Era Pump System NE-1600, Farmingdale, NY), media
reservoir, microfluidic scaffold, and media waste container. Fresh medium was perfused in a
non-pulsatile manner with a volumetric flow rate of 280 jpL/hr to feed a two-layer device.
Albumin samples were taken every 24 h by sampling the waste container and aspirating the
remaining medium to ensure the accuracy of future sampling. Upon stoppage of perfusion, cells
were fixed by injecting the device with 3.7% (v/v) paraformaldehyde in PBS (Sigma) manually
with a syringe under high hydrostatic pressures. This simultaneously fixed the cells and induced
swelling and delamination of the PGS sheets. The sheets were sectioned and serially immersed
in solutions of 25%, 50%, 75%, and 90% (v/v) ethanol in PBS for 5 min each. The samples were
then immersed in 100% ethanol followed by HMDS (Sigma) each for 15 min. The samples were
then allowed to air dry for 24 h prior to imaging. Optical imaging was performed using a Carl
Zeiss inverted microscope with AxioCam software. Albumin production was determined by a
human ELISA quantification kit (Bethyl Laboraratories, Montgomery, TX) with absorption
measurements made at 450 nm wavelength using a SpectraMax Plus 384 platereader (Moleculare
Devices, Sunnyvale, CA) equipped with SOFTmax Pro 4.0 software.
Ill. Results
A. Fabrication of Microfluidic Scaffolds
Figure 7 illustrates the process flow for microfabrication of multi-layered PGS devices. SEM
images supported by rhodamine flow experiments verified the patency of the device (Figure 8).
It is hypothesized that the ability for PGS layers to bond via covalent cross-linking has resulted
in high strength interfaces between PGS layers, which is virtually indistinguishable in the SEM
cross-section of a typical microchannel (Figure 8d). Devices containing up to five microfluidic
layers were stacked and bonded, however cell culture experiments were performed in devices
with two layers. The microchannels have a trapezoidal cross-sectional geometry instead of the
expected rectangular shape. The presence of molding artifacts can be attributed to a sucrose
accumulation artifact after baking the sacrificial sucrose layer. Knowledge of the relevant
transport coefficients of oxygen and carbon dioxide in PGS is critical when designing complex,
multi-level tissue engineering systems (Table 3). Using this knowledge, it is possible to
determine the critical length scale for mass transport within PGS for designing solid supports
with substantial volumes for tissue engineering applications. To study the length-scale of
diffusion limits of solid PGS, a simple mass transfer problem[1341 involving the supply of oxygen
via diffusion across a layer of PGS to a monolayer of mammalian cells [129] was studied. This
calculation suggests that PGS membranes have a maximum allowable thickness of
approximately 232 microns to avoid hypoxic oxygen concentrations (< 1%).[1351 To promote
proliferation and other highly metabolic cellular activities, it is desirable to maintain an
adequately oxygenated microenvironment. Therefore, it is a valid to assume that the diffusion
component of oxygen supply is negligible and
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Figure 7. Overview of Fabrication Strategy for PGS Microfluidic Devices.
a) Replica molding of PGS layers. Silicon substrates were micromachined and spin-coated with sucrose to
serve as a sacrificial release layer (not shown). PGS pre-polymer is cured into micropatterned sheets and
delaminated in water. b) Multiple layers are bonded by physically adhering individual sheets and curing the
films together. It is hypothesized that the additional curing step forms ester linkages from active hydroxyl
and acid groups between layers.
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aFigure 8. Characterization of PGS Microfluidic Devices.
a) Mask-layout for vascular (1) and hepatocyte (2) networks were designed and fabricated using AutoCAD
2000. Inlet ports are omitted to show detail. Insets show detailed schematics of the representative
microstructures used in each each two-dimensional layout. b) SEM of micromachined silicon "negative"
masters designed for polymer replica molding of microfluidic hepatocyte networks. c) Replica molded PGS
layer of silicon master in b. The rounded features are a result of an accumulation effect of sucrose. d) SEM
cross-sections of three-layer PGS device. e, f) Composite fluorescent micrographs of devices after flowing
rhodamine and DAPI solutions to demonstrate the patency of multi-layer hepatocyte devices. Scale bars
represent 5 mm in (a) and 200 microns in (b-f).
consequently, the oxygen for the cells within the device will be supplied via the media. To this
end, ensuring a well-oxygenated environment requires frequent reactor volume exchange, hyper-
oxygenated media, or both to achieve sufficient concentrations within the media to supply the
entire cell population within the device.
Table 3. Transport Coefficients for Common Gases in Poly(glycerol-co-sebacate) Membranes.
Transport Parameter Oxygen (n = 7) Carbon Dioxide (n = 3)
Permeabilitya (P) 8.31 + 1.05 18.1 + 4.58
Diffusivityb (D) 3.42 + 1.17 2.15 + 0.49
Solubilityc (S) 1.84 + 0.79 6.41 + 0.26
aBarrers (10"-1 cm3 gas (STP) cm-2s-'cmHg -')
b 10.8 cm2/sec
C cm3 gas (STP) cm "3 polymer atm-'
B. Hepatocyte Seeding in Microfluidic PGS Scaffolds
Two device layouts, termed vascular and hepatocyte constructs respectively , were designed and
fabricated. The vascular construct has the unique property of exhibiting constant maximum
shear stress within each channel of the device, making it a promising construct for an artificial
vasculature tissue engineering scaffold. [136] The general layout of the hepatocyte design was
designed to allow for high perfusion rates while also maximizing cell attachment. Therefore, a
network of staggered posts was used to protect the cells from shear forces associated with high
perfusion rates. The posts were flanked on either side by direct microchannels to reduce
pressures within the device during operation at high volumetric flow rates. Finite-element fluid
dynamic simulations predicted extremely high flow rates along the microchannels that flank the
network of posts. Two-layer microfluidic PGS devices featuring the hepatocyte construct were
statically seeded with hepatocyte carcinoma cells (HepG2, Figure 9) which were used as a model
for human hepatocytes. [1371, 38 1 Due to the extremely high cell densities used in the initial seeding,
cellular attachment occurred in virtually all microchannels throughout the device within hours.
The high cell seeding density resulted in the formation of HepG2 aggregates, which increased
the opportunity for adhesion of cells to the microstructures. Long-term cell viability was
inferred by cellular attachment within the microchannels. 1' 39]  Albumin production was also
measured every 24 h to assess the liver-specific cell function of the seeded cells.[140] The
albumin production rate was measured to be 24.3 ± 5.5 p~g/device-d, which was comparable with
previous reports. [83' 84] A maximum albumin production rate of 30.5 ± 0.2 CPg/device-d occurred
during the first 24 h, which can be attributed to the albumin production of cells located in the
waste container that did not attach during the seeding. Reactors were perfused for a period of up
to one week to demonstrate long-term viability within the devices.
Figure 9. Seeding and Long-term Culture of Hepatocytes in Microfluidic Scaffolds.
a) Bright-field optical micrograph of three-dimensional PGS device prior to cell seeding. Immediately after
seeding, partially confluent layers of cells are demonstrated at the inlet (b) and in the post network (c). d)
After 24 h, cell layers become confluent throughout the device). Devices were perfused for more than one
week and albumin production was measured to assess liver specific cell function. Upon stoppage of perfusion,
cells were fixed and devices were sectioned and imaged optically (e) and using SEM (f). Scale bars represent
200 microns in (a-d), and 50 and 100 microns in (e) and (f), respectively.
IV. Discussion
The fabrication process described in this work is fast, efficient, and scalable. One key advantage
to this technique is the ability for the polymer to be cured and bonded without the use of
additional cytotoxic solvents or adhesives. The ability to segregate flow in multi-layered devices
makes these scaffolds suitable for incorporating multiple cell types within the three-dimensional
scaffold (Figure 9f). We feel this aspect of device functionality is a critical development in the
design and fabrication of tissue engineering scaffolds for highly vascularized tissue. These
biodegradable microfluidic systems can also be integrated with existing biomaterial systems and
technologies for tissue-specific applications and increased functionality. For example, drug
delivery systems,[71 cell patterning techniques, [65' 141] contact guidance cues[27], and co-culture
systems for hepatocytes [142] can be integrated within the microchannels to promote the
organization of primitive seeded cells into complex tissues. Fully biodegradable systems
suitable for implantation can be fabricated by integrating flexible, small caliber PGS tubes and
affixing those using PGS pre-polymer as an adhesive (data not shown). The end result is an
adaptable tissue engineering device that can be easy integrated and perfused with the patient's
existing vasculature.
Chapter 3: Silk Fibroin Microfluidic Devices
The content of this chapter has been published in whole or in part in the following journal article:
C J Bettinger, K M Cyr, A Matsumoto, R Langer, J T Borenstein and D L Kaplan. Silk Fibroin
Microfluidic Devices. Advanced Materials 2007, 19, 2847-2850
I. Introduction
A. Polymeric Materials for BioMEMS
Precisely controlling spatio-temporal environmental parameters has become increasingly
important in the field of biotechnology. For this reason, biomedical research has increasingly
moved toward the design and implementation of microfabricated systems to efficiently improve
technologies such as drug delivery, [~ 43 ] diagnostics,[ ' 44] and tissue engineering.[145] Technologies
featuring micron length-scales tailored specifically for biomedical applications, termed Bio-
microelectrical mechanical systems (BioMEMS), are able to interact with biological systems
such as cells[88] or even single biomolecules. [146] Strategies for developing BioMEMS typically
involve adapting traditional microfabrication materials and processes resulting in systems
fabricated using non-degradable materials including silicon [100 ] and poly-dimethyl-siloxane
(PDMS).[82] Using biodegradable polymers allows for implantable BioMEMS to satisfy the
growing demand for in vivo applications such systems for drug delivery systems[85] or tissue
engineering. To address these potential applications, BioMEMS devices have been fabricated
using biopolymers, both natural and synthetic, including gelatin, 9°0] alginate,[E9 ] poly(L-lactic
acid) (PLA),[ss] poly(L-lactic-co-glycolic) acid (PLGA), [371 and poly(glycerol-co-sebacate)
(PGS).J147]
B. Silk Fibroin
An ideal biomaterial for BioMEMS fabrication from a material properties standpoint is one that;
1) can be processed using mild conditions to facilitate protein or growth factor incorporation; 2)
naturally promotes adhesion and normal function of seeded cells; 3) contains moieties for
potential chemical modification of the surface; 4) exhibits slow and predictable degradation rates
to maximize duration of functional implanted devices; 5) has robust, yet flexible mechanical
properties; 6) is relatively inexpensive. One class of natural biomaterials that could potentially
meet these material requirements is silk fibroin.[18' 115-117, 148-1501 Silk fibroin protein from the
Bombyx mori silkworm is FDA approved and has been used in medicine for a wide variety of
applications including surgical, drug delivery,[14 9] and tissue engineering.['51  Silk fibroin
exhibits in vitro and in vivo biocompatibility, [11 6, 151 robust mechanical properties including high
mechanical modulus and toughness, 152] and relatively slow, protease-mediated, proteolytic
biodegradation. [153]
C. Summary of Results
In this report, we describe techniques and materials processing strategies utilized in the
fabrication of cell-seeded silk fibroin microfluidic devices. We have developed material-specific
processes for silk fibroin micromolding and device assembly that is analogous to soft-
lithographic techniques. By implementing aqueous casting of regenerated aqueous silk fibroin
solutions to produce microfabricated silk films, we avoid the use of toxic solvents and harsh
processing conditions. Microfluidic devices were produced by laminating water-stable
micromolded silk fibroin membranes, which were modified with macroscopic fluidic
connections. Biocompatibility and functionality of patent devices with cells was studied by
seeding and perfusion of a model human hepatocarcinoma cell line for up to five days.
Hepatocytes cultured in silk fibroin-based microfluidic devices exhibited similar morphology
and cell function to those grown on other widely used biomaterials.
II. Materials and Methods
A. Preparation of Micromolded Silk Fibroin Films
Microfluidic networks with a constant shear design were chosen for device fabrication. [136] The
finalized mask layouts were converted to DXF files using AutoCAD 2000 and printed onto 1/20-
mil transparencies (International Phototool, Colorado Springs, CO). Standard photolithographic
and soft-lithography techniques were used in a mold-transfer process. Briefly, 100 mm diameter
silicon wafers were patterned with SU-8 2000 photoresist (Microchem, Newton, MA) according
to manufacturer's recommendations to produce a "positive mold". PDMS (Sylgard Elastomer
Kit, Essex Group, Edison, NJ) was cast on patterned SU-8 masters using a 10:1 (w/w) ratio of
polymer to curing agent and cured for at least 3 h at 65 oC. Masters were passivated with a
fluorocarbon treatment, and PDMS "negative molds" were delaminated and used for subsequent
replica molding of silk fibroin films. Aqueous silk fibroin solutions derived from B. mori
cocoons were prepared using a slight modification to previously published procedures.[14 8J
Briefly, cocoons were boiled for 30 min in an aqueous solution of 0.2 M Na2CO3 to extract
sericin proteins. The purified silk fibroin was dissolved in aqueous 9.3 M LiBr at 60 oC for 3 h
to produce a 20% (w/w) solution. The concentrated silk fibroin solution was dialyzed against
water in a Slide-a-lyzer cassette with a 3,500 MWCO (Pierce Biotechnology, Rockford, IL) for
48 h. Final aqueous silk fibroin solutions were estimated to be 8% (w/w). Silk solutions were
cast on both microfabricated PDMS negative molds and flat PDMS substrates through water
evaporation at room temperature and ambient humidity for 72 h. Silk fibroin films were
delaminated and treated with a methanol-water solution (50% v/v) for 4 h to produce water-
stable films, which were then washed in ddH20 for 24 h. Samples for attenuated total
reflectance FT-IR (ATR FT-IR) were prepared by first drying the film and mounting it on a
crystal for film analysis. Spectra were recorded using a Nicolet Magna 550 Series II IR
Spectrometer equipped with OMNIC Software using 32 scans across the wavenumbers 4000-400
cm "1 at a resolution of 2 cm "1. Surface roughness measurements were performed with a Wyko
optical profiler (Veeco, Fremont, CA).
B. Mechanical Characterization of Silk Fibroin Films
PGS films for use in mechanical testing were prepared in a previously published procedure. [1 47]
Briefly, a high molecular pre-polymer was thermally crosslinked onto sucrose-coated silicon
wafers at 150 oC for 15 h at a pressure of less than 50 mTorr. Sol-free PGS films were cut into
dog bone geometries with dimensions of 1 mm x 6.5 mm x 25 mm (T x W x L). Silk fibroin
films dedicated for mechanical testing were cut into dog-bone geometries with dimensions of
0.15 mm x 6.5 mm x 25 mm (T x W x L). Tensile testing was performed using an Instron 5542
using a 50 N load cell equipped with Merlin software. Samples were extended at a constant rate
of 50 mm/min and were elongated until failure. Young's modulus, toughness modulus, ultimate
tensile strength and elongation at break were calculated from tensile stress versus engineering
strain curves.
C. Silk Fibroin Device Fabrication
The strategy employed for microfluidic device fabrication was similar to that implemented in
PDMS microfluidics.[ 391 Briefly, silk fibroin sheets were trimmed and punched to achieve
appropriate macroscopic fluidic connections between layers (Figure 10). Devices were
fabricated by laminating micromolded and flat silk fibroin layers. Microfluidic layers were
stacked, aligned, and bonded together at 70 oC for 18 h under mechanical pressure using
additional 8% aqueous silk fibroin solution at the interface. Silicone tubing (1/16" ID, 1/8" OD,
Cole-Parmer, Vernon Hills, IL) was inserted into the devices in a sterile environment. Luer-Lok
connections were inserted into the tubing and the base of the connections was sealed with epoxy
(McMaster-Carr, New Brunswick, NJ). In some cases, additional PDMS structures were added
to the inlet and outlet to prevent dissociation of the tubing from the device. Samples used from
SEM were sputter-coated with Gold/Palladium using a Cressington 108 Auto sputter coater
(Cressington Scientific Instruments Inc, Cranberry Twp, PA). Scanning electron micrographs
were taken using a Hitachi S-3500N at 5kV. Fluorescent micrographs to demonstrate patency
were obtained by flowing 100 ýpg/mL rhodamine in PBS solutions (Sigma, St. Louis, MO)
through single layer devices.
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Figure 10. Fabrication Strategy for Silk Fibroin Microfluidic Devices.
a) The process flow is diagrammed in both an isometric view and a cross-sectional view through the mid-
plane (i) through the successive steps of the process. PDMS negative molds (i) are fabricated using traditional
soft lithography techniques (not shown). PDMS molds are modified with silicone tubing (ii) prior to solvent
casting of aqueous silk fibroin solution (iii). Upon water evaporation, micromolded films are delaminated
with integrated macroscopic fluidic connections (iv). Both micromolded and flat silk films are treated with
aqueous methanol solutions (see text). b) Final assembly of silk microfluidic devices was performed by
bonding appropriate water-stable silk fibroin layers using additional regenerated aqueous silk fibroin
solution. Layers are bound between rigid plates under mechanical pressure at 70 OC for 18 h to produce a
water-insoluble silk fibroin interface with increased beta-sheet content.
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D. Cell Culture
All cell culture products were obtained from Invitrogen Inc, Carlsbad, CA unless otherwise
noted. Hepatocyte carcinoma cells (HepG2, ATCC, Manassas, VA) were cultured with Eagle's
Modified Essential Medium supplemented with 10% fetal bovine serum, 25 mM HEPES, 100
jtg/mL streptomycin, 100 U/mL penicillin, at 37 oC and 5% CO 2. Cells were harvested using
Trypsin 0.025%/EDTA 0.01% and quenched with an equal volume of medium to re-suspend the
cells. Silk fibroin devices were prepared for seeding by incubating with medium for 4 h at 37 oC
immediately prior to cell seeding. The devices were statically seeded for 4 h to allow for cell
attachment using cellular concentrations of approximately 5 x 108 cells/mL. After this period,
the devices were set up in a linear perfusion circuit consisting of a syringe pump (New Era Pump
System NE-1600, Farmingdale, NY), media reservoir, microfluidic scaffold, and media waste
container. Fresh medium was perfused through single layer devices in a non-pulsatile manner
with a volumetric flow rate of 150 tL/hr. Albumin samples were taken every 24 h by sampling
the waste container and aspirating the remaining medium to ensure the accuracy of future
sampling. Cells were fixed by injecting the device with Accustain fixative (Sigma) manually
with a syringe under high hydrostatic pressures.. The sheets were sectioned and serially
immersed in solutions of 25%, 50%, 75%, and 90% (v/v) ethanol in PBS for 5 min each. The
samples were then immersed in 100% ethanol followed by HMDS (Sigma) each for 15 min. The
samples were then allowed to air dry for 24 h prior to further SEM preparation as previously
described. Optical imaging was performed using a Carl Zeiss inverted microscope with
AxioCam software. Polymer substrates for HepG2 albumin production were produced as
follows. Briefly, thermal crosslinking of PGS prepolymer on to glass slides and solvent casting
of 5% (w/w) solution of PLGA (65-35 High IV, Lakeshore Biomaterials, Birmingham, AL) in
hexafluoroisopropanol (Sigma) was used to produce PGS and PLGA films respectively. HepG2
cells were seeded at a density of 25,000 cells/cm 2. Albumin quantification was determined by a
human ELISA kit (Bethyl Laboraratories, Montgomery, TX) with absorption measurements
made at 450 nm wavelength using a SpectraMax Plus 384 (Moleculare Devices, Sunnyvale, CA)
equipped with SOFTmax Pro 4.0 software. Albumin secretion rates were normalized by surface
area of cell culture and volumetric flow rate, in the case of perfusion culture.
III. Results
A. Physical Characterization of Silk Fibroin Films
Silk films derived from regenerated aqueous silk solutions exhibited FT-IR absorbance peaks
that are characteristic of amorphous silk I structure, such as the amide I peak at 1656.6 cm-1 and
the amide II peak at 1541.5 cm -1. Treatment with aqueous-methanol solution shifted the peaks
from silk I configuration to the crystalline silk II configuration, as amide I and amide II peaks
shifted to 1616.3 cm -' and 1515.6 cm - ' for post-methanol treated films, respectively (Figure 48).
These peak shifts suggest an increase in the percentage of crystalline structure within the bulk,
which has been demonstrated by others.[15 4] Fully hydrated water-stable films processed in this
manner have been shown to increase P-sheet formation, 115 5] which result in increased stiffness, as
determined by tensile Young's modulus, increased toughness modulus, and an increased ultimate
tensile strength over thermally crosslinked PGS films (Table 4).
Table 4. Comparison of Mechanical Properties of Regenerated Silk Fibroin and PGS Films.
Young's Elongation Toughness
Modulus (MPa) UTS (MPa) at Break (%) Modulus (MJlm3)
PGS (n=8) 1.72 + 0.79 0.281 + 0.13 19.8 ± 1.11 0.0294 ± 0.0146
Silk Fibroin (n=5) 107.63 ± 18.29 7.60 ± 0.51 20.9 ± 0.16 1.21 ± 0.0118
B. Replica Molding of Silk Fibroin Films
Devices were fabricated from regenerated silk fibroin films that measured approximately 200
microns in thickness, which was controlled by the volume to surface area ratio during casting.
The lamination strategy utilized aqueous silk fibroin solution to bond replica molded water-
stable silk films. The average and root-mean-squared surface roughness of silk films after the
lamination process was 216.6 nm and 267.4 nm, respectively (Appendix 2, Figure 49). Replica
molded silk fibroin films cast on PDMS negative molds could be produced in rapid succession
while maintaining a high degree of feature fidelity. Features as small as 400 nm could be
produced using this method (Figure 1 la). Micromolded films (Figure 1 lb) were bonded to flat
films to produce microfludic devices (Figure 1 lc,d) that could support flow (Figure 1 le,f).
Occlusion of microchannels from excess aqueous silk fibroin solution during the bonding
process at the inlet/outlet both contributed to reduced device yield.
Figure 11. Silk Fibroin-based Microfluidic Devices.
Replica molded silk fibroin films produce high-fidelity features including (a) nanometer scale posts with
minimum widths of approximately 400 nm and (b) micron scale fluidic channels, which were used in
subsequent experiments. Scale bars represent 5 microns and 500 microns in (a) and (b), respectively. c, d)
SEM micrographs of the cross-sections of devices fabricated from the previously outlined strategy
demonstrate retention of feature geometries in thin films with microchannel widths of approximately (c) 240
microns and (d) 90 microns. Scale bars represent 200 microns and 10 microns in (c) and (d), respectively.
e,f) Patent microfluidic devices are demonstrated by fluorescent micrographs of devices perfused with
rhodamine solution. Retention of the perfusate within the microchannels suggests robust bonding at the
interface. Scale bars represent 500 microns and 50 microns in (e) and (f), respectively.
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C. Seeding and Perfusion of Hepatocytes in Silk Fibroin Microfluidic
Devices
The microfluidic layout used in this study has been designed to produce a constant maximum
wall shear stress within all microchannels in the device, given a steady volumetric flow rate. 136]
This device geometry assisted in initial cell seeding by allowing cells to be evenly distributed
throughout the device during attachment. Furthermore, the constant maximum wall shear stress
design facilitates rapid perfusion, while minimizing the potential detachment of seeded cells
from shear forces. The high cell seeding density resulted in the formation of HepG2 aggregates,
which increased the opportunity for adhesion of cells to the microchannels. Suitable perfusion
rates were characterized for the perfusion culture of HepG2 cells cultured in PGS microfluidic
devices with similar length scales. [147] The morphology of HepG2 cells seeded and perfused in
silk fibroin microdevices (Figure 12) was similar to that of HepG2 cells cultured on other
biomaterials including PGS[147] (Appendix 2, Figure 51). Viability and liver-specific function of
HepG2 cells cultured on silk fibroin were also determined to be similar across static and dynamic
cultures. HepG2 cells cultured on silk fibroin films exhibited similar albumin secretion rates as
those cultured on other typical biomaterials. Additionally, HepG2 cells cultured statically on
films had similar albumin secretion levels to those cultured in dynamically perfused silk fibroin
microfluidic devices (Appendix 2, Figure 52). An increase in albumin secretion levels was
observed from day 3 through day 5, which was likely due to increasing cell densities within the
microchannels.
Figure 12. Cell-Seeded Silk Microfluidic Devices.
a) Silk microfluidic devices prior to cell seeding are optically clear to permit observation via light microscopy.
Hepatocytes were statically seeded for four hours at which time perfusion commenced. b) Devices were
partially confluent with cells exhibiting native morphology after 24 h. Scale bars represent 100 microns in (a)
and (b). c, d) Viable cells remained attached and retained function within devices (see text) for up to 5 d of
perfusion as shown in SEM micrographs of sectioned devices. Scale bars represent 50 microns in (c) and (d).
IV. Discussion
A. Methods for Potentially Improving Device Yield
The device fabrication strategy in this study allows for the rapid and scaleable production of silk-
fibroin-based microfluidic devices without the need for harsh processing conditions or cytotoxic
compounds. The techniques employed in this strategy are scalable by designing systems with
increased surface area and lamination of multiple layers. Although the device yield for patent
devices in this study was relatively low, the success rate could be increased by designing flow
layouts with redundant microchannel connectivity and by employing additional covalent bonding
agents such as (1-ethyl-3-[3-dimehtylaminopropyl]carbodiimide hydrochloride) (EDC) and N-
hydroxysuccinimide (NHS), an established chemical route for bioconjugation of amines to
carboxylates.[' 51 , 156] Similar techniques could be used to covalently link peptides or other
bioactive molecules both on the surface and throughout the bulk of the material of the device as
previously shown for cell binding peptides and morphogens. [19' 281
B. Scalability of Silk Fibroin Microfluidic Scaffolds
The aspects of device scalability and incorporation of biomolecules may be important in the
design and fabrication of tissue engineering scaffolds for highly vascularized tissue. These
biodegradable microfluidic systems can also be integrated with existing biomaterial systems and
technologies for tissue-specific applications and increased functionality. For example, drug
delivery systems, [71 cell patterning techniques, [65' 141] contact guidance cues, [27] and co-culture
systems for hepatocytes [1421 can be integrated within the microchannels to promote the
organization of seeded cells into complex tissues. The robust properties including a high
toughness modulus and ultimate tensile strength could permit the use of silk fibroin-based
devices in dynamic mechanical environments associated with in vivo applications. In addition to
the fabrication of microfluidic systems, strategies for micromolding silk fibroin could be
potentially useful in other BioMEMS devices including biodegradable drug delivery devices,
scaffolds, or biosensors. [23' 3 51 The techniques in this report are general and could be used for
advancement of the field of implantable and resorbable microfabricated systems, further
expanding the impact of related technologies in biomedical applications.
Chapter 4: Amino Alcohol-Based Degradable
Poly(ester amide) Elastomers
The content of this chapter, in whole or in part, has been submitted for publication to the
following journal:
C J Bettinger, J P Bruggeman, J T Borenstein, R Langer. Amino Alcohol-Based Degradable
Poly(ester amide) Elastomers. Biomaterials 2008.
I. Introduction
A. Biomimicry of ECM Proteins Using Synthetic Elastomers
One critical aspect in realizing therapeutic tissue-engineered systems is the synthesis and
fabrication of scaffolds with appropriate chemical, physical, and mechanical properties. [17' 120]
Typical strategies that guide materials processing and development for tissue engineering
applications often focus on biomimicry of the extra-cellular matrix (ECM), a heterogeneous
network of proteins that provides support for cell attachment and chemical cues for seeded cells
and surrounding tissue. Implants are subjected to dynamic mechanical environments in vivo,
which is driving the need for biodegradable elastomers with chemical, physical, and mechanical
properties of native ECM for tissue engineering applications. While natural biodegradable
elastomers[116, 157, 158] are composed of natural proteins and support cell attachment, [117] there are
difficulties in bulk material processing and potentially dangerous immune responses upon
implantation.[ 159]  Numerous synthetic biodegradable elastomers [8 6, 87, 160-168] have been
developed to meet this growing, unmet need. Synthetic biodegradable elastomers are typically
composed of crosslinked networks of aliphatic molecules with polyester linkages. These
structural elements have led to several deficiencies including either; (1) extremely high
crosslinking densities resulting in high modulus materials, [167] (2) rapid biodegradation upon
implantation,[8 6, 87, 127] or (3) limited functional groups to increase the suite of available
chemistries for covalent conjugation of biomolecules including proteins and growth factors.1 160]
B. 1,3-diamino-2-hydroxy-propane as a Building Block for
Biodegradable Elastomers
Herein we describe the formation and characterization of a new class of synthetic, elastomeric,
biodegradable poly(ester amide) based on the amino alcohol 1,3-diamino-2-hydroxy-propane
(DAHP). This new class of biodegradable elastomers, termed poly(1,3-diamino-2-
hydroxypropane-co-polyol sebacate)s (APSs), exhibits many advantages of both natural and
synthetic materials for tissue engineering applications. We posed five general criteria that led to
the selection of DAHP as the appropriate monomer from which to base our material design: (1)
The monomer should be non-toxic[ '6 9] to enhance biocompatibility and tri-functional in nature to
enable the formation of cross-linked networks; (2) the melting point of the monomer should be
low (< 80 oC) to enable rapid, scalable, thermal batch polymerization processing; (3) the
monomer should contain primary amines to participate in hydrogen bonding, and be available for
subsequent conjugation reactions; (4) the monomer should be able to form both amide and ester
bonds to enable tunable properties including biodegradation half-life; (5) the monomer should be
inexpensive and commonly used in biomedical systems. The polycondensation reaction of an
amine-containing monomer is predicted to form primary and secondary amide bonds, which also
provide several advantages including a mechanism to control physical properties, mechanical
properties, and biological response. DAHP is the most appropriate monomer that satisfies all of
these criteria and was therefore used as the multifunctional amine-containing monomer.
We formed biodegradable elastomeric APS polymers through a facile and efficient
copolymerization of DAHP with a polyol and a diacid. The polyols and diacid investigated in
this study were glycerol, D,L-threitol, and sebacic acid, respectively. Polycondensation of these
monomers led to the formation of chemically crosslinked polymers through the formation of
ester and amide linkages. These elastomeric polymers are optically transparent, exhibit robust
mechanical properties, and demonstrate biocompatibility in vitro and in vivo. The combination
of these properties suggests that APS polymers exhibit desirable chemical, physical, and
mechanical properties, which are suitable for a variety of biomedical applications.
II. Materials and Methods
A. Synthesis of Poly(1,3-diamino-2-hydroxy-propane-co-polyol
sebacate) Elastomers
All materials were purchased from Sigma-Aldrich (St. Louis, MO USA) and used as received
unless otherwise specified. The polymer formulation 2DAHP-1G was synthesized in the
following manner. A round-bottom flask was charged with 0.06 mol of 1,3-diamino-2-hydroxy-
propane (DAHP), 0.03 mol glycerol (G), and 0.09 mol of sebacic acid (SA) to produce a molar
ratio of 2:1:3 of DAP:G:SA, respectively. The polymer formulation 2DAHP-1T was synthesized
in a similar manner: a round-bottom flask with 0.06 mol of 1,3-diamino-2-propanol (DAHP),
0.03 mol D,L-threitol (T), and 0.09 mol of sebacic acid (SA) to produce a molar ratio of 2:1:3 of
DAHP:T:SA, respectively. The reactants were heated under a nitrogen blanket at 120 oC for 3 h.
The pressure was then dropped to approximately 50 mTorr and the contents were allowed to
react for 9 h at 120 OC. The product was then stored under a desiccate environment until further
use. The product was spread onto glass slides and cured at 170 OC at approximately 50 mTorr
for either 24 h or 48 h. Film thicknesses of either 0.5 mm or 1 mm were achieved by applying
the reaction product at surface densities of 100 mg/cm2 and 200 mg/cm 2, respectively. Films
were delaminated in ddH20 at 70 OC for 18 h. Sol was removed by incubating polymer films in
100% ethanol for 24 h followed by washing and incubation with ddH20. Subsequent
characterization techniques were performed on sol-free samples only.
B. Characterization of Poly(1,3-diamino-2-hydroxy-propane-co-polyol
sebacate) Elastomers.
1. Physical Properties
The pre-polymer was prepared in a KBr pellet for FT-IR characterization. Spectra were recorded
using a Nicolet Magna 550 Series II IR Spectrometer equipped with OMNIC Software using 32
scans across the wave numbers 4000-400 cm 1' at a resolution of 2 cm-'. Sol content was
measured by measuring the difference in dry-weight before and after sol removal via ethanol
wash (n = 12). The mass densities were measured (n = 12) using a 49.97 mL pycnometer bottle
(Humboldt Mfg. Co, Norridge, IL USA). Atomic composition was measured using a Kratos
AXIS Ultra Imaging X-ray Photoelectron Spectrometer with Delay Line Detector. The water-in-
air contact angle of polymer films was measured using the sessile-drop method and VCA2000
image analysis software (n = 10). Sol content was determined by measuring dry mass
differential before and after incubation with ethanol, which dissolves unincorporated monomers,
and using the following relationship where Mwso, is the sample mass including sol, Msoiree is the
sample mass without sol:
M -M
SolContent(%) = Mo Msofree x 100 Eqn. 1
wsol Eqn. 1
Water uptake upon hydration was determined in a similar manner by measuring the differential
mass of sol-free polymer slabs before and after hydration for 24 h. given by the following
equation:
WaterUptake(%) = Mhyd - Mdy 100 Eqn. 2
Mdry Eqn. 2
Glass transition temperature (Tg) and other potential phase transitions were measured using a
Q 1000 DSC equipped with Advantage Software v2.5 (TA Instruments, Newcastle, DE USA) and
analyzed with Universal Analysis Software v4.3A (TA Instruments).
2. Mechanical Properties
Elastomeric films dedicated for mechanical testing were cut into dog-bone geometries with
dimensions of 0.5 mm x 6.5 mm x 30 mm (T x W x L). Tensile testing was performed using an
Instron 5542 using a 50N load cell equipped with Merlin software. Samples (n > 6) were
prepared by removing sol and hydrating films in ddH20 for at least 24 h prior to measurement.
Polymer slabs were extended at a constant rate of 50 mm/min and were elongated until failure at
ambient temperature. Young's modulus, toughness modulus, ultimate tensile strength and
elongation at break were all calculated directly from engineering tensile stress versus engineering
strain curves. Moles of active network n and molecular weight between crosslinks Mc were
calculated from the following equations for an ideal elastomer where Eo is the Young's modulus,
R is the universal gas constant, T is the temperature, p is the mass density:
E 
_ P
3RT M Eqn. 3
C. In vitro Degradation of Polymer Films
Cylindrical polymer slabs (n = 4) with dimensions of 0.5 mm x 6 mm (T x D) weighing
approximately 20 mg each were incubated at 37 oC in 3 M sodium acetate buffer solution with a
pH of 5.2 to induced accelerated mass loss via acid catalyzed hydrolysis. Buffer and enzyme
solutions were exchanged every 2 d and dry mass loss measurements were made after 6 wks.
Samples were washed in ddH20, incubated in ethanol and ddH20 for 24 h each, and finally dried
at 70 oC for at least 24 h. Mass loss MLoss was determined by the following formula where Mo is
the initial mass and Mf is the final time point:
M° - M
MLoss (%= x 100 Eqn. 4
MO
D. Cell Attachment and in vitro Biocompatibility.
Primary human foreskin fibroblasts (HFF, ATCC, Manassas, VA USA) were cultured in high
glucose Dulbecco's minimal essential medium (DMEM) supplemented with 10% (v/v) fetal
bovine serum, 100 .tg/mL streptomycin, and 100 U/mL penicillin, at 37 OC and 5% CO2. Cells
between passage four and six were harvested using trypsin 0.025%/EDTA 0.01% and quenched
with an equal volume of medium to re-suspend the cells. Polymer films of both 2DAHP-1G and
2DAHP-1T formulations were cured at 170 oC for 48 h for in vitro biocompatibility assessment
due to the ability to assess cell morphology using light microscopy (See Results). 6535 PLGA
(65% L-lactic acid, 35% glycolic acid, High MW, Lakeshore Biomaterials, Birmingham AL
USA) films were used synthesized via solvent evaporation of 1% (w/w) solutions in
dichloromethane at 100 gL/cm 2. Polymer films (n = 4) were seeded with HFFs at 25,000
cells/cm 2. Cell metabolism was evaluated by the XTT kit after 24 h according to the
manufacturer's instructions. Cells were incubated for 4 h in medium containing 20% (v/v) XTT
solution. Absorption measurements made in triplicate at 450 nm and 690 nm wavelengths using
a SpectraMax Plus 384 (Molecular Devices, Sunnyvale, CA USA) equipped with SOFTmax Pro
4.0. XTT measurements are reported as normalized ratios with respect to TCPS. Phase
micrographs of cells were taken at 10X magnification for each sample analyzed. The area and
circularity[' 70] of cell populations were calculated manually using perimeter and area
measurements by using Axiovision software (Zeiss, Germany). The circularity C was calculated
using the following formula:
4,rA
C=Eqn.5
p2 Eqn. 5
where A is the projected area of the cell and P is the perimeter of the cell. Circularity was used
as an index of cell spreading. Three distinct cell populations (n = 200 total) were measured to
find population means, which were used to determine statistical significance.
E. In vivo Biocompatibility and Tissue Response
Polymer slabs of the appropriate APS were synthesized and cut into cylinders with target
dimensions of D = 11 mm, T = 1 mm. PLGA slabs were obtained by melt pressing 0.3 g of 6535
PLGA pellets (65% L-lactic acid, 35% glycolic acid, High MW, Lakeshore Biomaterials,
Birmingham, AL USA) at 172 OC under 5000 MPa into target dimensions of D = 11 mm, T = 1
mm. All polymer slabs were incubated in 95% ethanol to remove sol and sterilized under UV for
15 min. Polymer slabs were disinfected for 20 min under UV and incubated in 0.9% saline prior
to implantation. Polymer slabs were implanted subcutaneous into seven-week-old female
Sprague-Dawley rates (Charles River Laboratories, Wilmington, MA USA) by a midline incision
and blunt lateral dissection under deep isoflurane-O 2 general anesthesia. The animals were cared
for in compliance with the regulations of MIT and the NIH.[1 7" Two implants of each material
used were implanted on the upper and lower back of the same animal. Rats were sacrificed at
pre-determined time points. Polymer explants were removed from rats at 6 wks, washed gently
in Dulbecco's phosphate buffered solution (DPBS), dried at 70 oC, and weighed to obtain dry
mass for degradation calculations. Specimens with intact implants of approximate dimensions of
15 mm x 15 mm were harvested en bloc with surrounding tissues for histology. The samples
were fixed in Accustain (Sigma) for 24 h and embedded in paraffin and stained appropriately.
Briefly, slides were stained with hematoxylin and eosin (H&E) and Masson's trichrome stain to
determine fibrous capsule thickness. Tissue macrophages were identified by staining sections
with primary rabbit anti-rat CD68 (1:200, Abcam, England UK) followed by goat anti-mouse
secondary antibody (Vector Burlingame, CA USA). Samples were incubated with strepavidin
horseradish peroxidase (1:100, Dako, Denmark) and developed with DAB substrate chromogen
(Dako). Histology images were recorded with a Zeiss CCD Camera equipped with Openlab v5.5
software. At least four measurements were taken in ten random sections to calculate fibrous
capsule thickness and macrophage frequency.
F. Statistics
All measurements of the projected cell area and circularity were based on the sampling over at
least n = 100 cells per population with a minimum of three cell populations per data point. XTT
metabolism assays were performed in triplicate samples (n = 3) with triplicate readings for each
data point. At least four fibrous capsule thickness measurements were made across at least ten
randomly selected images per sample. Histological macrophage scoring was also based on at
least ten randomly selected images. Two-tailed Student's t-tests with unequal variances were
performed to determine statistical significance, where appropriate (Microsoft Excel, Redmond,
WA USA). Non-parametric one-way ANOVA tests were also performed where appropriate
(GraphPad Prism 4.02, GraphPad Software, San Diego, CA USA). Dunn's multiple comparison
post-tests were used to determine significance between specific treatments. All tabulated and
graphical data is reported as mean ± s.d. Significance levels were set at * p < 0.05, ** p < 0.01,
and *** p < 0.001.
Ill. Results
A. Chemical, Physical, and Mechanical Properties of 1,3-diamino-2-
hydroxy-propane-based Poly(ester amide) Elastomers.
The polycondensation of 2DAHP-1G and 2DAHP-1T formulations produced solid, elastomeric
slabs. APS polymers were optically transparent when dry. Hydrated APS polymer films
crosslinked for only 24 h were opaque when hydrated while films crosslinked for 48 h
maintained transparency. The presence of esters, carboxylic acids, primary amides, secondary
amides, primary amines, and secondary amines was determined from FT-IR data (Figure 53).
The incorporation of amine groups into elastomeric networks is supported by the presence of
nitrogen in sol-free slabs as determined by elemental analysis via XPS, a surface technique for
elucidating the elemental composition at the surface (Table 7). Nitrogen content ranged from
2.24 and 3.97% by mass depending upon the polymer formulation and processing conditions.
H2N NH2
OH
P
1) 120 OC, N2
2) 120 OC
50 mTorr
3) 170 OC
S 50 mTorr
u u
HRO = X or Y (via amide), or H
HO OH R2 =X or Y (via ester), or H
Figure 13. Synthesis Scheme of APS Polymers.
The general synthetic scheme of APSs incorporated the following monomers; 1) a multifunctional amine
group (A), which was chosen to be 1,3-diamino-2-hydroxypropane in this example, 2) a polyol (P), and 3) a
diacid (S). Glycerol and D,L-threitol were chosen as representative polymers while sebacic acid was chosen
as the diacid because of it's ubiquitous presence in polyesters for biomedical applications. These monomers
were melted at 120 oC under a nitrogen blanket followed by a reduction in pressure to induce polymerization.
Further polymerization to produce solid slabs was continued at 170 oC at 50 mTorr. In this scheme, R1
represents either a single hydrogen, or bond to either group X or group Y via amide. R2 represents either a
single hydrogen, or bond to either group X or group Y via ester. See Materials and Methods for details on
synthesis.
The sol content of APS networks varied between 16.08% and 3.51% by mass (Table 15). Sol
content was reduced by using longer curing times or by increasing the degree of functionality of
the polyol by using D,L-threitol. The mass densities of APS networks varied between 1.096 and
1.114 g/cm3 and were dependent upon composition and processing (Table 15). APS networks
exhibited water uptake which varied from 14.2% to 19.8% by volume across composition and
curing conditions. The water-in-air contact angle of APS films varied between 91.50 and 93.70
and the glass transition temperature varied between 33.7 and 48.0 oC, of which both parameters
varied according to composition and curing conditions (Table 16; Figure 54). There were no
observable crystallization or melting transitions measured in APS polymers across the measured
temperature range (between -80 oC and 250 oC). The mechanical properties of APS networks are
summarized in Table 9. The Young's modulus varied between 1.449 and 4.338 MPa with
elongations at break varying between 21% and 92%. Increasing the maximum elongations could
be achieved by reducing the curing time (results not shown).
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Figure 14. Representative Tensile Stress vs. Strain Curves of APS Polymers.
Hydrated APSs exhibited elastomeric behavior under tension as indicated by high elongations at break and
relatively low Young's moduli across all tested samples.
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Despite the fact that the Tg of the tested polymers was above the ambient temperature at which
mechanical testing occurred, the films were qualitatively observed to be rubbery. This is likely
due to Tg depression upon hydration of the polymer network. Hydration leads to swelling and
polymer-water interactions, both of which can lead to increased chain mobility and a
corresponding reduction in Tg. The quantitative framework has been previously developed 1'72 ]
and the effect has been estimated in a variety of polymer network-diluent systems[' 73 ] including
situations in which the diluent is water.[174' 175] The estimated effective Tg of hydrated APS
networks was calculated using the following equation:
x1AC, T,, +x 2ACp 2Tg2
gl,2 x1ACpl + 2ACp2 Eqn. 6
where xi is the mass fraction, ACpi is the incremental change in heat capacity at Tgi, and Tgi is the
glass transition temperature for component i. Values for AC, and Tg were experimentally
determined values that were calculated from DSC thermograms (Figure 54). Component 1 is
defined as the polymer network and component 2 is defined as the diluent, which in this case is
water. The effect of crosslinking was assumed to be negligible to obtain a first order
approximation. The results are summarized in Table 17 where ATgl,2 is defined as:
Tgl, 2 = Tg - Tgl,2  Eqn. 7
where Tgo is defined as the glass transition temperature of the polymer network in the dry state
(no diluent) and Tgl,2 is the glass transition temperature of the hydrated polymer network (with
diluent). The values of Tg were calculated to be reduced significantly as the resulting effective
values of Tg ranged from -42.85 to -78.68 oC.
B. In vitro Properties
1. In vitro Degradation
All APS polymers in this study degraded in the presence of sodium acetate buffer. 2DAHP-1G
formulations cured for 24 h and 48 h exhibited 97.0% and 44.3% dry mass loss, respectively
after 6 wks of in vitro degradation. 2DAHP-1T formulations cured for 24 h and 48 h lost 70.4%
and 42.8% of dry mass, respectively.
2. In vitro Biocompatibility
Primary HFFs were chosen to study in vitro cell attachment and spreading because of the
importance of these cells in the wound healing response following the implantation of
biomaterials.[176-178] HFFs grown on APSs attached and exhibited similar morphology to HFFs
grown on standard control biomaterials including PLGA and tissue culture polystyrene (TCPS).
Cell circularity and projected cell area are two metrics that indirectly measure the ability for cells
to adhere and spread upon the biomaterial surface. [179' 180] These two parameters were both
statistically similar (p > 0.05; p > 0.05, respectively) across all tested materials as determined by
one-way ANOVA with Dunn's multiple comparison tests. HFFs grown on 2DAHP-1G
exhibited a similar level of mitochondrial metabolism at 24 h as compared to HFFs grown on
PLGA and TCPS, as measured by XTT cleavage assay. Although metabolism of HFFs grown
on 2DAHP-1T was similar when compared to TCPS (p > 0.05), it was reduced when compared
to PLGA (* p < 0.05) as measured by one-way ANOVA with Dunn's multiple comparison tests.
Confluent layers of HFFs were obtained after 3 d across all tested biomaterials.
Figure 15. Primary Fibroblast Culture on APS Elastomer Substrates.
Primary fibroblasts isolated from human foreskin cultured on APS substrates appeared to have a similar
morphology as other traditional biomaterials including PLGA and tissue culture polystyrene (TCPS). Scale
bars in all panels represent 200 microns.
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Figure 16. Characterization of Morphology and Metabolism of Human Foreskin Fibroblasts Cultured on
APS Films.
C. In vivo Biocompatibility and Degradation
Subcutaneous (SC) implants of 2DAHP-1G and 2DAHP-1T, both cured for 48 h, exhibited only
4.3 and 5.8% mass loss at 6 wks and 12.9 and 13.0% mass loss at 20 wks, respectively. Fibrous
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capsules were formed in response to SC implantation of APS polymer slabs. The fibrous capsule
thickness in all samples reduced from wk 1 to wk 2, which was followed by an increase at wk 20
and wk 12 for APS and PLGA implants, respectively. This increase was not statistically
significant in the case of 2DAHP-1G and PLGA, but was significant in the case of 2DAHP-1T
when compared to wk 1 fibrous capsule thickness. Histological sections indicated that the
fibrous capsule thickness of both 2DAHP-1G and 2DAHP-1T polymers was significantly less
(*** p < 0.001) than PLGA at both I and 2 wks as determined by two-way ANOVA (Figure
19a). These results suggest that APS polymers induce an in vivo tissue-biomaterial interaction
which is milder than PLGA in terms of the fibrous capsule during the foreign body response.
The concentration of macrophages was also observed to be lower in 2DAHP-1G and 2DAHP-1T
polymers both in the fibrous capsule and in the surrounding tissue (*** p < 0.001; *** p < 0.001,
respectively) as measured by the frequency of CD68+ cells at 1 wk and 2 wks (Figure 19b-c).
There was no significant increase in the frequency of CD68+ cells at 20 wks for APS implants
(Table 18). The percentage of CD68+ cells at 20 wks was approximately equal to that of wk 1
for the 2DAHP-1G formulation and smaller for the 2DAHP-1T formulation. Blood vessels were
not observed within the fibrous capsules of 2DAHP-1G and 2DAHP-1T polymers at both 1 and
2 wks. Neither 2DAHP-1G or 2DAHP-1T implants became heavily vascularized, recruited
macrophages, or allowed fibroblast penetration. PLGA implants remained intact for up to only
12 wks, which prohibited accurate assessment of fibrous capsule and macrophage recruitment
beyond this time point.
2DAHP-1 G 2DAHP-1 T
Figure 17. Histology of in vivo Tissue-Biomaterial Response to APS Implants.
H&E stain show fibrous capsules are formed at the implantation sites of all polymers. Minimal
vascularization was observed at 1 and 2 wks in the surrounding tissue and fibrous capsule of all polymers.
H&E stains show reduced fibrous capsule thickness and for 2DAHP-1G and 2DAHP-IT polymer implants
when compared to PLGA (See Figure 19a). The regions of polymer, fibrous capsule, and muscle are
indicated by P, F, and M respectively and separated by dashed lines. Long-term histology time points were
set at 20 wks for 2DAHP-1G and 2DAHP-1T implants and 12 wks for PLGA implants. Scale bars in all
images represent 200 microns.
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Figure 18. Macrophage Recruitment in APS Implants.
The presence of macrophages, as determined by CD68+ cells, was reduced within the fibrous capsule and
surrounding tissue of 2DAHP-1G and 2DAHP-1T polymers when compared to PLGA (See Figure 19b and c).
The regions of polymer, fibrous capsule, and muscle are indicated by P, F, and M respectively and separated
by dashed lines. Long-term histology time points were set at 20 wks for 2DAHP-1G and 2DAHP-1T implants
and 12 wks for PLGA implants. Scale bars in all images represent 200 microns.
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Figure 19. Characterization of Tissue-Biomaterial Response to APS Implants.
Fibrous capsule thicknesses were observed to be smaller in 2DAHP-1G and 2DAHP-1T polymers when
compared to PLGA at 1 and 2 wks (*** p < 0.001). The fibrous capsule thickness for PLGA implants at 12
wks was larger than both 2DAHP-1G and 2DAHP-1T at 20 wks. The presence of macrophages, as
determined by CD68+ cells, was reduced within the fibrous capsule and surrounding tissue of 2DAHP-1G
and 2DAHP-1T polymers when compared to PLGA at 1 and 2 wks (*** p < 0.001).
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IV. Discussion
The newly synthesized class of compounds, poly(1,3-diamino-2-hydroxypropane-co-polyol
sebacate)s (APSs), offers potential advantages of both natural and synthetic elastomeric
biomaterials as a material platform for implantable medical devices with a focus on devices that
are intended to be semi-permanent including cell-scaffolds for soft-tissue engineering
applications. Similar to protein-based elastomers, APS polymers are slowly degrading materials
with low moduli, high UTS, and are capable of large deformations. APS polymers also support
cell attachment and are also capable of amine-based chemistries for covalent protein
bioconjugation. Similar to synthetic biodegradable elastomers, APSs are inexpensive to produce,
easy to synthesize, and are adaptable to standard polymer processing capabilities. Previously
synthesized biodegradable elastomeric esters have used primarily ester linkages which are
susceptible to both esterase activity and hydrolysis.[ 86' 871 The presence of amide bonds leads to
reduced susceptibility of degradation via hydrolysis and esterase enzymes, which are excreted by
macrophages as a part of the foreign body reaction.1 •17 8 This potentially allows for the use of
APS polymers in expanded applications where long biomaterial half-lives are required such as
scaffolds for cardiovascular grafts and peripheral nerve regeneration conduitsE181] where implant
half-lives may need to approach 2-6 months or longer.
APS polymers described in this report were synthesized from combining a diacid with a polyol
and the trifunctinoal 1,3-diamino-2-hydroxypropane (DAHP). The incorporation of a polyol
proved to be important in sufficiently reducing the required thermal processing temperature from
approximately 210 oC to 170 OC for 2DAHP-1G and 2DAHP-1T formulations. APSs
synthesized from only sebacic acid and DAHP were technically challenging to synthesize and
subsequently process into films. Although glycerol and D,L-threitol were chosen as
representative polyols, other types of polyols could be used including xylitol, sorbitol, and
mannitol, which can serve as building blocks for other polymer systems. [182] Similarly, although
sebacic acid was chosen since it has been used extensively in other polymeric systems for
biomedical applications, 1 83] other types of diacids could be used in the synthesis to achieve a
broad range of properties.
A. Effect of Composition and Processing on Physical Properties
The elemental composition of APS polymers in this study generally suggested that there was
proportionately less nitrogen and more oxygen present in the elastomeric networks than the
stoichiometric amount present in the reactants. This suggests that, in general, the
polycondensation of sebacic acid with hydroxyl groups occurred more readily as compared to
amine groups. The preparation of APS networks under nitrogen and vacuum environments
coupled with the lack of nitrate fingerprints in FT-IR spectra suggest that this differential in
elemental composition is not due to oxidation of reactants. The relative nitrogen content, which
is presumed to exist in the context of primary amines, and primary and secondary amide bonds,
was not increased by increasing the curing times. Consider the 2DAHP-1G formulation: The
relative nitrogen content is reduced as the curing time is increased. Also, the relative mass
fractions of carbon and oxygen are increased and decreased, respectively. This suggests that
more sebacic acid molecules are being incorporated into the network, which would reduce the
overall relative mass fraction of nitrogen. The increased incorporation can also be inferred by
the effect of curing time on Tg. The Tg increased throughout this variation in material processing.
It is known that amide groups exhibit less bond rotation,E1' 84 which can lead to more rigid
polymer segments, and ultimately increase the Tg.[J 851 These observations suggest that higher
curing time leads to increased amide content despite the relative reduction in overall nitrogen
content. The 2DAHP-1T formulation behaved in a similar manner; although the relative
nitrogen content is increased only slightly upon increasing the curing time from 24 h to 48 h, the
Tg rose from 45.4 oC to 48.0 OC. Although altering the formulation and processing altered the Tg,
the observed variation the water-in-air contact angle for both formulations was minimal. This is
likely due to the dominating effect of the reagent composition and subsequent surface chemistry
of APS films when compared to the effect of material processing conditions.
B. Effective Tg of Hydrated APS Networks
The calculated Tg depression was extremely pronounced across all polymers and processing
conditions. This is likely due to the relatively high mass fraction of water observed in the
hydrated polymers as well as the extremely low Tg of water (-139 OC). Hence, all APS polymers
in the hydrated state were predicted to be exclusively rubbery, and therefore elastomeric, at
physiological temperature. The observed trends in mechanical properties of APS networks are
similar to other thermally processed polymeric elastomers. [86' 87] Namely, increasing the curing
time increases the moles of active network per volume and decreases the molecular weight
between crosslinks which in turn leads to increasing the tensile Young's modulus. This increase
in stiffness is often accompanied by a corresponding reduction in elongation at break. While this
trend is readily observed in the 2DAHP-1G formulation, the effects of higher crosslinking are
not as pronounced in the 2DAHP-1T formulation. This is possibly due to the increase in
functionality of the polyol to four hydroxyl groups present in D,L-threitol.
The presence of amine groups on the surface, as determined by XPS, expands the possible suite
of chemical modification strategies for functionalizing the surface with other biomolecules. One
convenient route is the one-step modification of surfaces with NHS-modified proteins. These
molecules will react immediately with primary and secondary amines on the surface to form
stable amide bonds between the protein and the APS. The physical properties of APS polymers
expand the potential parameter space for biodegradable elastomers. Specifically, the range of
attainable values for characteristics such as Tg, contact angle, hydration, elemental composition,
chemical modification techniques, and degradation kinetics has been expanded.
C. Evaluation of in vivo Tissue-Biomaterial Response Compared to
PLGA
PLGA was chosen as a control biomaterial for in vitro and in vivo biocompatibility because of
the ubiquitous use of PLGA for biomedical applications. The in vitro response of primary
human foreskin fibroblasts on APS polymer films demonstrates the ability for cells to interact
favorably with this new class of materials as verified by maintenance of spreading, morphology,
and metabolic activity when compared to other commonly used biomaterials. Although APS
polymers appear to remain stable in vivo for a much longer time period than the PLGA
formulation chosen in this study, PLGA was a suitable control material to assess the acute and
chronic tissue responses at 1 and 2 wks respectively. This is due to the fact that both APS and
PLGA implants exhibit very little mass loss over this time scale in vivo.[127] The reduced fibrous
capsule thickness and limited macrophage recruitment in response to subcutaneous APS implants
suggests a more favorable in vivo response as well, when compared to PLGA implants. The
reduced frequency of CD68+ cells found within the fibrous capsules surrounding APS implants
at 1 and 2 wk time points suggests a reduced inflammatory response when compared to PLGA
implants. Furthermore, the reduction of CD68+ cells in the surrounding tissue also suggests that
APS implants do not actively recruit macrophages from the surrounding tissue as readily as
PLGA implants. These data suggest that the in vivo stability and favorable immune response are
enabling properties of APS polymers, which make them potentially suitable for fabrication of
semi-permanent resorbable medical devices for use in long-term implantation applications.
V. Conclusions
APS polymers synthesized using the approach described herein are biomaterials that offer a wide
range of potential applications. Favorable in vitro and in vivo cellular responses suggest that this
new class of materials could be used as a biomedical device material platform. These materials
could be used as a structural material to fabricate resorbable implantable devices such as tissue
engineering scaffolds, drug delivery systems, and temporary diagnostic systems. [186]
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I. Introduction
A. Tunable Properties of Poly(L-lactic-co-glycolic acid)
Synthesizing biomaterials with tunable properties is important in developing application-specific
formulations. It is often desirable to tune properties such as mechanical characteristics and
degradation rates. Biodegradable polymers that are potentially useful for implantable should
ideally be tunable in order to meet the specific material requirements of the intended application.
For example, soft tissue engineering applications may require a relatively rapid degradation time
in order to resorb and promote vascularization on the time scale of a few weeks. Other
applications such as heart valves, vascular grafts, and other semi-permanent implantable medical
devices may require the implant to maintain mechanical integrity for months and even years.
Poly(L-lactic-co-glycolic acid) (PLGA) is an ubiquitous biomaterial that is used for a variety of
drug delivery[ 187] and tissue engineering applications.1[ 6  The degradation rate of PLGA
polyesters is often tuned by varying the co-polymer ratio of L-lactic acid to glycolic acid and by
controlling the molecular weight. Adjusting these parameters leads to the ability to a wide range
of degradation rates both in vitro and in vivo.[20 188, 189] Despite the widespread use of PLGA as
a biomaterial for many types of biomedical applications, there remain significant drawbacks
including acidic byproducts, bulk erosion, and rigid mechanical properties. These characteristics
limit the use of PLGA for soft tissue engineering applications.
B. Strategies for Controlling Degradation of Poly(1,3-diamino-2-
hydroxypropane-co-polyol sebacate) Elastomers
Several new biodegradable elastomers have been proposed as an alternative material for tissue
engineering applications, which offer more desirable mechanical properties and improved tissue
response.[86, 87, 166] We have previously described the synthesis and characterization of a new
class of synthetic, elastomeric, biodegradable poly(ester amide) based on the amino alcohol 1,3-
diamino-2-hydroxy-propane (DAHP).1' 901 This class of biodegradable elastomers, termed
poly(1,3-diamino-2-hydroxypropane-co-polyol sebacate) (APS) elastomers, exhibits many
potential advantages of both natural and synthetic materials for tissue engineering applications.
These advantages include slow, enzyme-mediated degradation, elastomeric mechanical
properties, and biocompatibility in vitro and in vivo. Furthermore, APS elastomers are synthetic,
which allows for rapid scalable synthesis and the reduction of immune responses upon
implantation.[ 190] The polycondensation of DAHP and polyols with diacids produces APS
polymer networks that contain both ester and amide bonds.[ 190] We hypothesized that the relative
frequency of ester and amide bonds could be tuned by adjusting the monomer feed ratios and
polymerization conditions. Predetermining the relative amounts of ester and amide bonds could
be used to control the chemical, physical, and mechanical properties of APS elastomers
including degradation rate and the dominant degradation mechanism.
In this work, we synthesized eight formulations of APS elastomers by controlling both the
stoichiometry of the DAHP and the polyol monomer ratios as well as the processing conditions.
The in vitro degradation of these polymers was studied to characterize the relative susceptibility
of these polymers to hydrolytic and enzymatic degradation. The in vivo degradation of select
polymers was also studied along with poly(L-lactic-co-glycolic acid) to compare relevant
properties such as mass loss, mechanical strength, swelling, and deformation. Increasing the
relative presence of ester and amide bonds resulted in achieving in vivo degradation half lives
between 6 wks and approximately 100 wks while exhibiting tensile Young's moduli between
0.56 and 4.34 MPa.
II. Materials and Methods
A. Synthesis of Poly(1,3-diamino-2-hydroxy-propane-co-polyol
sebacate) Elastomers
All materials were purchased from Sigma-Aldrich (St. Louis, MO USA) and used as received
unless otherwise specified. The general synthesis route has been previously described [190]
Briefly, a round-bottom flask was charged with the appropriate amount of 1,3-diamino-2-
hydroxy-propane (DAHP), glycerol (G) or D,L-threitol (T), sebacic acid (SA) to produce various
molar ratios of DAP:G:SA and DAP:T:SA, respectively. The reactants were heated under a
nitrogen blanket at 120 oC for 3 h. The pressure was then dropped to approximately 50 mTorr
and the contents were allowed to react for 9 h at 120 oC. The product was then stored under a
desiccate environment until further use. The product was spread onto glass slides and cured at
170 oC at approximately 50 mTorr for either 24 h or 48 h (Table 5). Film thicknesses of either
0.5 mm or 1 mm were achieved by applying the reaction product at surface densities of 100
mg/cm 2 and 200 mg/cm 2, respectively. Films were delaminated in ddH20 at 70 oC for 18 h. Sol
was removed by incubating polymer films in 100% ethanol for 24 h followed by washing with
ddH20. Subsequent characterization techniques were performed on sol-free samples only.
Table 5. Formulation of APS Polymers.
Curing Time (h) Curing Time (h)
Formulation Polyol A:P:S Ratio Curing Temp (OC) (Low Crosslinked) (High Crosslinked)
1 DAHP-2G Glycerol 1:2:3 130 48 96
1DAHP-1G Glycerol 1:1:2 150 24 48
2DAHP-1G Glycerol 2:1:3 170 24 48
2DAHP-1T D,L-Threitol 2:1:3 170 24 48
B. Physical Characterization of APS Polymers
1. Viscosity and Molecular Weight Determination of 1,3-diamino-2-hydroxy-
propane-based APS Pre-polymers.
The intrinsic viscosity of APS pre-polymers in 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) was
measured using an Ubbelohde viscometer. Briefly, the pre-polymer was dissolved in HFIP in a
series of concentrations from approximately 0.1 to 4 g/dL, filtered, and placed into the
viscometer, which was kept at 30 ± 0.05 OC in a constant temperature water bath. At least two
replicate measurements were taken for each sample. The intrinsic viscosity was used to
determine the molecular weight from the Mark-Houwink equation:
[r]= K,Mwa Eqn. 8
The Mark-Houwink coefficients for APS pre-polymers in HFIP at 30 oC were interpolated from
polyamides in HFIP(1 91 ] to be Km = 5.6 x 10 - dL/g and a = 0.746. The polymers were assumed
to be low molecular weight oligomers a priori, which would reduce the probability of branching
and therefore ensure the validity of the selected Mark-Houwink coefficients.
2. Characterization of 1,3-diamino-2-hydroxy-propane-based APS
Networks
Sol content was measured by measuring the difference in dry weight before and after sol removal
via ethanol wash (n = 12). All measurements are presented as mean ± s.d. The mass densities
were measured (n = 12) using a 49.97 mL pycnometer bottle (Humboldt, MFC, Co). Atomic
composition was measured using a Kratos AXIS Ultra Imaging X-ray Photoelectron
Spectrometer with Delay Line Detector. The water-in-air contact angle of polymer films was
measured using the sessile-drop method and VCA2000 image analysis software (n = 10). Sol
content was determined by measuring dry mass differential before and after incubation with
ethanol, which dissolves unincorporated monomers, and using the following relationship where
Mwso, is the sample mass including sol, Msolfree is the sample mass without sol:
M -M
SolContent(Mass%) = wo soree x100 Eqn. 9
wsol Eqn.9
Hydration was determined in a similar manner by measuring the differential mass of sol-free
polymer slabs before and after incubation in ddH20 for 24 h. The differential mass was
normalized by polymer density to obtain the volumetric hydration via the following equation
where Ppoly is the density of the elastomer, Mhyd is the hydrated mass and Mdry is the dry mass:
I Mhyd -Md'yHydration(Vol%) = hyd dry x 100 Eqn. 10
The hydration by mass can be found by eliminating the inverse density prefactor from the
equation. Glass transition temperatures and potential melting points were measured using a
Q1000 DSC equipped with Advantage Software v2.5 (TA Instruments, Newcastle DE USA) and
analyzed with Universal Analysis Software v4.3A (TA Instruments). Elastomeric films
dedicated for mechanical testing were cut into dog-bone geometries with dimensions of 0.5 mm
x 6.5 mm x 30 mm (T x W x L). Tensile testing was performed using an Instron 5542 using a 50
N load cell equipped with Merlin software. Samples (n > 6) were prepared by removing sol and
hydrating films in ddH20 for at least 24 h prior to measurement. Polymer slabs were extended at
a constant rate of 50 mm/min and were elongated until failure. Young's modulus, toughness
modulus, ultimate tensile strength and elongation at break were all calculated directly from
engineering tensile stress versus engineering strain curves. Moles of active network n and
molecular weight between crosslinks Mc were calculated from the following equations for an
ideal elastomer where Eo is the Young's modulus, R is the universal gas constant, T is the
temperature, p is the mass density:
E 
_p
3RT M- Eqn. 11
C. Degradation of APS Polymer Films.
1. In vitro Degradation of APS Elastomers
Cylindrical polymer slabs (n = 4) with dimensions of 0.5 mm x 6 mm (T x D) weighing
approximately 20 mg each were incubated at 37 oC in the following degradation media: 1) 3 M
sodium acetate buffer solution with a pH of 5.2; 2) 10 U/mL of bovine cholesterol esterase in
DPBS; 3) 10 U/mL of protease XIV in DPBS (pH = 7.2). Buffer and enzyme solutions were
exchanged every 2 d and dry mass loss measurements were made at specified time points.
Samples were washed in ddH20, incubated in ethanol and ddH20 for 24 h each, and finally dried
at 70 OC for at least 24 h. Mass loss MLoss was determined by the following formula where Mo is
the initial mass and M, is the dry mass at a specified time point:
Mo - M,(O/= x100MMLoss N =M t 100 Eqn. 12
In vitro degradation experiments were conducted for up to 6 wks. The Tg for degraded samples
was also calculated using the following equation where Tg,to is the glass transition temperature of
the dry network prior to degradation and Tg,deg is the glass transition temperature of the same
dehydrated network after degradation:
ATg = Tg,t O -Tg,deg Eqn. 13
2. In vivo Degradation of APS Elastomers
The following formulations were chosen for in vivo degradation kinetics based on the
performance during in vitro degradation experiments; 1) 1DAHP-2G cured for 48 h (low
crosslinked), 2) 2DAHP-1G cured for 48 h (high crosslinked), 3) 2DAHP-1T cured for 48 h
(high crosslinked). We hypothesized that these polymers would provide the limiting cases for
fastest (1DAHP-2G; 48 h) and slowest (2DAHP-1G, 2DAHP-1T; 48 h) degradation in vivo.
Polymer slabs of the appropriate APS elastomers were synthesized and cut into slabs with target
dimensions of D = 11 mm, T = 1 mm. PLGA slabs were obtained by melt pressing 0.3 g of 6535
PLGA pellets (65% L-lactic acid, 35% glycolic acid, High MW, Lakeshore Biomaterials,
Birmingham AL USA) at 172 OC under 5000 MPa initial pressure into target dimensions of D =
11 mm, T = 1 mm. All polymer slabs were incubated in 95% ethanol to remove sol. Polymer
slabs were disinfected for 20 min under UV and incubated in 0.9% saline for 24 h prior to
implantation. Polymer slabs were implanted subcutaneous into seven-week-old female Sprague-
Dawley rates (Charles River Laboratories, Wilmington, MA USA) by a midline incision and
blunt lateral dissection under deep isoflurane-0 2 general anesthesia. The animals were cared for
in compliance with the regulations of MIT and the NIH [171]. Two implants of each material used
were implanted on the upper and lower back of the same animal. Rats were sacrificed at pre-
determined time points. Polymer explants were removed from rats, washed gently in DPBS,
dried at 70 oC, and weighed to obtain dry mass for degradation calculations.
3. Characterization of Explants
The compressive modulus of pre-selected time point samples (n = 4) was measured using
previously described Instron hardware equipped with Merlin software. Hydrated samples were
tested upon explantation without further treatment. PLGA samples were compressed to failure
while APS polymers were not. Mass loss and swelling was measured in an identical manner to
samples used for in vitro degradation studies.
III. Results
A. Properties of APS Pre-polymers
The initial polymerization step resulted in the formation of waxy pre-polymers for all
formulations. APS pre-polymers are soluble in 1,1,1,3,3,3-hexafluoroisopropanol (HFIP). The
intrinsic viscosity was measured for all formulations and varied between approximately 0.10 to
0.13 dL/g (Table 6). This corresponds to weight-average molecular weights between 1074 and
1500 Da. The degree of polymerization (DOP) was found to be 7.32 and 9.90, depending on the
formulation, which suggests that pre-polymer synthesis produces very low molecular weight
oligomers.
Table 6. Molecular Weight Determination of APS Pre-polymers
Pre-Polymer [Tllint (dLg)a  Mb DOP
1DAHP-2G 0.1022 1074 7.32
1DAHP-1G 0.1235 1385 9.44
2DAHP-1G 0.1163 1278 8.72
2DAHP-1T 0.1311 1500 9.90
"Instrinsic viscosity of pre-polymers in HFIP at 30 oC.bWeight average molecular weight determined from Mark-Houwink coefficients of polyamides in HFIPt'9 ].
All formulations exhibited some amount of nitrogen in the network ranging from 2.24 to 4.25%
by mass (Table 7). The While there was no discernable trend in mass density across formulation
or processing, it was found that the 2DAHP-1T formulations had the highest mass density. Sol
content was reduced in networks with high crosslinking relative to networks with low
crosslinking. The low crosslinked 1DAHP-1G formulation had the highest sol content. The
observed hydration of APS networks was highest in 2DAHP-1T formulations. The mechanical
properties of various formulations could be tuned to cover a wide range of modulii and
maximum elongations (Table 9). The 1DAHP-1G formulation cured at 150 oC for 24 h produced
a network with a tensile modulus of 0.563 ± 0.14 MPa and a maximum elongation at break of
151 ± 70%. This contrasted with the 2DAHP-1G and 2DAHP-1T formulations cured at 170 OC
for 48 h which produced networks with tensile moduli of 4.338 + 0.32 MPa and maximum
elongations of 21 ± 2.2%, respectively. Although there was a wide range of mechanical
properties that can be achieved by altering monomer feed ratios and polymerization conditions,
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the water-in-air contact angle was relatively constant across these parameters, ranging only from
90.8 o to 95.8 o (Table 10). However, the glass transition temperature varies widely ranging from
0.13 oC to 48.02 oC (Table 10).
Table 7. Elemental Composition of APS Networks.
Formulation Curing Time (h) C O N
1DAHP-2G 48 81.96 15.15 2.89
1DAHP-2G 96 80.43 15.31 4.25
1DAHP-1G 24 84.52 12.45 3.02
1DAHP-1G 48 82.31 13.31 4.38
2DAHP-1G t  24 80.85 15.18 3.97
2DAHP-1Gt 48 85.76 10.58 3.66
2DAHP-1T* 24 85.48 12.28 2.24
2DAHP-1T* 48 85.40 12.34 2.26
aValues reported in percent by atomic mass.
t.Values taken from [190]
Table 8. Physical Properties of APS Networks.
Formulation Curing Time (h) Density (glcm3) Sol Content (%) Hydration (%)
1 DAHP-2G 48 1.097 15.66% 6.36%
1DAHP-2G 96 1.038 8.31% 10.81%
1DAHP-1G 24 1.042 21.96% 12.51%
1DAHP-1G 48 1.071 12.31% 13.58%
2DAHP-1Gt 24 1.101 16.08% 14.18%
2DAHP-1Gt 48 1.096 6.91% 17.61%
2DAHP-1TI 24 1.114 8.71% 19.81%
2DAHP-1TI 48 1.110 3.51% 15.85%
T'tValues taken from [I90]
Table 9. Mechanical Properties of APS Networks.
Curing Modulus, E Elongation Toughness
Formulation Time (h) (MPa) Max (%) UTS (MPa) (MJIm3) n (molIm3) Mc (g/mol)
1DAHP-2G 48 1.048 ± 0.06 89 ± 26 0.62 + 0.15 0.328 ± 0.16 141 ± 7.60 7784 ± 420
1DAHP-2G 96 1.782 ± 0.25 78± 13 0.86 ± 0.15 0.389 ± 0.12 240 ± 33.1 4330 ± 599
1DAHP-1G 24 0.563 ± 0.14 151 ± 75 0.45 ± 0.22 0.400 ± 0.36 75.6 ± 19.1 13787 ± 3479
1DAHP-1G 48 1.494 ± 0.28 80 ± 31 0.71 ± 0.28 0.372 ± 0.20 201 ± 37.1 5331 ± 983
2DAHP-1Gt 24 2.447 ± 0.33 92 ± 21 1.33 ± 0.25 0.730 ± 0.31 329 ± 45.4 3345 ± 461
2DAHP-1Gt 48 4.338 ± 0.32 64 ± 12 1.69 ± 0.14 0.638 ± 0.18 584 ± 43.6 1879 ± 140
2DAHP-1TI 24 1.449 ± 0.31 60 ± 26 0.39 ± 0.11 0.171 ± 0.18 195 ± 41.5 5718 ± 1219
2DAHP-1T* 48 1.481 ± 0.20 21 + 2.2 0.24 ± 0.50 0.028 ± 0.008 199 ± 26.4 5576 ± 739
T'.Values taken from [190].
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Table 10. Contact Angle and Glass Transition Temperatures of APS Networks.
Formulation Curing Time (h) Contact Angle (0) To (0C)
1 DAH P-2G 48 92.2 0.13
1DAHP-2G 96 90.8 6.51
1DAHP-1G 24 94.0 19.24
1DAHP-1G 48 92.6 21.07
2DAHP-1Gt 24 94.6 33.68
2DAHP-1Gt 48 91.0 38.08
2DAHP-1T* 24 91.5 45.37
2DAHP-1T* 48 95.8 48.02
t"'Values taken from 119.]
B. Degradation of APS Networks
1. In vitro Degradation of APS Networks
The relative susceptibility of APS networks to the domination mechanisms present in vivo was
studied. The in vitro degradation of each polymer formulation under three degradation
mechanisms was studied to determine the effect of each mechanism individually. The mass loss
kinetics of each formulation under different degradation mechanisms is shown (Figure 55
through Figure 58). The generalized mass loss profile consisted of an initial phase of relatively
rapid degradation in most samples. The rate of mass loss then became more attenuated for some
samples such as 2DAHP-1G and 2DAHP-1T formulations. The relative mass loss after 2 wks is
shown in Figure 20. In general, high crosslinked formulations exhibited reduced mass loss after
2 wks when compared to low crosslinked formulations. This trend held true for degradation
under all conditions including acid catalyzed hydrolysis, esterase activity, and proteolytic
degradation conditions. Also, the low and high crosslinked 1DAHP-2G formulation, which
contained the highest ratio of polyol to DAHP, was the most susceptible to degradation by
esterase activity, as determined by the highest relative mass loss after 2 wks. The susceptibility
of APS networks to degradation by esterase was strongly dependent upon the formulation as well
as the crosslinking. Formulations that featured a lower stoichiometric ratio of DAHP to polyol
degraded more rapidly in the presence of esterase. This trend was true across low and high
crosslinked APS polymer networks. In contrast to the biodegradation via esterase activity, the
susceptibility of APS polymers to degradation by proteolytic degradation generally followed a
reverse trend. APS polymer formulations with higher stoichiometric ratios of DAHP to polyol
were more susceptible to degradation by protease activity. The low crosslinked 1DAHP-1G
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formulation was the most susceptible to both acid catalyzed hydrolysis and esterase activity. The
effect of in vitro degradation upon the Tg of the samples was also studied to elucidate the effect
of biodegradation on network properties. The Tg of samples 6 wks post in vitro degradation are
shown in Table 11 and ATg is shown in Figure 21. The acid catalyzed hydrolysis mechanism
was found to greatly reduce the Tg across all formulations. However, the reduction in Tg of APS
networks degraded in the presence of both esterase and protease activity was subdued
dramatically. In some cases, ATg was observed to be positive: this indicates that the glass
transition temperature increased, despite the fact that substantial mass loss was observed. An
explanation for this observation is proposed (See Discussion). It should also be noted that data
was not available for samples (denoted by #) that were completed degraded after 6 wks.
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Figure 20. Susceptibility of APS Polymers to in vitro Degradation.
Mass loss at 2 wks suggests that APS polymers were able to be degraded by (a) acid catalyzed hydrolysis, (b)
esterase activity, and (c) proteolytic degradation. The dominant degradation mechanism varied according to
formulation. In general, high crosslinked APS polymers were less susceptible to degradation across all
mechanisms when compared to low crosslinked APS polymers of identical formulation.
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The effect of in vitro degradation upon the Tg of the samples was also studied to elucidate the
manner of biodegradation. The Tg of samples post 6 wks in vitro degradation are shown in
Table 11 and ATg is shown in Figure 21. The acid catalyzed hydrolysis mechanism was found to
greatly reduce the Tg across all formulations. However, the reduction in Tg of APS networks
degraded in the presence of both esterase and protease activity was subdued dramatically. In
some cases, ATg, was observed to be positive: This indicates that the glass transition temperature
increased, despite the fact that substantial mass loss was observed. An explanation for this
observation is proposed (See Discussion). It should also be noted that data was not available for
samples (denoted by #) that were completed degraded after 6 wks.
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Figure 21. Effect of in vitro Degradation on Glass Transition Temperatures of APS Polymers.
The ATg (see text) of (a) low crosslinked and (b) high crosslinked APS polymers after 6 wks of in vitro
degradation are shown across formulations and degradation mechanisms. The symbol # indicates that data
was unavailable for these samples because they were fully degraded after 6 wks.
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Table 11. Glass Transition Temperatures of Biodegraded Samples.
Formulation Curing Time (h) Pre-Degradation Hydrolysis Esterase Protease In vivo
1DAH P-2G 48 0.13 -11.36 --- 9.66 -3.49
1DAHP-2G 96 6.51 -12.96 --- 2.57 ---
1DAHP-1G 24 19.24 11.64 --- 24.1 ---
1DAHP-1G 48 21.07 7.86 22.82 23.31 ---
2DAHP-1G 24 33.68 33.45 40.86 42.51 ---
2DAHP-1G 48 40.29 10.00 42.56 42.09 14.60
2DAHP-1T 24 45.37 33.91 46.48 46.42 ---
2DAHP-1T 48 48.02 23.46 46.38 47.84 17.19
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2. Gross Morphological Changes of APS Polymers During in vivo
Degradation
The gross morphology of the explants monitored at predetermined time points is shown inFigure
22. Although PLGA implants were initially optically clear, they became opaque within only 1
wk. PLGA implants also became swollen with deformed geometry. 1DAHP-2G, 2DAHP-1G,
and 2DAHP-1T formulations were optically clear prior to implantation and remained optically
clear throughout the first and second predetermined time points (Figure 22). SEM images of
PLGA suggest that the degradation of PLGA implants is primarily due to decay of the material
from within the bulk phase. SEM images of 2DAHP-1G, and 2DAHP-1T suggest that the
surface of the implant begins eroding very slowly after 14 wks, but show appreciable surface
erosion after 28 wks (Figure 23). 1DAHP-2G formulation exhibits evidence of surface erosion
after 2 wks and continued erosion at 4 wks. PLGA implants exhibited erosion throughout the
bulk of the material at 2 wks with accompanying surface fracture formation after 4 wks. The
bulk material within PLGA at 4 wks consisted of an amorphous gel.
PLGA 1DAHP-2G 2DAHP-1G 2DAHP-1T
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Figure 22. Gross Morphology of APS in vivo Explants.
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Figure 23. SEM Micrographs of APS in vivo Explants.
Disc-like explants were sectioned and imaged using SEM at the following orientation (a) where the field of
view of the SEM images is indicated by the dotted red area. b) The bulk material of PLGA explants were
porous while the surface remained intact at 2 wks. However, at 4 wks, the PLGA explants exhibited surface
fractures while the bulk material consisted of a viscous gel (not shown). 1DAHP-2G explants exhibited
surface erosion with little bulk degradation over the same time period. At 4 wks, 1DAHP-2G explants
exhibited degradation via significant surface erosion. 2DAHP-1G and 2DAHP-1T also exhibited surface
erosion, albeit at a much slower rate. Explants at 14 wks indicate only slight surface erosion while explants
removed at 28 wks exhibited significant erosion for both polymers. Scale bars represent 30 microns.
3. Time Course of Critical Properties of APS Polymers During in vivo
Degradation
The in vivo degradation of APS was studied by monitoring relevant properties of the implant
material including mass loss, swelling, and compressive modulus using PLGA as a control
biomaterial for comparison (Figure 24). All APS formulations exhibited an initial decrease in
both mass loss and compressive modulus and an increase in swelling after 2 wks post-
implantation. The 1DAHP-2G formulation samples then exhibited a linear decrease in mass and
modulus throughout the remainder of the life of the implant. The swelling continued to increase
linearly and then plateaued at 60% (w/w) at 12 wks at which point polymer was almost
completely resorbed, making accurate mechanical measurements nearly impossible. 2DAHP-1G
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and 2DAHP-1T formulations exhibited a very slowly decreasing mass loss and a stable amount
of swelling from 2 wks to approximately 20 wks. During this time, however, the modulus
continued to decrease substantially. The 2DAHP-1G and 2DAHP-1T implants experienced
approximately 19.3 i 9.5% and 17.5 + 1.6% mass loss after 36 wks, respectively. The gradual
and mild changes of the properties of APS polymer implants lie in stark contrast to the kinetics
observed for PLGA implants. The mass loss is gradual up to 4 wks at which point there is a
catastrophic reduction in mass. A similar trend is observed with swelling in which the amount of
swelling is stable until 4 wks at which point there is a significant increase observed at 8 wks.
The compressive modulus is observed to decay linearly with time throughout the life of the
implant. However, this apparent linear decay is likely an artifact from the in vivo degradation
characteristics of PLGA. PLGA implants were almost completely resorbed by 8 wks, which
made accurate mechanical measurements nearly impossible.
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Figure 24. In vivo Degradation of APS Elastomers.
Mass, hydration, and compressive Young's modulus were monitored throughout in vivo degradation in (a)
PLGA, (b) low crosslinked 1DAHP-2G, (c) high crosslinked 2DAHP-1G, and (d) high crosslinked 2DAHP-1T.
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The glass transition temperature of in vivo explants was measured to compare with non-degraded
samples (Table 11). The ATg was measured for 1DAHP-2G after 2 wks and 2DAHP-1G and
2DAHP-1T after 14 wks. The ATg for these specific APS elastomers was measured to be -3.62, -
25.69, and -30.83 oC, respectively (Figure 25).
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Figure 25. Effect of in vivo Degradation on Glass Transition Temperatures of APS Polymers.
The T, of all formulations were reduced upon in vivo degradation. The 2DAHP-1T formulation experienced
the largest decrease with a reduction by 30.83 OC.
IV. Discussion
A. Tunable Physical Properties of the APS Networks
The synthesized APS pre-polymers consisted of low molecular weight oligomers, which
exhibited only minor dependence upon formulation with the exception of the 2DAHP-1T
formulation. The slightly higher molecular weight of the pre-polymer is likely due to the higher
degree of functionality of the D,L-threitol, which presents four hydroxyl groups for
polycondensation. The chemical composition of the final APS networks was observed to be vary
with both composition and processing conditions. Increasing the ratio of DAHP in the
formulation did not necessarily lead to a corresponding increase in the relative amount of
nitrogen in the final network. However, changes in nitrogen content were inversely correlated
with changes in carbon content. For example, when the relative amount of nitrogen decreases,
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the percent carbon increases (Table 7). This is likely due to the incorporation of proportionally
higher molar ratios of sebacic acid within the network which would induce this coupled effect.
In general, increasing the crosslinking led to a decrease in sol content and a corresponding
increase in tensile modulus (Table 8; Table 9). A wide range of mechanical properties were
achieved as the tensile modulus spanned nearly one order of magnitude. This wide range of
properties can be attributed to the altering the monomer feed ratios as well as the temperature
and duration of thermal curing (130 oC to 170 oC for between 24 and 96 h). The effect of
crosslinking on modulus was fairly pronounced for most formulations with the exception of
2DAHP-1T. Increased crosslinking only led to a marginal increase in modulus and minor
alterations in elemental composition, sol content, and hydration for the 2DAHP-1T formulation.
In addition to mechanical properties, a wide range of glass transition temperatures from 0.13 to
48.02 oC were achieved by altering the stoichiometry of the reactants as well as the curing
process. The Tg in APS networks is primarily influenced by the crosslinking density and the
relative presence of amide bonds. Amide linkages have limited bond rotation[ 184] and therefore
ultimately lead to an increase in Tg.[192] The Tg increased dramatically as the molar ratio of
DAHP was increased. Furthermore, the Tg was increased in conjunction with increasing
crosslinking density.
B. Mass Loss Kinetics of APS Polymer Degradation in vitro
All formulations were susceptible to in vitro degradation by the investigated mechanisms of acid
catalyzed hydrolysis, esterase activity and proteolytic degradation. The observed rapid, initial
mass loss is likely due to the immediate cleavage of loosely bound oligomers within the network.
The gradual mass loss after this point suggests that APS elastomers undergo degradation in all
examined degradation media. These degradation profiles are in contrast to in vitro degradation
of PLGA via acid catalyzed hydrolysis, which has been studied previously.[E93 1 PLGA retains the
majority of its mass until a critical time point in which dramatic mass reduction is experienced.
Similar mass degradation profiles have also been observed in the in vitro degradation of PLGA
slabs and films in PBS. [194' 195] This characteristic degradation profile suggests bulk degradation
of the sample. The kinetics that governs the precise time point at which drastic degradation
commences depends upon polymer formulation and degradation conditions. The kinetics of APS
network degradation can also be tuned. For example, higher crosslinked formulations degraded
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more slowly across all degradation conditions (Figure 20). This trend is expected since higher
crosslinked materials require more bonds to be dissociated prior to appreciable mass loss. The
increase in observed degradation rate of 1DAHP-2G in the presence of esterase is likely due to
the higher incidence of esters relative to amides, which can be inferred from the initial glass
transition temperatures. Conversely, the higher incidence of amides relative to esters can also
explain the slower degradation of 2DAHP-1G and 2DAHP-1T formulations. A similar argument
can be presented to explain the observed trends in degradation susceptibility of APS polymers in
protease solutions. Namely, APS polymers with higher stoichiometric ratios of DAHP likely
contain a higher incidence of amides, which are susceptible to proteolytic degradation. APS
polymers with higher stoichiometric amounts of polyols likely contain more esters and therefore
less susceptible to proteolytic degradation. The outlier case of the high crosslinked 1DAHP-1G
polymer can likely be attributed to a significantly lower crosslinking density, as inferred by the
reduced tensile modulus.
C. Trends in Glass Transition Temperature of Degraded APS Polymer
Networks
We anticipated there to be a reduction in Tg, corresponding to ATg < 0, after 6 wks of in vitro
degradation across all degradation mechanisms. The supposed reduction of Tg can be attributed
to the cleavage of bonds, which ultimately leads to the increase in free chains throughout the
network. The increase in free chains could lead to increased branching and free volume within
the network, which in turn lowers the Tg. While, this trend was observed in the case of acid
catalyzed hydrolysis, it was not observed in the cases of esterase activity or proteolytic
degradation despite the fact that significant mass loss of the network is observed in all studied
scenarios. In the case of acid catalyzed hydrolysis, the proton species that induce hydrolytic
cleavage of ester bonds can migrate throughout the APS network and can access virtually every
bond. Therefore, this leads to an increase in free chains through bond cleavage. In the case of
enzymatic degradation, we submit that the enzymes are too large to diffuse through the network
and access all of the ester and amide linkages (the molecular weights of bovine cholesterol
esterase and protease XIV are 67 kDa [196] and 16-27 kDa,197] respectively). Instead, we
hypothesize that the enzymes are able to cleave only accessible chains, which is a mere fraction
of the total network mass. The cleavage of accessible chains leads to an overall decrease in
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amount of free chains throughout the network, which effectively increases the Tg. The creation
of free chains by hydrolysis and local networks accessible by enzymes and the elimination of
free chains by cleavage produce two counteracting effects on the final Tg. This could explain
why the ATg of some APS polymers which undergo degradation via enzymes are negative while
others are positive. Also, this theory is consistent with the observed trend in which the ATg is
negative for all APS polymers which undergo acid catalyzed hydrolysis. It should also be noted
that the contribution of acid or base catalyzed hydrolysis in the enzymatic degradation solution is
considered to be negligible since the enzyme solutions are prepared in DPBS with a pH of 7.2 in
which proton concentration is roughly 100X less than 3M sodium acetate (pH of 5.2).
D. Tunable in vivo Degradation of APS Polymers
The in vivo degradation kinetics of APS polymers contrasts significantly from the degradation
kinetics of PLGA in this study. As the PLGA implants degraded, outer and inner regions of the
implant were observed. The outer region is composed of solid PLGA which encapsulated the
swollen, rapidly degrading interior gel region. As the interior region of the implant becomes
highly degraded and loses mechanical integrity, the overall effective bulk compressive modulus
of the implant is reduced. However, it the degradation of the internal region appears to be
dominant, and therefore governs the overall loss in mechanical properties. The observed mass
loss profile of PLGA slabs in vivo in this study is similar to previously reported mass loss
profiles of PLGA.[ 127' 193]
E. In vivo Degradation Mechanism of APS Polymers
All APS polymer implants exhibited a characteristic rapid, initial decay in both mass and
compressive modulus in vivo, which has been observed in other biodegradable elastomeric
polymers in vivo as well. [1 27' 160, 161] We hypothesize that this decay is due to the initial
degradation of both free chains and crosslinked chains with accessible bonds, which corresponds
not only to a reduction in mass, but also a reduction in compressive modulus. The plateau in
mass loss and compressive modulus is realized as the number of accessible bonds that can be
enzymatically degraded becomes exhausted. Degradation of locally crosslinked regions
continues primarily via acid catalyzed hydrolysis. Enzymatic activity can also contribute
significantly to degradation. We propose that the degradation mechanism for APS elastomers in
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vivo is a combination of both hydrolysis and enzymatic degradation, the dominant component of
which is contingent upon polymer formulation.
Consider the in vivo degradation of the IDAHP-2G formulation cured for 24 h. This material
was extremely susceptible to in vitro degradation via esterase (Figure 20b). The significant loss
of mass and modulus at 2 and 4 wks was accompanied by surface erosion (Figure 23).
Furthermore, the glass transition temperature was reduced only slightly (Figure 25). Taken
together, these data imply that the degradation was due to significant contributions from both
hydrolysis and enzymatic activity. Consider the in vivo degradation of the 2DAHP-1G and
2DAHP-1T formulations cured for 48 h. These formulations were significantly less susceptible
to enzymatic degradation through both esterase and protease activity. The significant loss of
mechanical modulus without significant mass loss (Figure 24) suggests that the crosslinks are
being cleaved without being fully detached from the network. This is consistent with the lack of
pore formation throughout the bulk of the network (Figure 59). Although surface degradation
through presumed enzymatic activity was observed at 14 and 28 wks, the ATg of 2DAHP-1G and
2DAHP-1T in vivo explants was found to be significantly negative, which is a similar
observation in the case of in vitro degradation via acid catalyzed hydrolysis. This suggests that
the creation of free chains is dominant, relative to the cleavage of free chains, which implies
hydrolysis is the primary mechanism for degradation of 2DAHP-1G and 2DAHP-1T APS
polymers in vivo. The origin of hydrolytic species is thought to be produced from two primary
sources. First, degraded sebacic acid species within the hydrated network can ultimately reduce
the local pH. Second, it is known that implants from synthetic materials often result in the
formation of fibrous capsules, which can lead to hypoxic conditions within the implant region.[21]
Depending upon the specific monomer chemistry, these hypoxic conditions can lead to local
regions of high acidity. In the case of APS elastomers which have a higher stoichiometric
amount of carboxylic acid groups relative to amines, it is hypothesized that a hypoxic region in
combination with a contribution from degradation by-products can produce a locally acidic
environment which in turn can lead to degradation of APS polymers primarily through acid
catalyzed hydrolysis.
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V. Conclusions
The properties of APS elastomers can be tuned by adjusting the stoichiometric ratios of the
starting monomers as well as the processing conditions. A wide range of chemical, physical, and
mechanical properties can be achieved including the tunable biodegradation. Although APS
elastomers could be biodegraded in vitro via a number of mechanisms including acid catalyzed
hydrolysis, esterase activity, and proteolytic degradation, the primary degradation mechanism in
vivo appeared to depend upon the formulation. APS elastomers can be engineered to exhibit a
wide range of half-lives in vivo, which potentially makes it a suitable biomaterial for
applications in scaffold fabrication for potential use in a wide range of tissue engineering
applications. Slowly degrading formulations could also be potentially more desirable for semi-
permanent implantable device applications because of the gradual decay of implant mass and
maintenance of mechanical integrity.
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Chapter 6: Commentary on the Future of
Microfabricated Scaffolds and Materials in Tissue
Engineering
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I. Microscale Fabrication Techniques for Scaffold Fabrication
Engineering the spatial and temporal microenvironment on a precise level is critical for inducing
the desired cellular response, which is especially important in the field of tissue engineering and
organ regeneration. Consequently, designing the micro-architecture of scaffolds used for said
applications is an important first step in inducing favorable cell-matrix and cell-cell interactions.
The need for microscale control has led to the development of a number of fabrication routes that
are able to control spatial location of scaffold features. One viable model that has produced the
current state of the art, and may continue to direct progress in the field of advanced scaffold
manufacturing, is the adaptation of tradition materials processing techniques. Replica molding,
electrodeposition, and solid free-form fabrication all represent examples of general material
processing techniques that have been applied to develop advanced processing platforms for
scaffold fabrication. This trend will likely continue as future technologies begin to mature such
as self-assembly and three-dimensional photolithography, for example. The adaptation of
nascent materials processing technologies in the development of scaffold systems, where
appropriate, could lead to advances in organ regeneration with the potential for clinical therapy.
II. The Future of Scaffold Design and Biomaterial Synthesis
Oftentimes, the driving force for scaffold design and fabrication is the desire to create a
biomimetic system. This manifests itself into designing materials and processes that try to
mimic tissue properties such as micro-architecture, mechanical properties, surface topography, or
chemical cues. There notion for the pursuit of biomimicry as effective design criteria for organ
regeneration may or may not prove to be the most efficient means. However, for the time being,
biomimetic strategies for scaffold fabrication provide challenges that drive the overall
improvement of tissue engineering systems and technology. Advancing engineering systems at
the present will therefore mature the technology in anticipation for the application of knowledge
to be gained by future advancements in unraveling the complexity of biological systems such as
the further elucidation of the proteome and the mapping of cell signaling networks. Hence, the
full potential of organ and tissue regeneration therapy in the future may only be realized upon
combining advanced scaffold fabrication techniques with design criterion outlined by
information of fundamental biological processes derived from integrated systems biology.
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Introduction to Nanotopography for Tissue
Engineering
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Chapter 7:
I. Contact Guidance and Substratum Cues in Native Tissues
A. Extracellular Matrix Proteins in vivo
Native extracellular matrix (ECM) proteins serve a multitude of function within the in vivo
microenvironment. Some examples of ECM proteins include fibronectin, victronectin, laminins
(A, B1, B2), Collagens (I, II, IV), and thrombospondin.1198' 199] At the primary level, ECM
proteins provide mechanical structure to support and protect attached cells. The rigidity of these
ECM proteins provides a suitable substrate with appropriate stiffness to counteract contractile
forces imposed on the surroundings by cells such as contractile fibroblasts and myofibroblasts.
The Young's modulus of ECM proteins can vary between 0.3-0.6 kPa for native elastin[200] and
34 MPa for hydrated collagen. [20 11 The Young's modulus of single molecules of collagen has
been measured to be as high as 2.9-9.0 GPa.[20 2] It is also widely known that the contractiility
forces imposed upon the ECM is both a function of the matrix as well as the cell type. The bulk
mechanical properties of the subsrate can provide a suitable method to modulate cell behavior on
synthetic substrates including cell adhesion [203] and spatial sequestration for micropatteming. [204]
The role of the interplay between mechanical forces and ECM protein function has been
extensively reviewed elsewhere.[ 205] While it is tempting to consider only the mechanical aspects
of ECM proteins, it is important to recognize the instrumental role that they play in controlling
cell function through via other physicochemical mechanisms. Most ECM proteins possess
specific cell-binding domain sequences that control cell function (Table 12). For example,
fibronectin, vitronectin, collagen I, and thrombospondin all contain amino acid sequences of
arginine-glycine-aspartic acid (RGD),[ 198' which is known to support the adhesion of many cells.
From this and other examples, it is known that the ECM proteins present chemical moieties that
are responsible for governing a variety of functions including adhesion, migration, and extension
of cellular protrusions such as neurites, lamellipodia, and filopoda. [206] Another aspect of ECM
proteins that is extremely important is the structural component that guides cell function through
topographical cues. Collagen I, for example, is an ECM protein that contains a repeating
structural element due to banding that occurs at a pitch of 66 nm. [20 7] Although the physical
dimensions of individual molecules is 300 nm in length and 1.5 nm in width, [20 81 these individual
molecules can form fibrils that extend for tens of microns in length and have diameters between
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260 and 410 nm. [ 209] The basement membrane of the corneal epithelium in macaque monkeys,
which is primarily made of collagen IV, is know to contain nanotopography with feature heights
between 76 and 319 nm and pore sizes of 22 to 216 nm with interpore distances of 87 nm.[210 ]
The basement membrane of the human corneal epithelium also has a sub-micron feature
scale.[ 211] The nanometer scale dimensions of these ECM molecules combined with the ability of
cells to detect the features via binding sequences presented by the ECM presents a flexible
framework with which to guide a multitude of cell functions including differentiation and
migration in mature cells and development and organogenesis in developing embryos.
Table 12. Selected Cell-Binding Domain Sequences of Extracellular Matrix Proteins.
Protein Sequence Role
Fibronectin RGDS Adhesion of most cells via aCs53
LDV Adhesion
REDV Adhesion
Vitronectin RGDV Adhesion of most cells via av33
Laminin A LRGDN Adhesion
SIKVAV Neurite extension
Laminin B YIGSR Adhesion of many cells via 67-kDA laminin receptor
PDSGR Adhesion
Laminin B2 RNIAEIIKDI Neurite extension
Collagen I RGDT Adhesion of most cells
DGEA Adhesion of platelets, other cells
Thrombospondin RGD Adhesion of most cells
VTXG Adhesion of platelets
a Reproduced from Hubbell (1995) after Y Yamada and Kleinman (1992).[J19 1991
B. Contact Guidance of Cells in Native Extracellular Matrix Proteins
1. Migration
Contact guidance plays an important role in guiding various cell functions in a variety of in vivo
environments. One of the most important aspects of contact guidance that plays an integral role
in organizing the spatiotemporal environment of cells is directed migration. The migration of
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cells through the ECM in an in vivo environment is modulated by the guidance of cells via
organized ECM proteins.1 2121 Migration can also be influenced by surrounding cells as in the
case of in vivo migration of fibroblasts[ 2131 and in the coordinated migration of epithelial cells on
a collagen substrate in vitro.[214] T cell migration is also known to be highly dependent upon
cell-biomaterial interactions with native ECM proteins. [215] The role of contact guidance can also
be important in the migration of individual cells, or groups of cells or tissue.1 216] For example,
the migration of nematocytes in hydra is guided bidirectionally by epithelial muscle processes,
which produce a fibrous mat.1217] It should be noted that this process occurs in the absence of
any perceivable chemotactic gradient. Yet another example of enhanced migration via contact
guidance in vivo occurs in amphibian gastrulation. [218] During migration, mesodermal cells form
lamelliopdia and filopodia. A network of extracellular fibers within the ectodermal layer
provides substratum cues that guide the migration of the aforementioned mesodermal cells.
From these examples, it appears that contact guidance not only plays a pivotal role in vivo in
mature cells, but also in organizing the migration of cells during development. Although the
specific mechanism of these functions is relatively unclear, it is known that ECM proteins play a
critical role in guiding the migration of cells.
2. Axonal Guidance
The guidance of neuronal development is also heavily dependent upon spatial cues that are
dictated by surrounding ECM proteins in vivo.12 19] One such example is the directed migration
cells of the neural crest in embryonic development. [2 0 ] The interactions of external signals
provided in part by ECM proteins play a crucial role in axonal guidance and growth cone
motility.1 22 ] The regulation of these processes is heavily dependent upon signaling via small
GTPases, which are responsible for successive stages of axon and branch growth. In general,
ECM proteins also provide a framework that provide neuronal cells with the necessary cues that
govern the function and fate. Again, the precise nature of these contact guidance responses is yet
unknown.
3. Polarization
The polarization of cells and tissues is often a critical component of maintaining appropriate
cellular functions. Even in unicellular organisms, it is important for biased directionality and
polarization to be maintained to execute a variety of cell functions. For example, yeast budding
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requires internal polarization for efficient budding.I222] It is known that ECM proteins such as
collagen and fibronectin can also provide a structural basis by which cells and tissues can
organize polarized constructs, although the exact mechanism is still unclear.[223] The production
and maintenance of polarized epithelial cells is critical in being able to maintain appropriate
function in vivo. For example, the formation of apical basolateral polarity in epithelial cells is
essential in defining the direction of biased transport and columnar morphology. [2241 It is thought
that the formation of cell-cell junctions, which are regulated by small Rho GTPases, signal a
cascade of events that lead to the definition of this polarity. Rho GTPases also contribute to
other polarized aspects of epithelial cells including directed transport. [225] In general, contact
guidance of cells is essential in being able to maintain proper cell function. The source of
contact guidance signals is almost invariably some combination of ECM proteins and cell-cell
contacts. Nonetheless, these external physical signals including topographical cues can
significantly influence cell function.
C. The Roll of Small GTPases in Cytoskeleton Remodeling and
Contact Guidance
Cell interaction with topography is only one of the multifactorial components that govern cell-
biomaterial interactions. Although there are cellular components that are known to modulate the
topographical component of cell-biomaterial interactions and therefore presumably contact
guidance both in vitro and in vivo, the precise mechanism of contact guidance has yet to be
elucidated. Therefore, the treatment on this subject will be brief. The response of cells to
synthetic substrate nanotopography (Disucssed in Section IV: Cellular Responses to Artificial
Nanotopography) is a useful tool for elucidating the underlying mechanisms of the coupled
contact guidance response. At the fundamental level, the contact guidance response is a
manifestation of response of the cytoskeleton to the chemical, physical, and topographical cues
that the substrate presents. While it is true that cytoskeleton signaling can directly impact other
cell functions through a variety of crosstalk mechanisms, it is important to understand the
primary signaling pathways of cytoskeleton rearrangement at a fundamental level. There has
been a large body of work regarding the role of small guanosine triphosphatases (GTPases) [226 ] in
the organization and remodeling of the cytoskeleton.[2 27 ] The Rho family of GTPases controls
the assembly of actin stress fibers and focal adhesion complexes. The Rac family regulates the
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accumulation of actin filaments within the plasma membrane to produce lamelliopdia and
membrane ruffles. Cdc42 signalling stimulates the formation of filopodia. There has been an
astronomical body of work performed on the family of small GTPases. The detailed role of the
Rho family of small GTPases as well as their downstream effector proteins has been reviewed
significantly elsewhere. 2[ 8] There are two intriguing aspects of this family of signaling proteins:
1) There is significant crosstalk within this family of proteins as one pathway regulates one
another, and 2) although the Rho family of GTPases is primarily involved in the regulation of
cytoskeleton function, they are directly related to controlling other cell functions including
migration and the regulation of transcription factors. Therefore the following is a brief
description of the role of each of the small GTPases with respect to the potential role in contact
guidance in vivo and in vitro.
1. Rho
The Rho family of small GTPases is responsible for the formation of contractile actin-myosin
fibers, termed stress fibers, within the cell. The dynamics of stress fiber formation and
remodeling are responsible in part for enabling cell motility during migration. Rho signaling is
also responsible for the formation of focal adhesions. Focal adhesions are clusters of proteins
that form in specific locations during cell-matrix and cell-cell contacts. [229] It is thought that the
Rho pathway interacts directly with the cytoskeleton by regulating the phosphorylation of
myosin light chain fragments. This phosphorylation is hypothesized to lead to bundling of actin
complexes, which in turn lead to the formation of integrins. [230] Rho also serves other roles that
provide potential avenues for crosstalk signaling between cytoskeleton remodeling and other cell
functions. For example, Rho mediates a signal transduction pathway that links lysophosphatidic
acid receptors to the activation of transcriptions factors. [230] Therefore, Rho signaling not only
plays an instrumental role in the cytoskeleton remodeling and activity, but can also control other
essential cell functions and determine cell fate.
2. Rac
The Rac pathway is primarily responsible for the formation of lamellipodia. Lamellipodia are
projections composed of cytoskeleton actin at the leading edge of cells. Lamellipodia are
primarily found in mobile cells, which emphasizes the role of Rac and lamellipodia formation in
migration. For example, Rac has been implicated in lamellipodia formation and migration in
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endothelial cells.[231] Lamellipodia formation also utilizes the focal complexes, which modulate
cell-matrix and cell-cell interactions. The Rac pathway is also responsible for growth factor-
dependent membrane ruffling in numerous cell types including fibroblasts.[232] Membrane
ruffles are a sub-structure of the cytoskeleton, which are formed by the accumulation of actin
filaments at the membrane edge. The asymmetry of membrane ruffles is another aspect of cell
polarity, which is established by Cdc42. Furthermore, Rac signaling, in conjunction with Rho, is
also implicated in the formation of stress fibers.
3. Cdc42
Cdc42 is an integral small GTPase signaling pathway. Cdc42 is responsible for the formation of
filopodia and small "focal complexes", which are, simply put, smaller and more dynamic
versions of focal adhesions. 12291 Filopodia are bundles of aligned actin fibers that extend from
the cell body of many cells types. Filopodia are hypothesized to play an important role in
detecting the physical properties of the immediate surrounding microenvironment, a
phenomenon that has been observed in fibroblasts [233] and neuronal growth cones. [234]
Mesenchymal cells from sea urchins have been shown to extend filopodia on the order of 500 nm
to probe and explore the surrounding environment. [235] Filopodia, as regulated by Cdc42
activation, are also thought to be responsible for synthesizing internal cell signaling to define
polarity. [236]
II. Introduction to Nanotopography for Tissue Engineering
The previously mentioned topographical cues of ECM proteins and the ability of mammalian
cells to detect these through the formation of filopida highlight what is now known as the
influence of topographical cues on cell function. These cues play instrumental roles in a variety
of cell functions including directed migration and maintenance of polarization for maintaining
proper cell function. Furthermore, understanding the fundamental mechanisms of these
collective contact guidance responses could aid in the engineering of cell-biomaterial
interactions to influence desired cell responses. However, to accomplish this broad goal, micro-
and nanofabrication technology must be developed sufficiently to enable the fabrication of
synthetic structures. The following section outlines a variety of micro- and nanofabrication
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strategies for producing synthetic topographical cues across a wide range of length scales in a
wide array of biomaterials including natural and synthetic polymers.
A. Strategies for Improving Tissue Scaffold Functionality
The design and engineering of suitable biodegradable scaffolds is central to the field of tissue
engineering and organ regeneration. Traditional advancements in scaffold fabrication have
focused developing new types of biomaterial systems with more desirable characteristics such as
reduced toxicity or immune response, increased strength, or elastomeric properties. Parallel
fabrication strategies have also been improved and developed to accommodate novel bio-
polymeric systems and to some extent have also been modified to improve and control a
similarly defined parameter-space including, for example, biocompatibility, pore size, porosity,
and pore connectivity.1122] Integrating drug delivery techniques to administer appropriate growth
factors or growth-factor encoding plasmids can lead to improved cell and tissue function and in
some cases can promote improved tissue function and vascular genesis within the construct.[6' 237]
This general approach has been shown to be useful in the application of designing systems to
support the growth of small volumes of simple tissues of primarily one cell type such as the
epidermis, cartilage or the bladder.[ 238] Complex or highly vascularized organs such as the
muscle, liver or kidney require the integration of many cells phenotypes where the functionality
of the organ is highly dependent upon spatially defined microenvironments and subsequent
heterotypic cell-cell interactions. While there have been substantial advancements in
engineering vascularized scaffolds through a variety of mechanisms including co-cultures,
controlled release, gene delivery and scaffold properties, 6' 12, 22,237] the inability to produce large
volumes of organs is still problematic. Controlling the mechanical, chemical, and spatial cellular
microenvironments within a scaffold is essential to designing tissue engineering systems. Of
particular interest is the ability to harness the power of synthetic nanotopographical features to
control cell fate and function.
B. Synthetic Micro and Nanofabrication Techniques for Improved
Tissue Engineering Scaffolds
The integration of micro- and nanometer scale technologies with biology and bioengineering has
led to significant advancements in the field of tissue engineering. Probing cells and biological
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systems with tools that operate at the micron and sub-micron length-scales have led to the
elucidation of some of the fundamental parameters of the cellular microenvironment that
influence cell processes and phenotype. Studying and controlling cell-matrix interactions is also
of extreme importance. While the chemistry and biology of cell-matrix interactions has been
studied extensively, the topography of this interface also plays an important role in regulating
cell function. The extracellular matrix is known to contain nanometer scale features, which
provide cues that influence essential cell functions such as proliferation, migration, and
spreading. Numerous synthetic systems with a variety of sub-micron scale feature sizes and
geometries have been used to study the behavior of cells in response to substrates rich in
nanometer scale topographical cues.127] Cells have also been known to respond to randomly
oriented topography such as nanometer scale roughness in addition to well-defined substrates
with sub-micon-scale fabricated features. Ordered topographic features on the order of 1 micron
or smaller can influence a number of cell functions including cell attachment, morphology, and
directed migration which are important cellular processes to control in fabricating cell-scaffold
constructs. Cell alignment, for example, has been shown to play an important role in developing
stronger tissues in the cases of smooth muscle cells, skeletal muscle, and fibroblasts.
Topography has also been shown to influence the gene profilel28 3 including the upregulation of
fibronectin mRNA levels in fibroblasts.[291 The generalized reaction of cells to topography has
been studied extensively.[27,30, 311 Techniques for fabricating functional topographical substrates
will be briefly reviewed followed by a summary of the current state of the art of cellular
responses to nanotopography.
III. Fabrication Methods for Nanotopographic Substrates
Manipulating cell geometries on the micron scale can lead to precise control over cell functions
such as differentiation, migration,[24] proliferation, and cell fate. 126] In addition to spatially-
dependent signals in homogenous cell populations, heterotypic cell-cell interactions have also
been proven critical in controlling cell function.[1421 Because nearly all functional tissues are
heterotypic, precisely defining the spatial organization of multiple cell types has been shown to
lead to improved function of said tissues. As the complexity of the organ increases, so does the
importance of precisely defining appropriate cell-cell interactions.
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A. Polymer Demixing and Microphase Separation
Capitalizing on characteristic phase separation behavior of polymer solutions and polymer
blends is another route toward developing systems for use as scaffolds with ordered features on
the micron and sub-micron length scale. The micro phase morphology and characteristic length
scale of features in polymer blends can be tuned by adjusting thermodynamic-dependent
parameters such as the composition of the blend and kinetic parameters such as temperature,
which govern the potential for spinodal decomposition and subsequent polymer demixing. The
most commonly observed microphase morphologies are spherical, cylindrical, and lamellar,
although numerous other classifications of morphologies have been observed in a variety of
systems including block co-polymer blends. [23 9] Modification of these bulk polymer blends via
selective polymer etching or dissolution could lead to the potential for development of ordered
tissue engineering scaffolds with micron scale geometries that are physiologically relevant for
numerous applications. The phenomenon of polymer de-mixing and phase separation can also
be adapted to the development of thin films as a method for chemical-induced topological
modification. For example, partially compatible polymer blends spin coated into a thin film can
produce topographically rich surfaces with structures of rounded pillar morphologies on the
order of 100 nm in height and width. [240] Surfaces with polymer demixed nanotopography have
been shown to affect the growth and spreading of human fibroblasts, for example. Further
development of a similar process could lead to the development of integrating topographically
rich surfaces with complex three-dimensional porous structures that enable the uniform
presentation of topographical cues throughout the spatial extent of the scaffold. Electrospinning
polymer blends provides another route for fabrication of nanometer-scale fibers with co-
continuous phase separation by using ternary mixtures of PLA and poly(pyrrolidone).[241
Freeze drying presents another possible route to producing scaffolds with micron scale
features,,242] although the control of spatial locations and distributions is reduced. A typical
freeze-drying procedure begins with the addition of water to a solution of PLGA in methylene
chloride. The solution is homogenized, poured into the appropriate mold, and then quenched
rapidly at approximately -180 oC using liquid nitrogen. This rapid quenching step leads to
immediate phase separation within the scaffold, which is then freeze dried to remove the water
and residual solvent. This process can produce scaffolds with pore sizes in the range of 15 to 35
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microns, which can be as small as one order of magnitude smaller than the standard PLGA
scaffolds fabricated using traditional porogen-leaching process. A similar method has been
demonstrated in the production of porous PLA scaffolds with incorporated bioactive
molecules.[ 2431 The potential advantages of this and similar systems for tissue engineering
applications are numerous and somewhat obvious. Drug release experiments suggest that
slightly elevated temperatures in the range of 55 OC to 85 oC and the presence of organic solvents
during preparation of these scaffolds has shown to slightly negatively impact the activity of the
released molecules. However, in terms of engineering the microscale structure of these scaffolds,
precise control of pore size, geometry, and interconnectivity is severely limited by the deferral to
equilibrium processes in the preparation of such scaffolds. This leads to control of the averaged
scaffold features, which can be manipulated through adjusting processing parameters. Another
adaptation of this technique is the solution deposition of polymeric nanoparticles onto a surface.
By controlling the diameter of the solution phase processing of the particles prior to deposition,
the effective length scale of the topography can be controlled. This technique was used by
Lipski et al in the synthesis of nanotopographic substrates for the culture of human mesenchymal
progenitor cells. E244] The nanoparticles in this system were composed of amine-modified
tetraethylorthosilicate (TEOS) nanoparticles between 50 and 100 nm in diameter. These paricles
were solubilized and spin coated on a substrate followed by solvent evaporation to produce the
topographic substrates for cell culture.
B. Electrospinning of Biomaterials
Photolithography is a time-consuming and expensive method to produce well-defined
microfabricated features with accurate spatial characteristics. Alternative methods to
photolithographic-based processes allow the fabrication of biomaterial surfaces with nanoscale
topography, which can improve cell functions such as adhesion, migration and proliferation.
Electrospinning is a convenient method for producing arrays of loose fibrous networks
containing rich nanometer-scale texture with individual fiber diameters on the order of hundreds
of nanometers. The electrospinning process draws a continuous narrow stream of material from
a reservoir of polymer melt or solution to a collecting plate where the material accumulates,
producing the fibrous mat. This is accomplished by inducing charge build-up on the surface of
the solution through the application of strong voltages. When the voltage is sufficiently strong,
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the electrostatic potential overcomes the energy associated with surface tension of the bulk
material at the orifice and the solution is accelerated towards the grounded collector. As the
polymer solution is propelled to the collector, the solvent evaporates resulting in a continuous
stream of ultrathin fibers. Electrospinning has been used to fabricate fibrous scaffolds using a
variety of natural materials such as silk fibroin,[2451 collagen, polypeptides and synthetic
polymers such as PLGA, PCL, poly(vinyl alcohol) (PVA) and poly(ethylene oxide) (PEO).
Ceramics and composite fiber networks have also been produced using electrospinning
techniques.[246] The diameters of individual fibers can range from approximately 30 nm to 1
micron and is varied by controlling the properties of the solution such as polymer concentration,
viscosity, conductivity for example, while also carefully defining electrospinning parameters
such as the applied voltage. Nanofibrous scaffolds produced by electrospinning typically results
in a thin three-dimensional film of non-woven mesh consisting of randomly oriented fibers.
These mesh constructs can then be laminated together by heating the scaffold to temperatures
slightly above the melting point of the polymer or by solvent dissolution and melding. These
processes produce fiber-bonds at the points of contact between the fibers and result in a cross-
linked network. Although random fiber mats are useful in producing surfaces with rich texture
and topography, improving the utility for electrospun materials in tissue engineering is
dependent upon developing processes to better control the large-scale fiber alignment.
Nanofibrous systems with aligned fibers have also been synthesized by using a rotating drum as
a collector[2471 or, in the case of PLGA, by annealing the fibrous network after applying
mechanical forces. [248 ] Fabricating topographically rich scaffolds with aligned nanofibers can
exploit the contact guidance response in cells and lead to engineered cell functions, such as
directed motility. Chemical modification of aligned electrospun nanofibers can also lead to
cooperative modulation of cell functions including those of which would be useful for wound
healing. For example, in work by Patel et al, covalently incorporating fibroblast growth factor
onto aligned PLA nanofibers led to enhanced neurite extension in PC12s and fibroblast
migration into wound beds when compared to randomly arranged fibers. [249] Detailed processes
and applications concerning electrospinning nanofibrous scaffolds has been reviewed extensively
elsewhere.[ 250]
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C. Laser Patterning of Biodegradable Polymers
Laser micromachining presents a method for rapid production of micron scale features without
the use of expensive photomasks. Microfabrication of polymeric substrates using ablation is
typically performed using UV laser types such as excimer, argon-ion, fluorine, helium-cadmium,
metal vapor, and nitrogen. Polymers are etched when the energy of the incident photoelectron is
large enough to dissociate chemical bonds directly while imparting little thermal damage to the
non-machined regions. Geometries such as holes and trenches can be produced in biodegradable
substrates with minimum feature sizes of approximately 10 microns in polymers such as PVA,
PCL, PLA.[78' Laser ablation, while proven directly useful for micromachining, can
simultaneously functionalize surfaces that have undergone laser treatment. Laser irradiation can
lead to the incorporation of nitrogen or oxygen molecules thereby creating functional groups
such as amines or carboxylic acids. These functionalities can serve as pre-cursors for surface
modifications such as covalent linkages of peptides or non-bio-fouling agents. Laser ablating
techniques can be used in combination with nanoparticles for the rapid fabrication of polymer
substrates with arrays of nanoscale features with dimensions much smaller than the wavelength
of light. One approach, termed nanosphere lithography, uses an ordered template of nanometer-
scale particles as a method to focus laser irradiation that is directed at the surface of the polymer
substrate to create arrays of nanoscale pits.[2511 A solution of silica nanoparticles is deposited
onto the surface of the substrate. Upon evaporation of the solvent, surface tension effects
dominates over the thermal energy ( kT), which results in an energetically-favored packing event.
The result is spontaneous ordering of nanoparticles into a hexagonal close-packed configuration.
A nearly-identical method can be used to create ordered micron scale sacrificial templates for use
in porogen-leaching scaffold fabrication, which will be described in the future section on
microscale self assembly. The ordered silica nanoparticles focus the UV irradiation upon
illumination causing localized ablation, which can produce features such as pits as small as 30
nanometers in diameter. The size and geometry of the features can be varied by adjusting
processing parameters including the diameter of the nanoparticles, the wavelength of the laser,
and the energy of radiation, and the angle of incidence of the irradiation [252]. Nanosphere
lithography provides a convenient method for creating large ordered arrays of features
dimensions that would otherwise be too slow, expensive, and in the case of features on the order
of 10 nanometers, impossible using tradition photolithographic methods. While the set of
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potential feature geometries and sizes is inherently limited by the top-down nature of nanosphere
lithography processes, the arrays of materials that can be use are fundamentally similar to those
used in laser ablation. Nonetheless, this method could serve to be useful in engineering
polymeric substrates to study or enhance cell-matrix interactions by providing nanotopographic
signals.
D. Replica molding of Biomaterials
1. Photolithographic-Defined Substrates
Photolithographic-based processes, originally used in the microfabrication of integrated circuits,
used in combination with polymer processing techniques and patterning of biomolecules
function as another primary method for studying the effect of microenvironmental parameters on
cell function. The two-dimensional nature of traditional photolithographic processes enables a
wide variety of substrate materials, geometries, and length scales to be studied very rapidly. UV
photolithography can reliably produce features from 100 microns down to approximately 500 nm.
Inorganic substrate materials such as silicon and silicon oxide can be rapidly fabricated using
reactive-ion etching to produce well-defined features. These substrates can then be used as
substrates for replica molding of other materials including biomaterials such as natural and
synthetic polymers. Soft lithography is another viable method for creating patterned two-
dimensional substrates to control cell function. These topics were discussed extensively in
Chapter 1.
2. Natural Extracellular Matrix Protein Substrates
Instead of utilizing microfabrication methods to construct substrates with synthetic features,
others have replica molded biomaterials directly from natural ECM proteins.[253' 254] In work by
Goodman et al, the underlying ECM of blood vessels from various species was extracted and
used as a substrate for replica molding. A biomedical polyurethane was cast and replica molded,
preserving the sub-micron features of the native sub-endothelial ECM proteins. Endothelial cells
from various sources were then cultured on these substrates with enhanced spreading and
projected cell areas. Although promising results regarding the spreading and attachment of cells
on nanofabricated substrates were observed using this strategy, this specific approach does not
appear to . In the specific case of replica molded synthetic biomaterials using natural ECM
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protein substrates, there are obvious questions and limitations. For example, why not simply
coat a synthetic biomaterial that exhibits the appropriate properties such as degradation kinetics
and mechanical properties with an aqueous solution of native ECM proteins that exhibit the
appropriate surface chemistry, charge, and topography. Nevertheless, there is a larger message
contained within these results, namely that reproducing the native substratum topography, even
in a synthetic biomaterial, can lead to enhanced cell-biomaterial interactions. Work by Goodman,
Nealey, and other laboratories has motivated the use of nanotopography to precisely control cell
function and enhance desired cell-biomaterial interactions.
IV. Cellular Responses to Artificial Nanotopography
There have been extensive reviews regarding the responses of populations of mammalian cells to
topography.[271 Although much research has been conducted in this filed, the underlying cellular
mechanisms governing contact guidance remain elusive This has relegated the understanding of
cell biological to predominantly phenomenological approaches within this field, though there
still remains a wide range of speculation.[2551 This section outlines some of the highlights of
cellular responses to nanotopographic substrates across a wide variety of cell types, biomaterials
and feature geometry. There are essentially two classes of nanotopography that has been used in
studying cell-topography responses: 1) Substrates with surface roughness typically contain
features on the order of 100 nm or smaller and contains short range order; 2) Substrates with
ordered topography typically have features that are 400 nm or larger, which enables
photolithographic processing, and have short and long range order.
A. Nanometer Scale Surface Roughness
Surface roughness on a wide variety of materials, both inorganic and organic, is known to impact
cell functions of a variety of cell types. Amongst inorganic materials, much work has been
published regarding the effect of nanophase materials that could be potentially useful for
orthopaedic applications such as titanium, silica, and carbon. Price et al found that nanofibrous
carbon substrates were able to improve the adhesion of osteoblasts[256] while Paulo et al found
that nanophase titanium materials increased the expression of bone sialoprotein and osteopontin
by osteogenic cells.[2571 In work by Dalby et al, human fibroblasts were cultured on 13, 35, and
90 nm tall islands on a polymer demixed system of poly(styrene)/poly(bromo-styrene).
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Fibroblasts cultured on the 13 nm islands were observed to have a larger projected cell area
relative to fibroblasts cultured on 35 and 90 nm. 12583 There has not been a consistent conclusion
on the effect of surface topography on the proliferation dynamics across cell types. Nanophase
titanium oxide of feature sizes on the order of 10 nm was not found to effect the proliferation or
attachment of osteoblastic cells. [259] Yet, in the previously referenced work by Dalby et al, [258]
enhanced proliferation as determined by the increased fraction of cells in S-phase was observed
only on fibroblasts cultured on the 13 nm tall islands. In general, surface roughness is thought to
promote the adhesion of cells by modulating filopoda formation dynamics. Nanophase titanium
oxide increased the frequency of filopods in osteoblastic cells, while not affecting overall cell
morphology or spreading. However, the effect of this response varies significantly across cell
types, biomaterials, and the length scale of the roughness.
Nanometer scale roughness can also lead to enhanced adhesion and metabolic function in cells.
For example, hepatocyte adhesion and function are enhanced when cultured on nanoporous
silicon, when compared to planar silicon control substrates. [26 0] Biocompatibility metrics such as
initial cell attachment, cell viability, albumin secretion, and urea synthesis were all maintained in
murine hepatocytes cultures on nanoporous silicon.
B. Ordered Substrate Nanotopography
Ordered nanotopographic substrates have also been shown to impact the morphological and
functional aspects of cells. The effect of ordered nanotopographic substrates on the morphology
of many cell types has been well-documented. The most pronounced effect occurs in cells
cultured on substrates with linear features. This leads to alignment with the cells along the
features as well as an elongated morphology. This effect occurs in a variety of cells types.
Synthetically fabricated substratum with feature sizes on the order of 1 micron or smaller
generally lead to elongation and alignment of cells parallel to the direction of the grating. This
aspect of the contact guidance response has been observed in a variety of cell types including
smooth muscle cells, [261] corneal epithelial cells,[95] rat fibroblasts,[262] Schwann cells, [2631 PC12
neurites, [264] mesenchymal stem cells, [265] and endothelial cells.[266, 267] Linear topographic
substrates are also known to enhance and direct the migration of various cells types. In work
performed by Diehl et al, linear topographic substrates with feature sizes between 200 nm and
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800 nm are observed to direct the migration of corneal epithelial cells along the parallel axis of
the features.1268] Furthermore, the migration velocity was also increased in cells cultured on
substrates with linear nanotopography. In a likely similar mechanism as observed in contact
guidance, ordered substrate nanotopography can also lead to enhanced adhesion on surfaces.
One potentially exciting aspect of contact guidance for tissue engineering is the potential for
modulating differentiation. In work by Yim et al, synthetic nanostructures are utilized to
differentiate human mesenchymal stem cells (hMSCs) into a neuronal lineage. [265] Similar
results have also been investigated for using synthetic substrate nanotopography for the
differentiation of hMSCs into osteogenic lineages. Dalby et al cultured hMSCs on poly(methyl
methacrylate) (PMMA) with nanopits of 120 nm in width and 100 nm deep. hMSCs cultured on
nanotopographic PMMA exhibited a similar amount of mineralization in vitro as hMSCs
cultured on planar PMMA controls in differentiation medium containing dexamethasone. [2691
These results were supported by quantitative polymerase chain reaction data which indicated that
hMSCs grown in the two conditions has similar levels of upregulated gene expression
fingerprints for osteogenic differentiation compared to planar PMMA controls.
C. Summary of the Current State of the Art
The effect of nanotopography on cell behavior is a complex and somewhat scattered field of
study because of many reasons. First and foremost, there are a virtually infinite number of
potential combinations of cell types, biomaterial composition, topographic length scales, spacing,
and geometry. Each cell type exhibits a specific set of cell surface receptors, cytoskeleton
proteins, and signaling pathways. Each biomaterial exhibits a specific set of physicochemical
properties including chemical moieties, electrostatic charge, nanometer scale roughness, surface
energy, and mechanical modulus. If this large potential set of experiments is coupled with a near
infinite cell-specific outputs such as selected protein expression, mRNA up regulation or down
regulation. Although gene chip studies have been conducted in cells such as fibroblasts on
micropatterned substrates, [270] the complex set of alterations in DNA expression are unable to
yield a coherent, mechanistic conclusion. Furthermore, the effect of topography on gene
expression, as well as other parameters, is transient.[270] Hence, in addition to the milieu of
multifactorial signaling, there is also a temporal aspect that confounds the difficulty in
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extricating a mechanistic view of the contact guidance response. This has resulted in a primarily
phenomenological approach to studying the various effects of natural and synthetic substratum
topography on cellular function.
D. Possible Mechanisms of the Morphological Contact Guidance
Response of Mammalian Cells to Nanotopography
The morphological response to contact guidance is the first order effect of substrate
nanotopography. Other effects of contact guidance observed in selected cell types including
enhanced migration and reduced proliferation (See Section IV: Cellular Responses to Artificial
Nanotopography) can be viewed as second order effects. For example, if ridge-groove substrate
geometries induce anisotropic stresses across a preferential axis, then this may induce
preferential migration along this axis as well. Furthermore, if cells are more likely to proliferate
in this microenvironment, then the cell may also be less likely to proliferate. Furthermore, the
morphological response can affect the gene profile indirectly by exerting mechanical and
morphological stresses on the nucleus of the cell. The elongation and alignment of the nucleus is
presumably another source for alteration of the gene profile as cells response to substrate
nanotopography. This observation was recorded in a comprehensive gene profile analysis of
fibroblasts on artificial groove substratum.[2701  A similar effect has been demonstrated in
chondrocytes as well wherein the deformation of the nucleus may be important in the mechanical
conditioning of cells for seeding on tissue engineering constructs. [271] The effect of synthetic
topography on gene expression through morphological alterations of the nucleus have been
reviewed in detail elsewhere.[ 272] The generalized consensus regarding the mechanism for the
morphological response is anisotropic stress generation due to cell-biomaterial interaction.
However, the precise origin of the anisotropic stresses is still under debate. One caveat to
proposed mechanisms of contact guidance with substratum nanotopography is that these theories
must also be in concert with related morphological observations observed in cells cultured on
substrates with patterned proteins. [2731
Since the effect of contact guidance in vivo is classically manifested in biased migration and
alignment, the study of cells to synthetic ridge-groove nanotopography substrates is of particular
interest. For example, the kinetics of the effects of acute contact guidance response to micron
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and nanometer scale ridge-groove substrate geometries on morphology have been studied in
fibroblasts cultured on microgrooved titanium.[ 2741 This study suggests that microtubules align
within only 20 min after attachment and preceded alignment of the overall cell. This cluster of
events is then followed by the alignment of microfilament bundles at 40-60 min and focal
adhesion contacts after 3 h. From this study, it is clear that there are numerous organelles that
are responsible for initializing and transmitting the effect of surface topography throughout the
cell to influence overall cell function such as stress fiber formation, lamellipodia, and filopodia.
One critical organelle that is thought to play an instrumental role in the contact guidance
response is filopodia. While it is known that filopodia play a critical role in sensing the
surrounding microenvironment of cells in vivo, filopodia also respond to synthetic topographical
features in vitro. It was found that filopodia become frequently aligned along the long axis of
synthetic ridge-groove nanotopographic geometries.[95] Hence, the origin of the contact guidance
response of cells to synthetic topography is likely to involve the function of Cdc42 activation via
filopodia formation, although the underlying mechanisms may not be explicitly known. The
following section outlines some possible theories for the morphological aspects of contact
guidance in cells cultured on synthetically fabricated ridge-groove geometries on the micron and
sub-micron length scales.
1. Intrinsic Protein Patterning via Substrate Discontinuities
The substrates oftentimes used in studies of contact guidance are synthetically fabricated using
tradition photolithography based microfabrication processes. These substrates featured
topography with step changes, which results in discontinuous changes in height with respect to
lateral planar coordinates. This led to one proposed mechanism for the morphological effects of
the contact guidance response, which was ultimately based on the discontinuities in the substrate
It was thought that these discontinuities led to preferential protein absorption, which in turn lead
to micron and nanometer scale patterning of proteins on substrates. Furthermore, it was thought
that this patterning lead to preferential alignment just as micropatterned protein substrates led to
preferential confinement of cells. [481 However, this theory has been all but ruled out due to more
recent studies. First and foremost, the morphological aspect of contact guidance is observed in a
variety of cell types cultured on a variety of smooth synthetically fabricated ridge-groove
geometries.[275] It has been shown that substrates with continuous features align cells to the same
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degree as substrates with discontinuous features across a constant feature pitch. Experiments
described in this work also serve to debunk this theory.[E88  Namely, the fabrication of smooth,
micron scale features in a biodegradable elastomer serves to induce the contact guidance
response in endothelial cells. Therefore, this explanation for the contact guidance response to
synthetic nanotopography is insufficient.
2. Spatial Biasing of Focal Adhesion Formation
Another possible explanation for the contact guidance effect is based on the role of focal
adhesion formation in controlling cytoskeleton morphology. Focal adhesions are clusters of
cytoskeleton proteins that are formed by the Rho family of small GTPases. It has been
demonstrated that the focal adhesions are intimately connected to cytoskeleton and nucleoplasm
structure, function, and signaling through integrins. [276] Therefore, it has been proposed that
synthetically fabricated substrate nanotopography can induce the overall alignment and
elongation of cells by first inducing the alignment of focal adhesions. The initial alignment of
focal adhesions could result from asymmetric probability of focal adhesion formation due to
feature geometry. The alignment of focal adhesions could then lead to an overall response in the
cell morphology through the aforementioned intimate signaling connection between focal
adhesions and cytoskeleton proteins. Although this theory may explain the connection between
aligned focal adhesions and the aligned, elongated gross morphology, it does not sufficiently
address the initial alignment of focal adhesions.
3. Preferential Actin Polymerization
Another theory for contact guidance on synthetic substratum invokes actin polymerization
dynamics involved in cytoskeleton rearrangement as a driving force for morphological
alterations. [277-2791 As previously mentioned, membrane ruffling is a primary cell function that is
implicated in establishing cell polarity. A critical component of establishing this function is the
ability for cells to sense the surrounding chemical and topographical signals and to orient the cell
with respect to these microenvironmental parameters. Filopodia are primarily responsible for
providing cells the ability to sense the microenvironment. When cells are cultured on synthetic
ridge-groove nanotopography, filopodia formation can occur in any direction. However, it is
hypothesized that the formation of filopodia perpendicular to the ridge-groove features is not
frequent due to unfavorable stress formation. Conversely, the formation of filopodia parallel to
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the ridge-groove features is more frequent. The formation of filopodia in the direction of the
long axis of features leads to propagation along this direction. This effect could lead to biased
cytoskeleton rearrangement, polarization of the cell body, and ultimately a gross morphological
effect of alignment and elongation. In other words, highly dynamic filopodia serve as
topographical sensors, which are able to detect the immediate surrounding environment.
Furthermore, the preferential adhesion and biased response of filopodia are able to transmit this
signal in order to induce an overall cellular response. This theory is most consistent with the
corpus of work that has since been conducted regarding this topic including observations
described in this work.[88] Furthermore, this theory suggests that there is a cascade of signaling
from extremely fine cytoskeleton components to higher order effects. However, additional
experimentation must be conducted to confirm the instrumental role of filopodia in detecting,
transmitting, and ultimately responding to topographical signaling.
V. Motivation and Summary of Results
Topographic substrates have already been investigated as a potential stimulatory function for
creating functional basal lamina.[94] This demonstrates the potential for utilizing micro- and
nanofabricated two-dimensional substrates as a methodology for advanced tissue regeneration
systems. Stem cells represent a crucial component in the field of tissue engineering. However
controlled differentiation of stem cells remains a challenging aspect of harnessing the true
potential of stem cells. As such, it is of paramount importance to characterize the contact
guidance response of stem cells to synthetic substrates. Furthermore, it is also important to
understand the interplay of the role of the cytoskeleton in the contact guidance response. As
previously mentioned, actin polymerization and depolymerization dynamics are extremely
important in regulating many aspects of the cytoskeleton. Therefore, it is hypothesized the
including chemical agents that disrupt natural actin polymerization will ultimately lead to effects
on the contact guidance response. The study of these topics is the subject of Chapter 8.
One potential role for utilizing contact guidance is the ability to guide the formation of well-
ordered vascular structures. It is known that human embryonic stem cells have the potential to
differentiate into endothelial cell phenotype in culture and on scaffolds. [ o'' " 3 We then
hypothesized that it was possible to guide the formation of vascular structures in vitro by
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culturing endothelial progenitor cells on synthetic microfabricated substrates with line-grating
geometry. This work is the subject of Chapter 9.
The biomaterial used in the fabrication of the substrates was poly(dimethylsiloxane) (PDMS),
which is convenient for cell-biomaterial characterization, but not suitable as a scaffold material.
The next milestone was to replicate the contact guidance response of endothelial cells using a
biodegradable substrate with similar elastomeric mechanical properties as PDMS. This was
demonstrated by using an adapted soft-lithographic process to create ridge-groove structures in
poly(glycerol-co-sebacate) (PGS) substrates. Terminally differentiated endothelial cells were
used as a model cell line to demonstrate the ability of these substrates to induce the
morphological contact guidance response in vitro, as demonstrated in the work described in
Chapter 10.
Although PGS is a suitable biomaterial for many applications, several shortcomings prompted
the synthesis of the poly(1,3-diamino-2-hydroxypropane polyol-co-sebacate) (APS) class of
bioelastomers. APS polymers featured chemical and mechanical composition that is more
similar to native ECM proteins such as collagen I. These include the presence of amide bonds
and primary amines as well as elastomeric mechanical properties with appropriate stiffness and
maximum elongation.' 190] However, these polymers do feature an intrinsic surface topography
with a length scale that is similar to native ECM proteins. Therefore, it was hypothesized that
fabricating substrates using APS with replica molded nanotopography could promote adhesion
and support function of primary hepatocytes. The results of this study are outlined in Chapter 11.
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Chapter 8: Effect of Actin Disrupting Agents on
Contact Guidance Response in Human Embryonic
Stem Cells
The content of this chapter has been published in whole or in part in the following journal article:
S Gerecht-Nir', C J Bettinger1, Z Zhang, J Borenstein, G Vunjak-Novakovic, R Langer. The
Effect of Actin Disrupting Agents on Contact Guidance of Human Embryonic Stem Cells.
Biomaterials 2007. 28 (28) 4068-4077.
' Authors contributed equally to this work.
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I. Introduction
A. Role of the Extraceullular Matrix
In vivo cellular microenvironments are immobilized within tissue, and consist of diverse
extracellular matrix (ECM) proteins that present biophysical cues to the cells via their rich three-
dimensional surface topography.t 2801 The topographic features within basement membranes are
on sub-micron length-scales.1 211] Individual cells integrate the external cues that arise from their
environment and dictate genotypic profiling. Importantly, it is not only the milieu of soluble,
diffusible factors, but also the adhesive, mechanical interactions with scaffolding materials that
drive the different states and functions of a cell, including gene expression, adhesion, migration,
proliferation, and differentiation.[23, 281, 282] For the binding interactions between the cells and
surfaces, it has become increasingly evident that cells are influenced by spatial domains,
structural compositions, and mechanical forces at the micron and nanometer scale.1283] Cells use
transmembrane actin-integrin adhesion complexes as mechanosensors to probe the rigidity of the
extracellular environment, mediate adhesion, trigger signaling, and remodel the ECM.1 284]
B. Contact Guidance Using Synthetic Fabricated Substrates
This has led to the widely tested hypothesis that cellular structure and function can be influenced
by substrates containing with micron and sub-micron scale topography.1 311 Cellular responses to
synthetic micro- and nanofabricated substrates [255] via contact guidance[ 285] has been observed in
a variety of mature cell types1271 including, but not limited to epithelial cells,[95, 286, 287]
fibroblasts,[262, 279, 288, 289] oligodendrocytes,1 290] astrocytes,1290] and endothelial cells.[88] In
addition to changes in gross morphology and migration, contact guidance induced up regulation
of fibronectin mRNA in human fibroblasts,1291 increased adhesion of epithelial cells,12861 and
increased mineralization and alkaline phosphatase activity in rat bone marrow cells.1 29
1]
Human embryonic stem cells (hESCs) have a capability to differentiate into derivatives of all
three primary germ layers, both in vitro and in vivo. [292] Human ESCs differentiation in vitro
follows temporal patterns that recapitulate early embryogenesis in many ways. [293] The in situ
environment of a developing blastocyst contains a complex ECM network, forming a micro-
environment that has ability to affect cell behavior. ESCs are known to respond to the chemical
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and mechanical constitution of the ECM through lineage-specific differentiation for example. In
this report, we describe the morphological and proliferation responses of hESCs to synthetic
nanotopography. Furthermore,' we studied the contact guidance responses of hESCs in the
presence of actin disrupting agents (ADAs).
C. Summary of Results
We hypothesized that the nanotopography of the substrate can be used to control morphology
and proliferation of hESCs via in vitro contact guidance responses. Utilizing substrates with
nanometer-scale line grating features, we examined the effect of contact guidance of hESCs on
cell cytoskeleton organization and proliferation. In addition to gross morphological changes
including elongation and alignment of cells with the substrate features, spatial polarization of
gamma-tubulin complexes was also observed in cells cultured on nanotopographic substrates.
Furthermore, culturing hESCs in the presence of ADAs further demonstrated that cytoskeleton
remodeling through actin polymerization is critical in the manifestation of morphological and
proliferative aspects of hESCs cultured on nanotopography. To our knowledge, this is the first
study to examine and characterize the contact guidance response of hESCs to linear
nanotopography in the presence of soluble factors that are able to supercede effects for substrate
signaling alone. The identification of downstream effectors of the contact guidance response in
hESCs could lead to subsequent investigations to implicate upstream signaling pathways.
II. Materials and Methods
A. Fabrication and Preparation of Nanotopographic Substrates
Traditional photolithographic techniques were used to fabricate silicon masters with line-grating
geometries with target dimensions of 1200 ± 200 nm periodicity (600 nm ridges with 600 nm
spacing) and 600 + 150 nm feature height (MEMS Exchange, Reston, VA). Briefly, 100 mm
silicon wafers were coated with Shipley SPR220-3 photoresist, exposed using a GCA AS200
stepper, and post-baked. Wafers were etched using a silicon ICP etch process using SF6/Argon
in a VLR-700. Silicon wafers were then plasma ashed and cleaned for preparation in replica
molding. Silicon masters were used to replica-mold substrates with linear nanotopographic
features using poly(di-methylsiloxane) (PDMS, Dow Sylgard 184, Essex Chemical, Clifton, NJ),
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which was chosen for ease of fabrication and optical clarity to facilitate characterization. Due to
the hydrophobic nature of PDMS, which typically leads to low adhesion of cells to surfaces,
fibronectin was adsorbed onto the surface to promote adhesion and attachment of hESCs.
Briefly, substrates were plasma cleaned (PDC-001, Harrick Scientific Co) for 300 sec at
approximately 80 W RF power with atmospheric gas at pressures between 200 and 500 mTorr.
A 2.5 ýtg/mL solution of fibronectin in PBS (Invitrogen Corporation, Carlsbad, CA) was
immediately adsorbed onto the surface, which was incubated for 3 h at 37 oC and 95% humidity.
When applied to PDMS substrates, this procedure resulted in fibronectin film thickness of
approximately 100 nm in previous studies. [294' 295] This suggests that the resulting fibronectin
film will not "washout" the nanoscale topography of the substrate.
B. Human Embryonic Stem Cell Culture
Non-differentiating hESCs (lines H9 and H13, WiCell Research Institute, Madison, WI; p19-40)
were grown on inactivated mouse embryonic fibroblasts (MEF) in growth medium consisting of
80% KnockOut DMEM, supplemented with 20% KnockOut Serum Replacement, 4 ng/ml basic
Fibroblast Growth Factor, 1 mM L-glutamine, 0.1 mM --mercaptoethanol, 1% non-essential
amino acid stock (Invitrogen Corporation, Carlsbad, CA). hESCs were passaged every 4 to 6 d
using 1 mg/ml type IV collagenase (Invitrogen Corporation, Carlsbad, CA). For individual cell
suspension (i.e. cultured on nanotopographic and flat substrates), hESCs were digested with
EDTA 5 mM in PBS, supplemented with 1% (v/v) FBS (HyClone, Logan, UT), and separated
into individual cell suspension using a 40-micron mesh strainer (Becton Dickinson -Falcon, San
Jose, CA). Undifferentiated hES individual cell suspensions were plated on type-IV collagen-
coated six-well dishes (Becton Dickinson, Franklin Lakes, NJ). For contact guidance studies, the
cells were seeded on substrates at densities of approximately 10,000 cells per cm 2 in a
differentiation medium composed of alpha-MEM medium (Invitrogen Corporation, Carlsbad,
CA) supplemented with 10% FBS (HyClone, Logan, UT) and 0.1 mM 3-mercaptoethanol
(Invitrogen Corporation, Carlsbad, CA).
C. Inhibitor Preparations
For pathways studies, cells were cultured in media with the following respective concentrations
of inhibitors in solvents (Sigma, St. Louis, MO) listed as noted: 1 pg/mL cytochalasin D in
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DMSO, 6.25 ViM Latrunculin A (EMD Biosciences, San Diego, CA) in DMSO, 8 tpM
Latrunculin B (EMD Biosciences, San Diego, CA) dissolved in DMSO. Media was charged
with fresh inhibitors during daily exchange and the final concentrations of all solvents were kept
below 0.25% (v/v).
D. Proliferation Assays
Cell metabolism was evaluated by the XTT kit (Sigma) according to the manufacturer's
instructions. Human ESCs were incubated for 4 h in medium containing 20% (v/v) XTT
solution. For analysis, triplicates of 150 jpl of the medium were removed, placed in a 96-plate
well and read in a microplate reader at 450 and 690 nm. Proliferating cells were examined via
BrdU incorporation. BrdU staining kit (Invitrogen) was used in situ, according to
manufacturer's instructions. Briefly, cells were incubated with BrdU labeling reagent (1:100) for
24 h, washed several times with PBS (Invitrogen), and fixed with 70% ethanol for 30 min at 4 oC.
A standard staining procedure, provided by the manufacturer, was performed and cells were
examined and manually characterized using an inverted light microscope (Zeiss, Germany).
E. Immunofluorescence of Cytoskeleton, Focal Adhesions, and
Gamma-Tubulin Complexes
Human ESCs were fixed in situ with accustain (Sigma) for 20-25 min at room temperature. After
blocking with 5% FBS, cells were stained with one of the following primary antibodies: anti
human alpha smooth muscle actin (SMA; 1:50), anti human calponin, (1:50), anti human
vimentin (1:20; all from Dako, CA), anti human vinculin (1:100; Chemicon Temecula, CA), anti
human alpha-tubulin (1:20; Sigma), anti phosphorylated myosin light chain (1:50; Cell
Signaling), and anti human gamma-tubulin (1:100; Abcam, Cambridge, MA). Cells were then
rinsed three times with PBS (Invitrogen) and incubated for 30 min with suitable Cy3-conjugated
(Sigma) secondary antibody. Samples were then counterstained with DAPI (1:200; Sigma) for 5
min. Cells were imaged using either fluorescence microscopy (Zeiss) or DeltaVision RT
Deconvolution Microscopy (Applied Precision, WA, USA). Exposure times were kept constant
across micrographs only when making qualitative comparisons.
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F. Cell Morphology Imaging and Characterization
The transparent PDMS substrates allow for the direct measurement of cell alignment angle using
an inverted light microscope (Zeiss). SEM and phase micrographs of cells using a 10X objective
lens were used to characterize morphological parameters for each sample analyzed. The
circularity [170] and alignment angle of the cell were calculated manually using perimeter and area
measurements by using Axiovision software (Zeiss). Digital zoom was used to increase the
magnification and, in turn, increase the accuracy of the measurements. Alignment angle was
calculated by fitting an ellipse to the cell body, measuring the relative normalized angle between
the major axis and the feature orientation. The cell areas and perimeters were measured using
Axiovision measurement software and were used to calculate the circularity using the following
formula:
C 4
p 2  Eqn. 14
where A is the projected area of the cell and P is the perimeter of the cell. Circularity was used
as a metric of cell elongation; average angle was used as an index cell alignment (Figure 60a, b).
SEM was also used to assess three-dimensional morphology. Characterization of polarized
gamma tubulin complexes (GTCs) was performed by calculating the angle made between the
longitudinal axis of the nucleus and the line containing the GTC of interest to the center of the
nucleus (Figure 60c).
G. Scanning Electron Microscopy
Cells were fixed with accustain formalin-free fixative (Sigma) for 20 min at room temperature,
washed three times with DPBS, and post-fixed with 1% (w/w) OsO4 in water for 20 min. A
graded ethanol series was implemented for dehydration of the cells (25%, 50%, 75%, and 90%,
100% v/v ethanol in ddH20), 5 min per step. The samples were then immersed for 10 min in
100% ethanol followed by HMDS (Sigma), and allowed to air dry at room temperature for 24 h
prior to imaging. Samples were sputter-coated using a Cressington 108 Auto sputter coater
(Cressington Scientific Instruments Inc, Cranberry Twp, PA). Scanning electron micrographs
were taken using a Hitachi S-3500N at 5kV.
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H. Statistics
All measurements of the cell alignment, circularity, SEM imaging, proliferation, and plating
density were performed in triplicate samples across two independent experiments (n = 6).
Morphological observations were based on the sampling over at least n = 100 cells per
population with a minimum of three cell populations per data point. GTC orientations were
calculated from at least 150 total complexes per data point. XTT metabolism assays were
performed in triplicate samples (n = 3) with triplicate readings for each data point. One-tailed
Student's t-tests with unequal variances were performed to determine statistical significance,
where appropriate (Microsoft Excel, Redmond, WA). Parametric one-way and two-way
ANOVA tests were also performed where appropriate (GraphPad Prism 4.02, GraphPad
Software, San Diego, CA). Bonferroni's multiple comparison post-tests were used to determine
significance between specific treatments. All graphical data is reported as mean ± s.d.
Significance levels were set at * p < 0.05, ** p < 0.01, and *** p < 0.001.
Ill. Results
A. Human ESC Response to Linear Substrate Nanotopography
PDMS films were established with high fidelity of the feature geometry and dimensions that
were verified through SEM (Supplementary Fig 2). Single-cell suspensions of hESCs cultured
on nanotopographic substrates responded to linear nanotopography by increased alignment and
elongation (Figure 26a), as measured by reduced average angle of alignment and circularity
(Figure 26b). Due to the hydrophobic nature of PDMS, a low frequency of hESC attachment on
unmodified PDMS substrates was observed. Less than 50% of cells attached to unmodified
PDMS when compared to fibronectin-coated surfaces as determined by cell density, although
alignment and elongation, fingerprints of the contact guidance response, were observed (data not
shown). Therefore, subsequent studies were performed using fibronectin-coated PDMS
substrates. Human ESCs cultured on nanotopographic substrates exhibited reduced projected
cell areas (Figure 26c) and reduced proliferation, as measured by cell growth kinetics (Figure
26d). Reduced proliferation was also observed at 24 h and 48 h timepoints via BrdU assay ( * p
< 0.05) as assessed by two-way ANOVA (Figure 26e, f).
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Figure 26. Morphological and Proliferative Response of hESCs to Substrate Nanotopography.
a) Phase images of hESCs cultured on flat and linear nanotopograhy PDMS substrates. b) Circularity and
average angle of alignment (all graphical data is reported as mean ± s.d.) were reduced on nanotopographic
substrates when compared to flat substrate. c) Cells cultured on nanotopographic substrates exhibited lower
projected cell areas as well as determined by t-test (*** p < 0.001). d) Cell growth kinetics showed that cells
cultured on nanotopography had higher initial cell densities followed by stagnant proliferation. These
kinetics were in contrast to those of cells grown on flat surfaces, which exhibited continued proliferation
through 120 h. e) Representative color micrographs of BrdU assay revealed increased uptake of hESCs
cultured on flat substrates compared to cells cultured on nanotopographic substrates after 24 h. f) BrdU
uptake was reduced from 24 h to 48 h across both types of substrates. Statistical significance across 24 h and
48 h timepoints was determined by two-way ANOVA (* p < 0.05). Scale bars in all micrographs are 100
microns.
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B. Contact Guidance Induces Cytoskeletal Organization
Cellular responses to nanotopography including alignment, elongation, and organization of
cytoskeleton were observed on substrates with nanotopography. Linear nanotopographic
substrates organized cytoskeletal components, which was evident through differences in
morphology, and cytoskeletal filaments organization and alignment in the same axis as the grid-
lines including ct-SMA, vimentin, an intermediate filament which forms part of the cytoskeleton,
as well as, a-tubulin, and calponin (Figure 27). Cell alignment was further verified by SEM
micrographs (Figure 27) and deconvolution fluorescent microscopy (Figure 28) in hESCs after
24 h.
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Figure 27. Nanotopography Induces Organization of Cytoskeleton Proteins.
Human ESCs cultured on substrates with linear nanotopographic features responded to topography and
exhibited organized cytoskeleton proteins including: a-SMA, a-tubulin, vimentin, and calponin. These
morphological alterations were also confirmed through SEM micrographs. Direction of grid lines is
indicated by white arrow. Scale bars represent 10 microns.
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Figure 28. Deconvolution Images of a-SMA in hESCs Cultured on Flat and Nanotopographic Substrates.
Deconvolution images revealing a-SMA in hESCs cultured on flat substrates are globular without
organization within the cytoskeleton (left panel). This observation lies in stark contrast to hESCs cultured on
nanotopographic substrates (right panel) which exhibit organized aligned fibers in the direction of the
nanotopography (right panel is a composite image of two micrographs). Direction of grid lines is indicated by
white arrow. See online version for video of micrograph sections. Scale bars represent 10 microns.
C. Polarization of Gamma-Tubulin Complexes
Gamma-tubulin complexes (GTCs) were present in hESCs at the frequency of approximately
2.98 GTCs per cell. GTCs present in hESCs cultured on flat substrates exhibit a random radial
distribution with respect to the longitudinal axis of the nucleus when compared to cells cultured
on nanotopographic substrates (Figure 29). The average normalized angle of GTCs in hESCs
cultured on flat and nanotopographic substrates, was observed to be 40.68 ± 25.42 degrees and
28.42 ± 24.72 degrees (mean ± s.d.), respectively (* p < 0.05).
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Figure 29. Nanotopography Polarizes Spatial Distribution of Gamma-Tubulin Complexes within hESCs.
GTCs present in hESCs after 24 h of culture on flat substrates exhibit a random radial distribution with
respect to the longitudinal axis of the nucleus when compared to cells cultured on nanotopographic substrates.
Individual GTCs in each cell are indicated by white arrowheads. See Figure 60 for additional information
regarding the scoring of GTC alignment. Scale bars in all figures are 10 microns.
D. Actin Disrupting Agents Attenuate Contact Guidance Response
1. Reduction of Morphological Bias
To further understand the phenomena of topographic-induced alignment and elongation of
hESCs, we examined the effect of two actin disrupting agents (ADAs) on cytoskeleton
reorganization and proliferative states; cytochalasin D and latrunculin B (herein also referred to
as cyto D and latr B, respectively). The effect of latrunculin A, another actin disrupting agent,
was studied. However, poor cell attachment was observed, which prohibited further in-depth
study (data not shown). Latr B possesses higher specificity in inhibiting actin polymerization
and microfilament-mediated processes. The addition of cyto D and latr B independently reduced
the projected area of hESCs cultured on both flat and nanotopographic substrates (Figure 62).
Cells cultured on nanotopographic substrates in the presence of ADAs lost cytoskeleton
organization in a variety of cytoskeletal proteins including ca-smooth muscle actin, a-tubulin,
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vimentin, and calponin (Figure 30). Human ESCs cultured with soluble ADAs also exhibited a
more rounded three-dimensional morphology as indicated by SEM images (Figure 30).
Furthermore, the addition of cyto D and latr B to the medium attenuated the contact guidance
response by suppressing elongation as measured by circularity, and alignment as measured by
the angle of alignment (Figure 31a). The alignment angle was significantly increased in hESCs
cultured on nantopographic substrates in the presence of both cyto D and latr B as determined by
one-way ANOVA with Bonferroni post-tests (*** p < 0.001 and ** p < 0.01 for cyto D and latr
B, respectively) . In general, the addition of ADAs reduced the project surface area and
increased circularity on both nanotopographic and flat substrates.
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Figure 30. Actin Disrupting Agents Reduce Nanotopography-Mediated Morphological Responses.
Treatment of hESCs cultured on nanotopographic substrates, with cyto D, or latr B, two varieties of
cytoskeleton disrupting agents, leads to a loss of cytoskeleton protein organization including a-SMA,
vimentin, and a.-tubulin. Culturing hESCs in the presence of ADAs also leads to a more rounded three-
dimensional cell morphology. Scale bars represent 10 microns.
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2. Uniform Increase in Proliferation
Proliferation rates were also increased in the presence of these agents as demonstrated by
increased growth kinetics as measured by cell densities (Figure 3 l1b), which resulted in colonies
of rapidly proliferating cells. This observation was corroborated with increased BrdU uptake of
cells in the presence of cyto D and latr B at 24 h (*** p < 0.001) as determined by one-way
ANOVA (Figure 31 c). The metabolic activity of the cells was increased in the presence of cyto
D (Figure 31di) and latr B (Figure 31dii) alike at 24 h, as measured by XTT cleavage assay.
This increase in proliferation and metabolic activity upon the addition of ADAs was observed
across both nanotopographic and flat substrates (Figure 63). Consequently, the observed
reduction in proliferation of hESCs cultured on nanotopographic versus flat substrates is lost in
the presence of actin disrupting agents. The statistical significance of differential BrdU uptake
of cells cultured on nanotopographic versus flat substrates is lost in the presence of ADAs (* p <
0.05 without ADAs; p = 0.64 with ADAs).
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Figure 31. Actin Disrupting Agents Reduce Morphological, Proliferative, and
Nanotopography-Induced Contact Guidance.
a) Morphological characterization of cells cultured on nanotopographic substrates in
and latr B resulted in increased circularity and a loss of bias of alignment angle as
ANOVA (*** < p 0.001). b) Increased cell densities at time points 24 h, and 48 h as
ANOVA (*** p < 0.001) in combination with increased BrdU uptake at 24 h as
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ANOVA (*** p < 0.001) (c) suggests that treatment with actin disrupting agents leads to increased
proliferation. d) Metabolic activity, as measured by XTT cleavage assay, increased for cells cultured with
treatment of both cyto D (i) and latr B (ii) treatment at 24 h when compared to no drug as measured by t-tests
(* p < 0.05, * p < 0.05 for cyto D and latr B, respectively).
IV. Discussion
A. In vitro Control of Human Embryonic Stem Cell Morphology and
Function
Our objective was to characterize the in vitro contact guidance response of hESCs to ordered
substrate nanotopography. Of specific interest was the assessment of gross morphology,
alignment, proliferation, and cytoskeleton organization. The hierarchal preference of signaling
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through substrate chemical patterning versus substrate topography has been studied in various
cell types by others. However, we were interested in exploring the coupled effects of soluble
factors present in culture medium and nanotopographic cues provided by the substrate.
There have been numerous studies that document contact guidance in mammalian cells using
microfabricated substrates with a variety of feature sizes and geometries. [27, 95, 262, 279, 286-290] In
this study, the motivation for using a line-grating with 600 nm as a feature size for our
subsequent nanotopographic studies was two-fold: 1) Features should be large enough allow
fibronectin coating absorbance while maintaining feature fidelity; 2) Features should be small
enough to prevent morphological alteration by spatial confinement. The morphological
alterations and cytoskeleton protein organization induced by nanotopography in hESCs is in
concert with subsequent observations in other mature cell types. Furthermore, we observed that
the contact guidance response of hESCs to surface nanotopography includes a significant
reduction in proliferation when compared to flat substrates, which is in concert with similar
experiments involving mammalian cells including SMCs.[261 The contact guidance response
also manifests itself through the organization of cytoskeleton proteins including a-SMA, a-
tubulin, vimentin, and calponin. These cytoskeleton proteins became unequivocally oriented in
the direction of the grid lines in cells cultured on nanotopographic substrates. The structural bias
of cytoskeleton proteins led to the investigation of the possible alignment of microtubule
organization centers as well. Microtubules are known to play a critical and active role in
governing cytoskeleton function. Gamma-tubulin complexes (GTCs) have been implicated as
the initiators of microtubule assembly through the formation of such structures as microtubule
organization centers (MTOCs).J296]  The spatial polarization of GTCs induced by
nanotopography in hESCs observed in this study suggests that morphological manifestations of
the contact guidance response may originate at these localized regions of microtubule formation.
The spatial polarization of well-defined MTOCs containing gamma-tubulin has been previously
studied in SMCs on nanotopography in response to wound healing[2611 and the presence of
gamma-tubulin complexes have also been studied in P19 embryonic carcinoma cells.[297]
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B. Role of Cytoskeleton Proteins in Contact Guidance Response
The assembly of filamentous actin was hypothesized to play a direct role in controlling
cytoskeletal and morphological aspects of the contact guidance response in hESCs. Therefore,
we investigated the effect of the ADAs cyto D and latr B on gross morphology and the
organization of cytoskeleton proteins. Previous studies also reported that cyto D caused
observable changes in cellular morphology, with the rounding of the cell body and reduced
spreading in mouse mesenchymal stem cells.1298' 299] We observed morphological changes
including reduction of cell area and organization of cytoskeleton proteins in hESCs cultured on
nanotopographic substrates in the presence of ADAs. The observed reduction in cell alignment
on nanotopographic substrates may be linked to the impaired ability of the cell to detect and
respond to topographic cues presented by the substrate. Furthermore, the cell density,
proliferation, and metabolic activity were all subsequently increased, in nanotopographic
substrates cultures treated with cyto D or with latr B. This observation has been made in
mammalian cells: namely that precluding cytoskeleton organization via inhibition of filamentous
actin polymerization suggests a link between cytoskeleton dynamics and proliferation. [300' 301]
C. Disruption of Actin Polymerization in Contact Guidance Response
While cyto D and latr B impact cell spreading and proliferation of hESCs cultured on flat
substrates as measured by reduced cell area (Figure 62) and increased circularity (Figure 63a), it
was found that disrupting cytoskeleton remodeling activity through the additions of ADAs leads
to a loss of the differential morphological and proliferative specificity of hESCs cultured on
nanotopographic (Figure 30) versus flat substrates (Figure 63a-d). This suggests that the reduced
proliferation component of the contact guidance response may be linked to the organization of
the cytoskeleton. Furthermore, this cytoskeleton-linked effect of contact guidance on
proliferation can be overcome by chemical signaling through soluble factors. It thus appears that
there is a link between cytoskeleton function and proliferation that may explain the reduced
proliferation of mature cells cultured on nanotopographic surfaces and that this effect can be
altered by soluble factors.
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V. Conclusions
From this work, and studies performed in other laboratories, 1 15,284, 302] it is being established that
the cytoskeleton is an active organelle with vital cellular function. Human ESCs respond to
nanoscale substrate topography in a similar manner as other terminally differentiated mammalian
cells, including elongation and alignment, reduced proliferation, and the organization and
polarization of cytoskeleton proteins. The cytoskeleton plays an important role in the
morphological and proliferative responses to contact guidance cues. However, characteristic
morphological and proliferation behavior induced by the contact guidance response can be
superceded by soluble factors that directly interact with structural components of cell including
actin-based stress fibers.
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Chapter 9: Enhancement of in vitro Capillary Tube
Formation by Substrate Nanotopography
The content of this chapter has been published in whole or in part in the following journal article:
C J Bettinger, Z Zhang, S Gerecht, J Borenstein, R Langer. Enhancement of in vitro Capillary
Tube Formation by Substrate Nanotopography. Advanced Materials 2008. 20 (1) 99-103.
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I. Introduction
Vascular engineering remains a key thrust in advancing the field of tissue engineering of highly
vascularized, complex, metabolic organs. A wide variety of strategies have been employed to
control the formation of organized vascular structures in vitro and in vivo. Some of these
methods include, but not limited to, controlled growth factor delivery,16] filamentous scaffold
geometry,[303] protein micropatterning,[304] and enhanced scaffold biomaterials.[221 Many of these
approaches are motivated by biomimicry of the in vivo microenvironment. ECM proteins, both
in vitro and in vivo, provide mammalian cells with biophysical cues including specific surface
chemistry and rich three-dimensional surface topography[280] with features on the nanometer
length scale.[2 1 ' ECM substrates provide chemical and physical external cues that dictate a
variety of cell responses. Therefore, it is not only the milieu of soluble, diffusible factors, but
also the adhesive, mechanical interactions with scaffolding materials, both natural and synthetic,
that control select cell functions including cell attachment, migration, proliferation,
differentiation, and regulation of genes.[23, 281, 305] We hypothesized that physical features on
nanofabricated substrates could promote the organization of endothelial cell lineages into well-
defined vascular structures in vitro by inducing the contact guidance phenomenon, which is
known to affect the morphology of endothelial cells.[88' 266, 267] We found that endothelial
progenitor cells (EPCs) responded to ridge-groove grating of 1200 nm in period and 600 nm in
depth through alignment, elongation, reduced proliferation and enhanced migration. Although
endothelial-specific markers were not significantly altered, EPCs cultured on substrate
nanotopography formed supercellular band structures after 6 d. Furthermore, an in vitro
Matrigel assay led to enhanced capillary tube formation and organization.
II. Materials and Methods
A. Fabrication and Preparation of Nanotopographic Substrates.
100 mm silicon wafers were coated with Shipley SPR220-3 photoresist, exposed using a GCA
AS200 stepper, and post-baked. Wafers were etched using a silicon ICP etch process using
SF6/Argon in a VLR-700, plasma ashed, and cleaned for preparation in replica molding (MEMS
Exchange, Reston, VA) using poly(di-methylsiloxane) (PDMS, Dow Sylgard 184, Essex
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Chemical, Clifton, NJ, Figure 64). PDMS was chosen for ease of fabrication and optical clarity
to facilitate characterization. Due to the hydrophobic nature of PDMS, which typically leads to
low adhesion of cells to surfaces, collagen was adsorbed onto the surface to promote adhesion
and attachment of EPCs. Briefly, substrates were plasma cleaned (PDC-001, Harrick Scientific
Co) for 300 sec at 80 W RF power with atmospheric gas at 250 mTorr. A 25 [tg/mL solution of
collagen I from rat tail in PBS (Sigma, St. Louis, MO) was immediately adsorbed onto the
surface and incubated for 3 h at 37 oC.
B. Human Endothelial Progenitor Cell Culture
EPCs (commercially available from NDRI, Philadelphia PA) were purified from cord blood with
99.2% CD31+/CD45- purity according to manufacturer specifications. EPCs were grown on
type I collagen-coated tissue culture polystyrene in Clonetics Endothelial Basal Medium-2
(EBM-2) (Cambrex Corporation, East Rutherford, NJ) with 0.1% VEGF in addition to
manufacturer-supplied SingleQuots growth supplements. Cells were incubated at 37 OC with 5%
CO2 and passaged every 3-4 d. EPCs were seeded onto substrates at 15,000 cells per cm 2 and
maintained in EBM-2 medium.
C. Proliferation and Metabolism Studies
EPC proliferation on nanotopographic and flat substrates was studied with BrdU incorporation
assays using the BrdU Staining Kit (Invitrogen Corporation). EPCs received BrdU labeling
reagent (1:100) 2 d and 4 d after being plated upon patterned and flat substrates. Cells were
incubated for 24 hours with the reagent, then washed twice with PBS (Invitrogen Corporation)
and fixed with 70% ethanol for 20 min in 4"C. Micrographs of cells were taken at 2 d and 4 d to
examine cell density kinetics
D. Cell Morphology Imaging and Characterization
SEM and phase micrographs of cells taken at 10X magnification were used to characterize
morphological parameters for each sample analyzed. The circularity [ 170' 179, 180] and alignment
angle of the cell were calculated using perimeter and area measurements by using Axiovision
software (Zeiss). Alignment angle was calculated by fitting an ellipse to the cell body,
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measuring the normalized angle between the major axis and the feature orientation. The
circularity C was calculated using the following formula:
4,rA
C = Eqn. 15
P2
where A is the projected area of the cell and P is the perimeter of the cell. Circularity was used
as a metric of cell elongation; average angle was used as an index cell alignment.
E. Scanning Electron Microscopy
Cells were fixed with Accustain formalin-free fixative (Sigma) for 20 min at room temperature,
washed three times with DPBS, and post-fixed with 1% (w/w) OsO4 in water for 20 min. A
graded ethanol series was implemented for dehydration of the cells (25%, 50%, 75%, and 90%
v/v ethanol in PBS), 5 min per step. The samples were then immersed for 10 min in 100%
ethanol followed by HMDS (Sigma), and dried for 24 h at 24 oC. Samples were sputter-coated
using a Cressington 108 Auto sputter coater (Cressington Scientific Instruments Inc, Cranberry
Twp, PA). Scanning electron micrographs were taken using a Hitachi S-3500N at 5kV to assess
three-dimensional morphology.
F. Immunohistochemistry and Fluorescent Microscopy
EPCs were fixed with Accustain (Sigma), incubated with 0.1% triton X-100 in PBS (v/v), and
stained for cytoskeleton proteins and endothelial markers. The primary antibodies used were:
anti-a smooth muscle actin (Sigma), anti-CD31 (R&D Systems, Minneapolis, MN), anti-von
Willebrand Factor (Dako, Carpinteria, CA), anti-VEGF receptor-2 or KDR (Cell Signaling,
Danvers, MA), and anti-vascular endothelial cadherin (Chemicon/Millipore, Billerica, MA).
Cells were washed twice with PBS (Invitrogen Corporation) and incubated with Cy3-conjugated
secondary antibodies (Sigma) followed by FITC-conjugate lectin (Sigma). Cells with anti-KDR
were stained according to manufacturer's instructions. Cells were counterstained with DAPI for
2 min, mounted, and viewed using a Zeiss microscope equipped with OpenLab software.
Exposure times were kept constant when comparing immunohistochemistry across substrates for
each specific marker.
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G. Cell Migration Studies
EPCs on both nanotopographic and flat substrates were imaged at 48 h. Time-lapse images were
taken every 3 min for 90 min for a total of 31 images. Cell migration was quantified by
manually tracking the spatial coordinates about the nucleus of 100 migrating cells using
AxioVision software. Average migration velocity Vmig was calculated by the following equation:
: (X- x, ) + (y,- yi-) 2
V. i=g Eqn. 16
i=1
The effective displacement due to migration Dmig, ff was calculated from the difference in spatial
coordinates by the following equation:
Dmig,eff = (Xffin - X0 f+ -Y 0  Eqn. 17
where the initial and final coordinates are given by (xo, yo) and (xfn, Yfn), respectively.
H. In vitro Capillary Tube Formation Assay
Capillary tubes were formed in vitro using BD Matrigel Matrix (BD Biosciences, Franklin Lakes,
NJ). Culturing cells with endothelial phenotype on Matrigel substrates has been shown to
produce capillary tube structures.[30 6-30 81 After 6 d of culture on specified substrates, medium
was aspirated from the cells, and 500 pLL of 4 OC Matrigel was added and incubated for 60 min at
37 OC followed by the addition of 500 pL of EBM-2 medium. Capillary tube formation was
assessed 24 h after Matrigel deposition using light microscopy.
I. Statistical Methods
All observations of morphology and proliferation were based on three populations of n > 100 for
each experiment across two experiments (n = 6). Metabolism assays were performed in triplicate
for each experiment (n = 3). All graphical and tabulated data displayed as mean + s.d.
Significance tests were calculated using unpaired, two-tailed Student's t-Test with unequal
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variance (Microsoft Excel, Redmond, WA).
0.01, and *** p < 0.001.
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Figure 32. EPCs Respond to Substrate Nanotopography.
(a) EPCs cultured on nanotopography exhibited morphological alterations when cultured on substrates with
topographical features at 2 d. EPCs are aligned and elongated as measured by (b) reduced circularity (*** p
< 0.001) and reduced average angle of the major axis (*** p < 0.001) at 2 and 4 d. These morphological
changes were observed after 4 h and stable throughout 6 d as well. (c) Substrate nanotopography also
reduces the proliferation of EPCs. Growth rates were reduced in EPCs cultured on nanotopography when
compared to those cultured on flat surfaces. The doubling time was increased from 16.2 to 20.9 h. The
reduced proliferation was verified by reduced frequency of cells in S-phase as determined by a BrdU
incorporation assay at 2 and 4 d (*** p < 0.001). The direction of the linear nanotopographic features is
indicated by the arrow. Scale bars in (a-i) and (a-ii) are 100 and 5 microns, respectively.
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Ill. Results
A. Endothelial Progenitor Cells Respond to Substrate
Nanotopography
Feature geometry and dimensions of nanotopographic PDMS substrates were verified by SEM
(Figure 64). The 600 nm width for ridge and groove features was chosen to promote optimal
contact guidance effects in EPCs by minimizing feature masking from the collagen coating and
maximizing cell alignment through sub-micron features. [88 92, 95] The EPCs seeded as individual
cells on nanotopographic substrates and responded to linear nanotopography by alteration in
morphology as observed by increased alignment and elongation (Figure 32). These alterations
were quantified by reduced average angle of alignment and circularity at 2 and 4 d. SEM
imaging confirms that the EPCs were aligned an elongated in direction of substrate features.
Furthermore, the morphological alterations were maintained throughout long-term culture on
nanotopographic substrates for up to 6 d. EPCs cultured on nanotopographic substrates also
exhibited reduced proliferation as measured by BrdU assay (Figure 32, Figure 65) and reduced
cell growth kinetics as determined by cell density compared to EPCs cultured on flat substrates.
The observed doubling time was 16.2 ± 0.8 to 20.9 + 1.9 h for cells grown on flat and
nanotopographic substrates, respectively. A third component of the contact guidance response
that was observed in EPCs was enhanced migration. EPCs on nanotopographic substrates
exhibited a higher overall migration velocity as well as enhanced directed migration, as
measured by effective migration distance (See Materials and Methods). The average velocity of
EPCs on nanotopographic and flat substrates was 0.80 ± 0.45 and 0.54 ± 0.27 pCm/min (*** p <
0.001), respectively, while the effective displacement due to migration was 23.6 ± 12.1 and 15.6
± 10.1 .m (*** p < 0.001), respectively (Figure 66).
B. Protein Level Expression of Endothelial Cell Markers is Constant
Across Substrate Topography
Linear nanotopographic substrates organized populations of EPCs into band structures at 6 d
consisting of hundreds of cells and extending for millimeters in length. The supercellular bands
contained a well-defined edge that paralleled the feature grating. This edge was identified by
EPCs with highly elongated, constrained morphology. These band-like structures were distinct
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from each other and did not merge to form confluent monolayers of cells. These gross
morphological changes were observed for up to 6 d. The morphology of EPCs cultured on
nanotopography lies in stark contrast to EPCs cultured on flat substrates, which did not form
supercellular structures and instead produced confluent monolayers of EPCs after 6 d. Despite
the marked alterations in morphology, proliferation, and migration states, the level of protein
level expression of selected markers was observed to be similar across substrates, as assessed by
immunohistochemistry at 6 d. These markers included CD31 (PECAM-1), vascular endothelial
cadherin (VEcad), and a-smooth muscle actin (a-SMA, negative staining) (Figure 33).
Additional markers that were similarly expressed in cells cultured on both substrates include von
Willebrand factor, VEGF-2 receptor (KDR), and lectin receptor (Figure 67). The effects of
nanotopography on morphology and endothelial-cell specific marker expression were observed
to be independent.
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Figure 33. Nanotopography Induces the Formation of Supercellular Band Structures in Long-term EPC
Culture.
EPCs cultured on flat substrates simply began forming confluent layers of cells after 6 d of culture. This lies
in stark contrast to EPCs cultured on nanotopography, which did not form confluent layers of cells. Rather,
EPCs began to form supercellular band structures aligned in the direction of the features after 6 d of culture.
These morphological differences are evident through staining of PECAM-1 and VEcad. The absence of a-
SMA suggests that these cells maintain their endothelial cell phenotype. The protein level expression of these
endothelial-specific markers is similar in cells cultured on both nanotopographic and flat substrates. The
direction of the linear nanotopographic features is indicated by the arrow. Scale bars represent 50 microns.
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C. In vitro Capillary Tube Formation
The addition of Matrigel induced capillary tube formation in EPCs cultured on both substrates in
less than 4 h as assessed by light microscopy. EPCs cultured on flat substrates formed short,
randomly oriented capillaries while EPCs cultured on nanotopography formed well-defined
capillary tubes with increased length (Figure 34). Furthermore, capillary tubes on
nanotopographic substrates exhibited enhanced alignment and organization. The fraction of
EPCs recruited into capillary tubes was also increased dramatically in cultures with substrate
nanotopography. This observation contrasted with the observed tube formation in EPCs culture
on flat substrates, which was characterized by a high density of tubes with short lengths oriented
in random directions. Furthermore, only a small fraction of cells cultured on flat substrates
participated in capillary tube formation. Although the three-dimensional morphology of cells
was not explicitly studied in this work, others have shown that the culture of endothelial cells in
the presence of Matrigel induces the formation of three-dimensional capillary tubes with
lumens.[10, 309]
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Figure 34. In vitro Capillary Tube Formation Assay.
Capillary tube formation was induced by that addition of Matrigel after 6 d. (a) EPCs cultured on flat
substrates (i) formed a low density of unorganized capillary tubes while EPCs cultured on nanotopographic
substrates (ii) formed extensive networks of organized structures, (b, c) which had longer average lengths
when compared to EPCs cultured on flat substrates (*** p < 0.001). Furthermore, the vast majority of EPCs
on nanotopographic substrates were recruited into capillary tubes, which was far greater than that of EPCs
on flat substrates. Image was angled to demonstrate the length of observed tubules. The direction of the
linear nanotopographic features is indicated by the arrow. Scale bars represent 200 microns.
IV. Discussion
A. Contact Guidance Response in Endothelial Progenitor Cells
The observed cell response of EPCs to linear substrate nanotopography in this study is in concert
with previous work on a variety of substrate materials and cell types. Alignment of cells to
linear micron and sub-micron scale features is a well-characterized response that occurs in many
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different cells types including endothelial cells. [88, 95, 262, 264, 310, 311] Reduced proliferation has
also been observed in a variety of cell types including smooth muscle cells and human
embryonic stem cells.1261, 311] The increased migration velocity of EPCs on substrate
nanotopography is also in agreement with previous work of various mammalian cell types
including corneal epithelial cells.[ 268] This collective response is a principle element in the in
vitro contact guidance with substratum cues. One result of note regarding this aspect of EPC
responses to nanotopography is that the morphological changes were maintained for long-term
culture. Oftentimes the elongated morphology becomes affected as cell growth leads to
impingement of protrusions. The maintenance of this morphological aspect can be attributed to
the formation of aligned bands of cells which enabled preservation of the elongated morphology.
B. Role of Topography in Enhanced in vitro Capillary Tube Formation
Cells have been shown to respond to substrate nanotopography at the protein level as well.[265]
While it is likely that nanotopography impacts the genetic profile of EPCs, the expression profile
of selected markers was similar in EPCs cultured on both substrates, which implies that surface
nanotopography has no significant impact on the protein level of endothelial-specific markers.
Despite this observation, the impact of nanotopography on the overall organization of EPCs and
the enhanced in vitro capillary tube formation was maintained. The nanotopographic features
were hypothesized to play a governing role in this observation via the enhanced formation of
band structures primarily through two means. First, linear nanotopographic features align and
elongate individual EPCs which ultimately form clusters of EPCs. This clustering is
hypothesized to promote cell-cell interactions, which ultimately lead to the formation of the
observed band structures. Second, the reduction in proliferation prevents the growth of EPCs
into confluent monolayers of cells on nanotopographic substrates. The unoccupied surface area
is hypothesized to enable the rapid formation of capillary tubes in vitro. Conversely, the
formation of confluent layers, as observed in cells cultured on flat substrates, possibly retards the
formation of capillary tubes because of the spatial constraint of EPCs interfering with each other.
V. Conclusions
The observations in this study further suggest the continued application and integration of
nanotopographic features in tissue engineering systems. For example, biodegradable polymers
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amenable to soft-lithography could be used in future studies. [92' 96, 262] Furthermore, other
vascular progenitor cells and co-culture systems could also be employed to explore the use of
systems with physical surface cues for therapeutic applications.1312] This system could also be
directly used to study the mechanisms of vascular genesis by investigating the cellular pathways
involved in the observed enhanced capillary tube formation. The introduction of co-cultures
could potentially serve as a platform to elucidate the underlying homotypic and heterotypic
cellular processes that are biologically relevant to blood vessel formation in vitro and in vivo.[12]
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Chapter 10: Microfabrication of Poly(glycerol-co-
sebacate) for Contact Guidance Applications
The content of this chapter has been published in whole or in part in the following journal article:
C J Bettinger, B Orrick, A Misra, R Langer, J T Borenstein. Microfabrication of poly(glycerol
sebacate) for Contact Guidance Applications. Biomaterials 2006, 27, 2558.
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I. Introduction
A. Contact Guidance
Extracellular matrix proteins are known to contain a rich three-dimensional surface topography
that presents biophysical cues to cells.[280] The topographic features within basement membranes
have been shown to contain sub-micron length-scales.1211] This discovery led to the well-tested
hypothesis that cellular structure and function can be influenced culturing cells on a variety of
substrates modified with micron and sub-micron sized features.1311 Inducing cellular responses
using synthetic micro- and nanofabricated substrates,1 2551 termed contact guidance,1 285] has been
observed in a variety of cell types[ 27] including, but not limited to embryonic stem cells,1 3111
endothelial progenitor cells,1 313] epithelial cells,195' 286, 287] fibroblasts,1 262, 279, 288, 289]
oligodendrocytes,1 290 1 and astrocytes.[2901 Contact guidance has been shown to induce a variety
of cellular responses such as the up regulation of fibronectin mRNA in human fibroblasts,1291
increased adhesion of epithelial cells,12861 and increased mineralization and alkaline phosphatase
activity in rat bone marrow cells.[2 911 However, if substrates are fabricated with sub-micron
features, the cellular response varies across cell type and depends heavily on other factors such
as feature size, geometry 1314] and cell-cell interactions. [31s1
B. Poly(glycerol-co-sebacate): A Novel Biodegradable Material
Platform.
One of the most promising applications of contact guidance is in the field of tissue engineering.
The ability to control cell morphology and orientation using mechanical cues alone is a
potentially useful technique. However, one limiting factor in previous work in contact guidance
has been the choice of material. Microfabricated silicon and replica molded poly(dimethyl
siloxane) (PDMS), although ubiquitous and inexpensive, are not biodegradable, have limited
biocompatibility, and therefore are not suitable biomaterials for tissue engineering systems.
Poly(L-lactic-glycolic acid) (PLGA), while biodegradable, exhibits sub-optimal properties for an
implant material such as rigid mechanical properties, 126] bulk degradation kinetics, [86] and
questionable biocompatibility in some cases. [127] High concentrations of PLGA by-products has
also been shown to be cytotoxic, 128] which is a major limitation in the prospect of fabricating
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large, organ-size scaffolds using PLGA. Poly(glycerol-co-sebacate) (PGS), a recently
synthesized biocompatible and biodegradable elastomer with superior mechanical properties,
serves as a promising alternative material for fabricating contact guidance substrates. [86 1 PGS is
a tough, biodegradable, elastomer that is biocompatible, inexpensive, and easy to synthesize.
Polymers containing sebacic acid and glycerol, the monomers used in PGS synthesis, have both
been approved for use in medical applications by the FDA. Both in vitro and in vivo
biocompatibility studies[8 6, 127] suggest improved cellular response and morphology of PGS when
compared to PLGA, which eliminates the need for surface treatment through chemical
modification. PGS is also a suitable material from a processing perspective. PGS pre-polymer
can be replica molded and cured on silicon masters to form layers as thin as 100 microns in a
process that is analogous to replica molding of PDMS.[3 91 PGS degrades via a surface erosion
mechanism, 1' 271 which allows the substrate to retain feature fidelity after implantation thus
continually providing contact guidance cues throughout the lifetime of the material.
C. Micron Scale Substrate Geometry
The corpus of work in contact guidance has focused primarily on fabricating substrates with
well-defined microstructures of various feature sizes to study the response of cellular
morphology. Obtaining well-defined topographical features with tight distributions in feature
size is characteristic of work that utilizes traditional microfabrication processes. However, one
unfortunate consequence of traditionally microfabricated substrates is the creation of sharp
features with salient corners. While it has been shown that the cellular responses often vary as a
function of the length-scale of basic ridge-groove features or randomly oriented, nanometer scale
posts,[240, 316, 317] the sharp edges of these features are not biologically relevant. There are,
however, reports of mammalian cells aligning and elongating in response to rounded geometries,
namely along the longitudinal axis of cylindrical substrates [3181 and in the direction of continuous
wavy features with micron scale periodicities. [98]
In this study, we developed a method for fabricating flexible, biodegradable substrates with
micron scale features for contact guidance applications. We have developed a fabrication
technique for achieving sub-micron scale features down to 500 nm in a flexible biodegradable
material platform. This technique is flexible, allowing for the application of this process to
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microfabricate rounded features on other types of replica molded biomaterials. Using bovine
aortic endothelial cells (bAECs) as a model cell system, we studied the morphology of bAECs
grown on substrates with periods of approximately 2.5 and 4.5 microns with constant feature
height of 0.45 microns. Cells cultured on substrates with smaller periods exhibited stronger
alignment and reduced circularity relative to substrates with larger features. A hypothesis that
describes a possible mechanism for contact guidance is proposed to rationalize the results, which
focuses on the role of filipodia in the detection of local topographic cues.
II. Materials and Methods
A. Fabrication of Nanopatterned Silicon Masters
Standard photolithographic and plasma etching techniques were utilized to produce "negative
mold" silicon masters for use in replica molding just as PDMS is used to fabricate microfluidic
devices quickly and easily. 3 91 Briefly, patterns printed on high-resolution transparency films
were transferred to chrome-on-glass masks to be used in the photolithography step. 100 mm
diameter wafers were patterned with photoresist using one photolithography cycle. Features
were etched using an STS etcher (Surface Technology Systems, Newport, South Wales, UK)
using etch-passivation cycles. The remaining photoresist was stripped in a series of acetone,
isopropanol, and methanol rinses. Prior to replica molding of PGS, a sacrificial sucrose release
layer was spin-coated on the silicon master. Micromachined silicon masters were cleaned using
piranha solution (Mallinckrodt, St. Louis, MO) and plasma cleaned (March, St. Petersburg, FL)
at 250 mTorr and 100 W for 120 sec. A 90% (w/w) solution of sucrose (Sigma, St. Louis, MO)
in water was spin-coated at 3000 RPM for 30 sec. The sucrose layer was pre-baked on hot plate
at 95 oC for 90 sec and post-baked in an oven at 120 oC for 24 h.
B. PGS Replica Molding
PGS pre-polymer was synthesized using previously established methods.[86 ]  Briefly,
stoichiometric amounts of sebacic acid and glycerol were reacted at 120 oC for 120 h under
nitrogen. Vacuum was then applied for 28 h after which the reaction was stopped. The pre-
polymer was allowed to cool and stored at room temperature in a desiccate environment until
further use. The replica molding process is summarized in (Figure 35). 3.5 + 0.05 g of PGS pre-
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polymer was melted at 160 oC and applied to the wafers for replica molding and smooth sheet
formation. The polymer was cured at 150 oC for 15 h under a vacuum of 20 mTorr, which
produced firm, highly cross-linked, elastomeric PGS layers of approximately 500 microns in
thickness. The PGS substrate was statically incubated in a ddH20 bath at room temperature for
24 h to induce delamination through sucrose dissolution. The PGS substrate was then serially
placed in solutions consisting of 100% ethanol (Pharmco, Brookfield, CT) for 24 h, 70% (v/v)
ethanol in ddH20 for 2 h, 35% (v/v) ethanol in ddH20 for 2 h, and IX Dulbecco's phosphate
buffer (PBS, Gibco, Carlsbad, CA) for 2 h. To enhance optical clarity, the PGS membranes were
then dehydrated in an oven at 120 oC for 15 h. The substrates were then rinsed three times with
lX PBS, once with medium (See Cell Culture and Cell Imaging), and sterilized using UV
overnight in a laminar flow hood. The substrates were then incubated in medium at 37 OC for the
24 h prior to cell deposition.
C. PGS Substrate Characterization
Surface topology of micropatterned PGS substrates was determined using a combination of
optical profiling, scanning electron microscopy (SEM) and atomic force microscopy (AFM).
Prior to optical profiling, PGS substrates were dehydrated in an oven at 150 TC for 15 h and
sputter-coated with gold/palladium using a Cressington 108 Auto sputter coater for 36 sec, which
deposited a 30-45 nm thick film to attain enhanced optical contrast (Cressington Scientific
Instruments Inc, Cranberry Twp, PA). A Wyko optical profiler (Veeco, Fremont, CA) was used
in characterizing the feature geometries and dimensions. Two locations were measured for each
pattern and a total of fifty measurements were performed. The feature height was characterized
by measuring the vertical distance between peaks and valleys. Feature pitch was characterized
by measuring peak-to-peak as well as valley-to-valley lateral distances between features as
obtains by non-contact optical profiling (Figure 68). The large standard deviations in feature
height and period can be attributed to non-uniformities imparted by the sucrose coating. Cross-
sections of PGS were prepared by sectioning microfabricated PGS substrates and sputter coated
for 15 sec. A Nanoscope IIIa Atomic Force Microscope (Veeco, Digital Instruments, Santa
Barbara, CA) was used to simultaneously corroborate optical profiling data as well as investigate
nanometer scale roughness.
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Table 13. Summary of Feature Dimensions of Microfabricated Topographical PGS Substrates.
Pattern Perioda Heighta Curvature per feature (m~-m)b Curvature per length (pmr2)c
G1 2.5 ( + 0.3) 0.45 ( + 0.15) 0.51 0.20
G2 4.1 ( + 0.4) 0.45 ( + 0.20) 0.20 0.05
G3 4.5 ( + 0.3) 0.45 ( + 0.20) 0.17 0.04
Flat -- -- -- --
a Given values are for mean values with standard deviations in parenthesis for a total ofn > 50 for each pattern.
b The curvature per feature was calculated by approximating the feature trajectory as a chord of a perfect circle and
calculating the subsequent radius. The curvature was then calculated by calculating the inverse of this radius.
C The curvature per length was simply calculated by diving the curvature per feature by the period of the
corresponding feature.
D. Cell Culture and Cell Imaging
All materials were supplied by Cambrex, San Diego, CA unless otherwise noted. Bovine aortic
endothelial cells (bAECs) were cultured with EGM-MV medium kit with a final and incubated at
37 oC and 5% CO2. After reaching no more than 80% confluence, the cells were harvested in
their 5th or 6th passage using trypsin 0.025%/EDTA 0.01% and quenched with a trypsin
neutralizing solution. The cells were re-suspended in medium and plated on the nanopatterned
substrate at a surface density of 7500 cells/cm 2 for 15 h. The medium was removed at the end of
the incubation period and the cells were stained for cell nuclei and filamentous actin using FITC-
phalloidin.[951 However, the resolution of cell bodies and structures was not possible due to
dramatic auto fluorescence despite a blocking step of 1% bovine serum albumin (Sigma) in PBS
for 1 h prior to staining. Efforts of digital contrast enhancement led to unsatisfactory images.
Cell samples selected for SEM imaging were fixed at 3.7% (v/v) paraformaldehyde in PBS
(Sigma). The samples were sectioned and serially immersed in solutions of 25%, 50%, 75%, and
90% (v/v) ethanol in ddH20 for 5 min each. The samples were then immersed in 100% ethanol
followed by HMDS (Sigma) each for 15 min. The samples were then allowed to air dry for 24 h
prior to imaging. Samples were sputter-coated for 12 sec resulting in a film thickness between
10-15 nm. Scanning electron micrographs were taken using a Hitachi S-3500N at 5kV
acceleration voltage unless otherwise noted.
E. Cell Morphology Measurements
The transparent PGS substrates allow for the direct measurement of cell alignment angle using
an optical microscope (Zeiss, Germany). Phase micrographs of cells were taken at 10X
magnification and relative angle of the cell to the feature was calculated using Axiovision
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software (Zeiss). Each data set consists of measurements of at least two hundred cells across two
experiments.
III. Results
A. Microfabricated Substrates
Three microfabricated surfaces with varying feature sizes were used in contact guidance studies.
SEM images of the silicon masters for patterns G2 and G3 reveal some degree of non-
uniformities in the feature sizes and spacing (Figure 36). This can be most likely attributed to
the inaccuracies that accompany the microfabrication of sub-micron features using near-UV
wavelength photolithography. SEM and AFM imaging studies suggest that the surfaces of the
replica molded PGS substrates were smooth with no detectable features or characteristic
roughness larger than 5 nm (Figure 36). This surface smoothening is primarily due to the
sacrificial sucrose layer that aids in the release of the PGS substrate from the silicon master.
This sucrose layer also results in a general smoothening of features and a reduction in the salient,
step changes in feature height. Because there are not clearly defined ridges and grooves, it is
convenient to characterize the feature size by measuring the periodicity of the features and
vertical height from the peak of one ridge to the valley of the adjacent groove. Similarly, the
periodicity of the features was determined by calculating the horizontal distance between two
consecutive ridge peaks or two consecutive groove valleys. The metrology data for all of the
samples is summarized in Table 13.
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Figure 35. Fabrication of Replica Molded PGS Substrates.
a) Silicon wafers were processed using deep reactive etch microfabrication processes. b) A sucrose solution
was spin coated and post-baked on to the wafer to create a sacrificial sucrose release layer. Additionally, this
layer leads to a smoothening of the salient silicon ridges and grooves. c) Poly-glycerol sebacate was replica
molded on this surface, cured, and removed via sucrose-dissolution in water. d) The resulting substrate is a
flexible, biodegradable material with rounded contact guidance cures. Schematics in figure are not drawn to
scale.
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Figure 36. Characterization of Silicon Masters and Replica Molded PGS Substrates.
Silicon masters for patterns Gi, G2, and G3 are shown (a, c, and e respectively) along with the corresponding
replica molded PGS (b, d, and f respectively). The silicon masters for patterns G2 and G3 were
uncharacteristically non-uniform, which is curious for work in microfabrication. This can be attributed to
inaccurate reproduction of sub-micron features using near-UV photolithography. The sharp features in the
silicon mold become rounded due to the effect of the sucrose release layer. This results in rounded PGS
features, which is evident by the diffuse nature of the features in the SEM images (See b, d, and f). Insets (b,
d, and f) in combination Wyko optical profiling (Figure 68) show feature heights and periods for patterns G1,
G2, and G3. Features with periods as small as 1 micron could be fabricated using this technique (g). Scale
bars represent 10 microns in the large figures and 5 microns in the insets.
180
B. Morphology, Cell Alignment and Circularity
The cell alignment and circularity of cells was controlled through microfabricated PGS
substrates when compared to smooth control substrates (Figure 69). Qualitatively, SEM images
(Figure 37) suggest that cells cultured on PGS substrates with microstructures exhibit a more
rounded, spindle-like geometry compared to cells cultured on flat PGS substrates, which
appeared to have randomly oriented cell projections and a more flattened appearance. In many
of the SEM images, cell protrusions were shown to extend to the apex of the rounded ridge
structures in all data sets with microfabricated substrates. Cell alignment angles were
normalized to a single quadrant with resulting angles between a range of 0 and 90 degrees
relative to a reference angle (Figure 38a). The reference angle is parallel to the features in the
case of ridge-groove geometries. The cell angles were discretized into ten-degree intervals and
the normalized frequency of each cell discrete range was plotted (Figure 38b). At least three
different spots on each pattern were measured and a one-way Student's t-test was performed to
determine statistical significance. Cells with angles less than ten degrees were considered to be
aligned (Figure 38c). Cells cultured on substrate GI showed more cell alignment when
compared to substrates G2, G3, and flat PGS surfaces while cells cultured on substrates G2 and
G3 both showed more alignment than the flat PGS surfaces as well (*** p < 0.001). The
circularity index, C, was calculated using the formula:
4mi
C P2 Eqn.18
where P is the perimeter of the cell in microns and A is the projected area of the cell in square
microns. The equation for circularity is such that a value of unity corresponds to a perfect circle,
while values of circularity index much less than unity correspond to high aspect ratio geometries.
Cells cultured on substrates G1 had smaller circularity indices compared to substrates G2, G3,
and flat PGS surfaces (*** p < 0.001), which implies more elongation. Cells cultured on
substrates G2 and G3 also had lower circularity indices as compared to flat PGS surfaces (*** p
< 0.001).
181
Figure 37. SEM Images of Cell Morphology on Microfabricated PGS Substrates.
Bovine aortic endothelial cells cultured on substrates with topographic structures of 2.5 micron period (a)
exhibited spindle-like morphologies, higher alignment frequency, and more elongated geometry, when
compared to substrates having 4.1 micron (b) period, 4.5 micron (c) period, and flat samples, respectively.
Cells extend filopodia, which appear to make contact with the apex of the microstructures of topographically
patterned substrates as indicated by triangles in the figure (a inset, b). Cells cultured on flat substrates
appear to extend filipodia in random directions (d). Scale bars represent 10 microns in the large figures and
1 micron in the inset.
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Figure 38. Alignment and Elongation of Cell Populations on Microfabricated PGS substrates.
a) Cell alignment was calculated by measuring the angle, 0, between the major axis of the cell body and the
direction of the microstructure. b) Cells cultured on substrates G1 had a higher frequency of cell alignment
and a (c) tighter distribution of orientation angle compared to G2, G3, and Flat substrates. d) Cells cultured
on all substrates with topographic patterning had more cell alignment and reduced circularity when
compared to control surfaces without ordered topography. Values indicated with (**) correspond to
significant differences between substrates G1 and G2-G3 as determined by Student's t-test. Values indicated
with (*) correspond to significant differences between substrates G2-G3 and flat substrates as determined by
Student's t-test.
IV. Discussion
A. Adaptable Process for Developing Smoothed Micron Scale
Features for Biopolymers
The microfabrication process demonstrated in this work has potential applications for
engineering surfaces of implants and other tissue engineering systems. No solvents are used in
this generalized replica molding process, which can be expanded to produce biomaterials with
rounded features of mircon and sub-micron scale. This process can be expanded to fabricate any
large range of materials that can be microfabricated using solvent casting, embossing, or similar
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processes that employ a mold. However unlike inorganic materials such as silicon and PDMS,
the improved biocompatibility of PGS does not require treatment of the surface with adhesion
proteins such as fibronectin. Treatment of PGS with low-serum media (5%) coats the surface
with non-specific proteins, which in combination with the rounded topographical features,
simulates an in vivo environment and is more appropriate for therapeutic applications.
B. The Potential Role of Filopodia in Cell Alignment in Response to
Microstructures
While the mechanism of contact guidance, cell alignment, and elongation is not yet fully
understood, there are several prevalent observations that support a variety of possible
mechanisms. One initial hypothesis suggested that discontinuous features in ridges lead to
selective protein absorption on microfabricated substrates with subsequent cell alignment and
elongation.[31 ,31 9] However, data presented here and in other work with rounded features [320 ] has
suggested that sharp features are not required for cell alignment. More recent work suggests the
importance of filipodia in detecting substrates with microstructures. The cytoskeleton is a
dynamic cellular component that is responsible for altering cellular morphology via the rapid
extension and contraction of filopodia and lamellipodia in response to substratum structural cues
as well as other microenvironment parameters. This response is known to occur in a variety of
cell types including fibroblastsl2 40, 317] and endothelial cells.13161 In the context of contact
guidance and cell alignment, it is well-known that epithelial cells periodically extend filopodia
and lamellipodia preferentially parallel to the pattern direction in ridge-groove geometries, but
are not necessarily limited in this regard. [95' 321] For example, filipodia in epithelial cells were
able to adhere to grooves and ridges and were frequently aligned by nanotopographic features.[95]
Filipodia of endothelial cells cultured on surfaces with nanometer-scale islands show preferential
attachment to the vicinities of the island surfaces.[ 316] These studies suggest that filipodia play a
key role in assessing the surface topography of the localized microenvironment of the cell. The
results of this study also support the theory that the filipodia play an important role in the
detection of rounded microstructures and subsequent alignment of cells. Many of the cells
observed through SEM showed preferential attachment of filopodia to the apex of the
microstructures (Figure 37a inset, b). Based on these results, we speculate that, in the case of
bAECs, the filopodia can detect gradients in surface topography and may preferentially adhere to
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microstructures at the highest point. The biased location of cellular adhesion points may
manifest itself into cue that could trigger the observed contact-guidance reaction. This theory is
supported by the observations from this work in relation to previous studies. Since the cells
appear to have a preference for attachment to the apex of the microstructures, this implies that
the filipodia of cells have an inherent ability to detect local gradients in topography and adhere
preferentially. Assuming smooth microstructures, the radius of curvature and the radius of
curvature per length both vary inversely with periodicity. Substrates containing smoothed micro
features exhibiting smaller periodicity (GI) have a higher mean curvature than substrates
containing features with relatively larger periodicities (G2, G3). We hypothesize that this
increased curvature presents a stronger topographic cue leading to an increase in cell alignment.
The value of mean curvature of the substrates G2 and G3 presented in this work are similar to the
curvature of cylindrical substrates used in the elongation and alignment of fibroblast cultures. [318]
These data support the hypothesis that filipodia are able to detect curvature in general, which
may lead to cytoskeleton rearrangement and subsequent elongation and alignment in cell
morphology. However, further experiments must be performed to confirm these hypotheses and
further elucidate the exact mechanism of contact guidance.
V. Conclusions
We have fabricated flexible, biodegradable, biocompatible substrates with rounded features as
small as 500 nm. Substrates containing smooth features with periods on the order of microns can
be used to align and elongate bovine aortic endothelial cells. The superior mechanical and
biocompatibility properties of PGS coupled with the observed strong contact guidance responses
of cells cultured on microfabricated PGS renders this system appropriate for in vivo applications.
This could lead to the development of engineered implant materials that can organize and align
cell populations to facilitate desirable cell-cell interactions and promote tissue formation.
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Chapter 11: Nanofabricated Synthetic Collagen
Analogues for Enhanced Primary Hepatocyte Culture
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I. Introduction
A. Biomaterials Development for Tissue Engineering
Biomaterial development has become a substantial component in tissue engineering over the last
two decades. The primary drivers for this thrust have been the pursuit of cell-biomaterial
interactions to promote attachment, enhance cell function, or both. Hepatic tissue engineering is
of particular interest for a variety of applications including bioartificial liver (BAL) optimization,
in vitro toxicity models,[322] and cell-based therapeutic tissue engineering devices. t4 1 A wide
variety of natural and synthetic biomaterials have been engineered and synthesized with the goal
of recapitulating native hepatocyte behavior in vitro. Engineering natural materials has focused
primarily on novel methods for production and purification of native extracellular matrix (ECM)
proteins such as collagen.[116 , 157, 1581 ECM proteins support cell attachment and incite a variety
of functions in many cells types including hepatocytes. [66 ' 1171 However, natural ECM proteins
have a limited range of properties, are subject to difficult bulk material processing, and have the
potential to induce potentially dangerous immune responses when used as xenografts or
allografts.'" 591 Natural protein extraction and purification directly from tissues also leads to
significant batch to batch variations in composition and physical properties. These variations can
lead to unpredictable cell behavior, which can impact performance of cell-based tissue
engineered devices for therapeutic and drug discovery applications. [322 ] Synthetic peptide
biomaterials produced through recombinant DNA and protein engineering strategies have been
introduced as a possible means to overcome these limitations in natural peptides. [323] Although
protein-based biomaterials have shown promise in achieving native-like properties through
synthetic polypeptide sequences, [324] materials synthesis and production is very costly due to the
dependence upon recombinant microbal hosts for synthesis as well as subsequent purification
steps. Numerous biodegradable, synthetic thermoplastic, thermoset, and photocrosslinkable
polyesters have been developed for tissue engineering applicaitons. [86' 87, 160-168] Although these
materials can be synthesized in large batches, most of these materials lack sufficient
physicochemical properties to recapitulate native cell function. Hence, synthetic biomaterial
systems typically rely on a variety of surface treatment techniques to improve cell-biomaterial
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response including protein coatings, chemical modification, and biotynlated conjugates to
enhance adhesion.
B. Summary of Results
We hypothesized that an entirely synthetic biomaterial could be engineered to promote
attachment and native function of primary hepatocytes, a notoriously difficult cell to culture in
vitro. The rational behind synthesis was aimed at the biomimicry of surface chemistry and
nanotopography of native collagen films. Collagen molecules are primarily composed of
repeating polypeptide sequences with amide linkages. Although the physical dimensions of
individual molecules is 300 nm in length and 1.5 nm in width,120 8] these individual molecules can
form fibrils that extend for tens of microns in length and have diameters between 260 and 410
nm.[209]  Poly(ester amide) elastomers were nanofabricated with pillar geometries of
approximately 400 nm in width for use as a biomimic synthetic collagen. Nanotopographic
poly(ester amide) substrates were found to enhance the attachment and spreading of primary
hepatocytes. The morphology and metabolic function of hepatocytes cultured on
nanotopographic poly(ester amide) elastomers was found to be similar to that of hepatocytes
cultured on collagen films.
II. Materials and Methods
A. Preparation of Nanofabricated Silicon Masters
Photolithographic and plasma etching techniques were utilized to produce "negative mold"
silicon masters for use in replica molding in a similar manner as PDMS.[ 39] Four-inch diameter
silicon wafers were oxidized for 10 h at 1100 oC in atmospheric pressure oxygen at 50 standard
cubic centimeters per minute flow rate (sccm), and hydrogen (30 seem) to grow an oxide layer of
2 microns. The oxide layer thickness was measured with Filmetrics F20 and F50 spectral
reflectometers. Silicon wafers with oxide layer were baked at 110 oC to dehydrate their surface
and spin-coated with hexamethyldisilazane (HMDS) at 5000 RPM for 10 sec to promote resist
adhesion. Photoresist (Shipley 1805) was then spin-coated (EVG101) on the wafers at 3500
RPM for 20 sec. The wafer was then softbaked on a hotplate at 115 oC for 1 min to yield a resist
film thickness of approximately 500 nm. Resist exposure was done with a Karl Suss MA-6
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contact aligner with an exposure dose of 96 mJ/cm2, and the resist was developed for 45 sec in
Shipley MF-319 developer followed by a three minute rinse in de-ionized (DI) water and spin
drying. Wafers were etched using a silicon ICP etch process using SF 6/Argon in a VLR-700
(Surface Technology Systems, Newport, South Wales, UK) using etch-passivation cycles,
plasma ashed, and cleaned for preparation in replica molding (MEMS Exchange, Reston, VA).
The remaining photoresist was stripped in a series of acetone, isopropanol, and methanol rinses.
Micromachined silicon masters were cleaned using piranha solution (Mallinckrodt, St. Louis,
MO) and plasma cleaned (March, St. Petersburg, FL) at 250 mTorr and 100W for 120 sec.
Wafers were then passivated using an STS etcher (Surface Technology Systems) with only SF 6
gas for 30 sec to create a hydrophobic layer to enhance release of replica molded substrates.
Wafers were rinsed with methanol immediately prior to replica molding of polymers.
B. Replica Molding of Poly(ester amide) Elastomers
Poly(1,3-diamino-2-hydroxy propane-co-polyol sebacate) (APS) pre-polymers was synthesized
as previously described. ['190 The pre-polymer was allowed to cool and stored at room
temperature in a desiccate environment until further use. The replica molding process is
summarized as shown in Figure 39. Approximately 3.5 ± 0.05 g per 20 cm2 of APS pre-polymer
was melted at 170 oC and applied to wafers for replica molding and smooth sheet formation. The
polymer was cured at 170 OC for 48 h under a vacuum of 50 mTorr, which produced firm, highly
cross-linked, elastomeric APS polymer films of approximately 500 microns in thickness. APS
polymers were statically incubated in a ddH20 bath at 70 oC for 24 h to induce delamination.
The APS substrate was then serially placed in solutions consisting of 100% ethanol (Pharmco,
Brookfield, CT) for 24 h, 70% (v/v) ethanol in ddH20 for 2 h, 35% (v/v) ethanol in ddH20 for 2
h, and 100% (v/v) ddH20 for 24 h. APS polymers were dried at 70 oC for 24 h and autoclaved
and dried for 20 min each. The substrates were then irradiated with UV in a laminar flow hood
for 15 min and incubated at 37 oC for 1 h prior to cell seeding.
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2. Cure at 170 0C, 3. Delaminate in ddH20
50 mTorr, 48 h at 700C
Figure 39. Preparation of Replica Molded Nanofabricated APS Substrates.
a) Passivated silicon molds are rinsed with methanol prior to application of the APS pre-polymer. b) APS
pre-polymers are heated to 170 TC to facilitate spreading across the mold. APS polymers are then cured at
170 OC under 50 mTorr vacuum for 48 h to induce crosslinking. c) The crosslinked APS elastomers are then
delaminated in ddH20 at 70 OC. Note: schematic not drawn to scale.
C. Preparation of Collagen Substrates
Collagen-coated poly(di-methylsiloxane) (PDMS) was chosen as the control biomaterial. PDMS
(Dow Sylgard 184, Essex Chemical, Clifton, NJ USA) was chosen as a base material due to ease
of fabrication, optical clarity to facilitate characterization, and similar Young's modulus as APS
polymers. [3 25] Briefly, substrates were plasma cleaned (PDC-001, Harrick Scientific Co) for 300
sec at 80 W RF power with atmospheric gas at 250 mTorr. A 50 jtg/mL solution of collagen I
from rat tail in PBS (Sigma, St. Louis, MO USA) was immediately adsorbed onto the surface
and incubated for 2 h at 37 oC.
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D. Substrate Characterization
Surface topology of nanofabricated substrates was determined using both optical microscopy and
scanning electron microscopy (SEM). Hydrated and dehydrated APS substrates were imaged
using optical microscopy (Nikon Imaging, Melville, NY USA). Dehydrated APS substrates
were imaged by SEM by undergoing a dehydration bake at 70 oC for 15 h followed by sputter
coating with gold/palladium using a Cressington 108 Auto sputter coater for 36 sec. This
process deposited a 30-45 nm thick conductive film to eliminate charging of the sample
(Cressington Scientific Instruments Inc, Cranberry Twp, PA).
E. Primary Hepatocyte Isolation and Seeding
Primary rat hepatocytes were isolated using a two-step collagenase digestion as previously
described. [326] Briefly, adult male Lewis rats were anesthetized by methoxyflurane (Metofane;
Pitman-Moore, Mundelein, IL USA) inhalational anesthesia. Animals were then prepared and
draped in a sterile environment. After a midline incision was made, the infrahepatic inferior
vena cava was cannulated with a 16-gauge angiocath (Critikon, Tampa, FL USA). The
suprahepatic inferior vena cava was then lighted and the portal vein was incised to allow for
retrograde efflux. Blood within the liver was washed out with an isotonic saline solution. The
extracellular matrix was digested with a 0.05% type D collagenase solution (Boehringer-
Mannheim, Indianapolis, IN USA). The liver was excised and mechanically agitated, resulting
in a single cell suspension. Viable hepatocytes were isolated from cellular debris and non-
parenchymal liver cells by differential sedimentation and Percoll gradient centrifugation (Sigma)
at 4 OC at 1000 x g. Hepatocyte number and viability were determined by trypan blue exclusion.
Cells were resuspended in serum free hepatocyte growth medium. Hepatocytes were then
immediately seeded on untreated APS and collagen substrates at a density of approximately
200,000 cells/cm2. Cells on substrates were incubated at 37 OC and 5% CO2 at 95% relative
humidity. Cells were cultured in serum-free medium for 24 h, rinsed once with DPBS, and
replaced with serum containing medium.
F. Characterization of Cell-Biomaterial Response
Cell density was characterized by calculating cell density at 24, 72, 120, and 168 h time points
by cell counting at 10 randomly selected regions per well (Nikon Eclipse TE2000-U, Nikon
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Imaging, Melville, NY USA). Intial cell attachment was calculated by normalizing cell density
at 24 h with that of the cell density of the collagen substrate. Cell adhesion was calculated by
assessing the relative attachment per condition at 120 h versus 24 h. Cell attachment and
adhesion was calculated across three independent experiments (n = 18 in total). Cell
morphology was characterized after 24 h by light microscopy and scanning electron microscopy.
Cell areas were calculated by measuring at least 150 cells per condition across two independent
experiments using AxioVision software (Zeiss Imaging, Thornwood, NY USA). Cell samples
selected for SEM imaging were fixed using Accustain formalin-free fixative (Sigma). The
samples were rinsed 3X in DPBS and immersed in solutions of 25%, 50%, 75%, and 90% (v/v)
ethanol in ddH20 for 5 min each. The samples were then immersed in 100% ethanol followed
by HMDS (Sigma) each for 15 min. The samples were then allowed to air dry for 24 h prior to
imaging. Samples were sputter-coated for 12 s resulting in a film thickness between 10-15
nanometers. Scanning electron micrographs were taken using a Hitachi S-3500N at 5kV
acceleration voltage unless otherwise noted.
G. Assessment of Hepatocyte Function
Hepatocyte function was assessed by the traditional metrics of albumin secretion and urea
production (n = 6) across two independent experiments. For albumin secretion, medium was
harvested at 24, 72, 120, and 168 h time points and stored at -20 oC until further analysis.
Medium was replaced with hepatocyte growth medium containing 2 gtM ammonia. Cells were
incubated with ammonia-containing medium for 3 h at which point the medium was harvested
and stored at -20 oC. Medium was then replaced with regular hepatocyte growth medium until
the next time point. Albumin concentrations were measured by rat-specific albumin ELISA
assay (Bethyl Laboratories, Montgomery, TX USA) and urea concentrations were measured by
Urea quantification assay (QuantiChrom, BioAssay Systems, Hayward, CA USA). Albumin
secretion rates and urea synthesis rates were normalized by cell density.
H. Statistical Methods
All graphical and tabulated data displayed as mean + s.d. Significance tests to assess the effect of
topography alone were calculated using unpaired, two-tailed Student's t-Test with unequal
variance (Microsoft Excel, Redmond, WA). Significnace tests to assess the effect of specific
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substrates for cell attachment, adherence, and spreading were conducted using an unpaired,
nonparametric Kruskal-Wallis one-way ANOVA with Dunn's multiple comparison post tests.
The specific effect of nanotopography was also further analyzed by a two-tailed Student's t-test.
Significance tests to assess the effect of specific substrates on cell metabolism was conducted
using a paired, nonparametric two-way ANOVA with Bonferroni post tests. Significance levels
for all statistical methods were set at * p < 0.05, ** p < 0.01, and *** p < 0.001.
Ill. Results
A. Nanofabricated Elastomeric Poly(ester amide) Substrates
The replica molding process designed for the reproduction of nanometer scale features produced
substrates with high feature fidelity (Figure 40). This is likely due to the combination of 1) van
der Waals attraction, which is dominant on the nanometer length scale and 2) the low mechanical
modulus of APS elastomers, which cannot resist these forces. High modulus materials replica
molded from these substrates have been shown to resist this collapse. Furthermore, once the
substrate is hydrated, the collapsing force is relieved and the pillars are restored to an ordered
formation (Figure 70). This ordering of features in the hydrated condition is also confirmed by
microscopy of cell-seeded substrates (Figure 71).
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Figure 40. Replica Molded Nanofabricated APS Polymer Substrates.
Replica molding of both 2DAHP-1G (00 tilt) and 2DAHP-1T (450 tilt) formulations are able to reproduce
nanometer scale features with high fidelity. The column features on these substrates have approximate
dimensions of 400 nm at the tip and 600 nm at the base with feature heights of 1000 nm and a pitch of 1200
nm. Note the collapsing of these structures upon each other in the dehydrated state. The ordering of these
features is restored upon hydration. Scale bars represent 2 microns.
B. Poly(ester amide) Elastomers Support Attachment and Maintain
Native Morphology of Primary Murine Hepatocytes
Elastomeric poly(ester amides) supported the attachment and spreading of hepatocytes without
the use of coating in serum-free conditions. The morphology of hepatocytes seeded on APS
substrates was generally similar to that of hepatocytes cultured on collagen substrates (Figure 41;
Figure 42). The morphology of hepatocytes cultured on PDMS substrates indicated a non-
native morphology and poor spreading, as was expected. PDMS substrates supported the
attachment of a small number of hepatocytes with limited spreading as measured by a smaller
projected surface area (Figure 43b). Hepatocyte morphology appeared to be rounded, as
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determined by SEM. Furthermore, there appeared to be protrusions extending from hepatocytes
cultured on nanotopographic 2DAHP-1G substrates (Figure 42; see white arrows). These cell
components were also observed in hepatocytes cultured on flat 2DAHP-1T and collagen
substrates (Figure 42; see white arrows).
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Figure 41. Phase Contrast Imaging of Primary Rat Hepatocytes on Nanofabricated APS Substrates.
The morphology of hepatocytes seeded on uncoated APS substrates in the absence of serum for 24 h appeared
similar to that of collagen substrates. However, cells cultured on collagen substrates more readily organized
into multi-cellular structures. Hepatocytes cultured on PDMS exhibited less cell attachment and a non-native
morphology. Scale bars represent 200 microns.
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Figure 42. Detailed Morphology of Cell-Substrate Interactions.
Hepatocytes cultured on all APS substrates exhibited a rounded morphology while those cultured on PDMS
and collagen substrates exhibited a more flattened morphology. Hepatocytes appear to have extended
filopodia on nanotopographic 2DAHP-1G, flat 2DAHP-1T, and collagen substrates (see white arrows).
Hepatocytes induced wrinkling of PDMS substrates (see white arrows and inset). Again, note the collapsing
of the posts on the nanotopographic substrates due to van der Waals forces. Scale bars represent 2 microns.
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C. Nanotopographic Poly(ester amide) Elastomers Enhance
Attachment and Spreading
Nanotopographic APS substrates were found to impact both the initial adhesion and spreading of
primary hepatocytes. This effect was evident on both APS elastomers. In the 2DAHP-1G
formulation, the relative initial attachment was increased from approximately 0.41 ± 0.11 to 0.55
+ 0.18 (* p < 0.05). A more dramatic increase was observed in the 2DAHP-1T formulation in
which the relative attachment was increased from 0.51 ± 0.12 to 0.75 ± 0.22 (*** p < 0.001).
Nanotopographic surfaces also enhanced the spreading of hepatocytes on APS substrates as
measured by the increase in projected cell area. The cells area of hepatocytes cultured on
nanotopographic APS substrates versus flat APS substrates was increased approximately 30%
across both polymers. In the case of 2DAHP-1G and 2DAHP-lT, cell area of hepatocytes was
increased from 1199 ± 112 to 1633 ± 108 gpm2 and from 1119 ± 81 to 1589 ± 79 p.m2,
respectively. The cell area of these hepatocytes cultured on both nanotopographic substrates was
significantly less than that of collagen substrates (* p < 0.05 for both conditions). In addition to
enhanced attachment and spreading, nanotopographic APS substrates also enhanced adhesion of
primary hepatocytes. This was determined by examining the relative cell densities after 120 h,
which resulted in a series of six wash steps.
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Figure 43. Nanofabricated APS Substrates Improve Initial Attachment and Increase Spreading of Primary
Hepatocytes.
a) Nanotopographic APS substrates increased the degree of initial hepatocyte attachment over flat APS
substrate counterparts (normalized to collagen substrates). b) A similar trend was found in the case of
projected cell area, which serves as a metric for cell spreading. Significance levels ( * p < 0.05 and *** p <
0.001) determined by two-tailed Student's t-test.
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Figure 44. Nanotopography Increases the Adhesion of Primary Hepatocytes.
Nanotopographic substrates increased the relative adhesion of hepatocytes to APS substrates. The
nanotopographic 2DAHP-1G formulation exhibited a higher amount of relative adhesion than collagen
substrates. Significance levels ( *** p < 0.001) determined by two-tailed Student's t-test.
D. Maintenance of Liver Function in Hepatocytes Cultured on
Poly(ester amide) Elastomers
Liver-specific function of primary hepatocytes cultured on APS substrates was maintained, as
assessed by albumin secretion and urea conversion. The normalized albumin secretion rate is
reduced significantly from day 1 to day 7 in hepatocytes cultured on all substrates. This can be
attributed to the characteristic reduction of liver-specific function of hepatocytes in vitro.
Albumin secretion was increased significantly in 2DAHP-1T Flat versus 2DAHP-1T Nano
substrates at day 3 (** p < 0.01). There were no significant differences between
nanotopographic or flat substrates for the 2DAHP-1G elastomer. In general, the normalized rate
of albumin secretion was reduced with time regardless of substrate. Albumin secretion rates,
while initially having a wide range of values, appeared to converge between 2-6 ptg- 106 cells-1-24
h-' in hepatocytes cultured on all studied substrates. Hepatocyes cultured on 2DAHP-1G
exhibited the highest initial rate of albumin secretion regardless of the topographical condition.
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However by 168 h, it appeared that hepatocytes cultured on flat APS substrates had higher
albumin production than those cultured on both nanotopographic APS substrates, PDMS, and
collagen. Urea conversion was generally higher in hepatocytes cultured on flat APS substrates
across all time points. The normalized urea synthesis rate remained relatively stable across the
entirety of the experiment. Urea synthesis rates were found to be elevated in hepatocytes
cultured on 2DAHP-1T Flat versus 2DAHP-lT Nano substrates (*** p < 0.001). This
differential effect was observed across all timepoints. A similar increase in urea synthesis was
observed in hepatocytes cultured on 2DAHP-1G Flat versus 2DAHP-1G Nano substrates at day
3. However, this effect was significant at day 3 (** p < 0.01). Surprisingly, collagen substrates
induced the lowest specific rate of urea conversion at 120 and 168 h.
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Figure 45. Specific Hepatocyte Function is Maintained in Cells Cultured on APS Polymer Substrates.
a) The normalized albumin secretion rate is reduced significantly from day 1 to day 7 in hepatocytes cultured
on all substrates. This can be attributed to the characteristic reduction of liver-specific function of
hepatocytes in vitro. Albumin secretion was increased significantly in 2DAHP-1T Flat versus 2DAHP-1T
Nano substrates at day 3 (** p < 0.01) as determined by two-way ANOVA (See Statistical Methods). There
were no significant differences between nanotopographic or flat substrates for the 2DAHP-1G elastomer. b)
The normalized urea synthesis rate remained relatively stable across the entirety of the experiment. Urea
synthesis rates were found to be elevated in hepatocytes cultured on 2DAHP-1T Flat versus 2DAHP-1T Nano
substrates (*** p < 0.001). This differential effect was observed across all timepoints. A similar increase in
urea synthesis was observed in hepatocytes cultured on 2DAHP-1G Flat versus 2DAHP-1G Nano substrates
at day 3. However, this effect was significant at day 3 (** p < 0.01).
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IV. Discussion
A. Synergistic Effect of Nanotopography
1. Effect on Attachment, Adhesion, and Spreading
This work was designed to utilize nanotopography as a tool to produce synethetic polymer
substrates that mimic the behavior of collagen to improved cell-biomaterial interactions. Perhaps
one of the most difficult cell phenotype to grow in culture is primary hepatocytes. For this
reason, we assess the enhanced attachment function of primary hepatocytes on nanofabricated
elastomeric poly(ester amide) substrates. It is known that the biophysical properties of substrates
can drastically reduce the genotype and phenotype of hepatocytes.[327] In general, the addition of
nanometer scale topography to synthetic biodegradable substrates led to enhanced attachment,
spreading, and adhesion of primary hepatocytes. This result has been corroborated in other cell
types on other substrates as well. The added effect of topography enabled the robust attachment
of hepatocytes to a similar degree of collagen in terms of cell retention (Figure 44). The
attachment and adhesion of a non-negligible density of hepatocytes to PDMS was not alarming
as other systems have utilized PDMS for the culture of hepatocyte cell lines.[84] Similarly,
plasma treating with oxygen has been shown to permanently reduce the water-in-air contact
angle from 1130 to 970, which could leave to subsequent improvement in attachment.1328] The
observed high retention of hepatocytes on these surfaces suggests that the limited number of cells
attached to these surfaces are tightly bound. SEM micrographs indicate wrinkling at the surface,
which is indicative of strong traction forces exerted by the cell on the PDMS substrate (Figure
42). This wrinkling artifact was not observed on any other substrate including the flat APS or
collagen substrates.
2. Effect on Liver-Specific Function of Hepatocytes
While increasing adhesion is beneficial for some cell phenotypes, it is known that increasing the
adhesion of hepatocytes is sometimes counter productive with respect to the effects on liver-
specific function. Namely, when hepatocytes adhere to substrates and are tightly bound, then
there is typically a corresponding drop in the productivity of tranditional metrics for hepatocyte
function including albumin secreation and urea conversion. This is evident in the case of
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culturing primary hepatocytes on substrates with variable concentrations of ECM. The
corresponding increase in adhesion of hepatocytes on substrates with high-density ECM induces
a reduction in liver-specific function. Conversely, hepatocytes cultured on substrates with low-
density ECM preserves function. The results observed in this study corroborate with these
previous studies in the context of nanotopography. Namely, the increase in hepatocyte adhesion
due to nanotopography simultaneously reduces the efficiency of liver function. A similar trend
is observed in the case of collagen substrates in which increased attachment, adhesion, and
spreading correlates negatively with liver-specific function. In this sense, the nanofabricated
synthetic poly(ester amide) elastomeric substrates induce function that trends toward that of
native collagen, with respect to substrates that are physically and chemically identical, yet lack
nanotopographic features.
B. Applications of Synthetic Collagen
Synthetic biomaterials that mimic the properties of native ECM molecules have a large potential
for utilization in a variety of medical applications. Nanotopographic APS substrates could be
used as a substrate that is able to serve as a synthetic ECM for applications where reducing
batch-to-batch variation is important. Furthermore, this synthetic ECM can be utilized for tissue
engineering applications. As previously mentioned, the use of xenografts based on natural ECM
protein scaffolds or matrices can lead to serious, detrimental immune responses. Synthetic
polymers that can function in a similar mode to ECM proteins could provide a material platform
for scaffold fabrication, which could dramatically reduce the likelihood of a negative immune
response upon implantation.
V. Conclusion
Elastomeric poly(ester amide) substrates demonstrated in vitro biocompatibility with primary
hepatocytes by supporting attachment, adhesion, native-like morphology, and liver-specific
function. APS substrates modified with replica molded nanotopography demonstrated increased
attachment, spreading, and adhesion across two polymer forumulations tested. The observed
increase in adhesion resulted in a corresponding reduction of liver-specific cell function. A
similar trend was observed in hepatocytes cultured on collagen substrates in which increased
attachment and adhesion was reciprocated by reduced albumin synthesis and urea conversion.
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This consistent trend observed across synthetic nanotopographic poly(ester amide) elastomeric
substrates and collagen suggests that the nanotopographic features provide a substrate that better
mimics native collagen with respect to cell-biomaterial interactions.
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Chapter 12: Concluding Remarks
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I. The Role of Interdisciplinary Studies in Scaffold
Fabrication for Tissue Engineering
The key to advancement of scaffold development is continually facilitating the interaction
between at least these three key fields of study; 1) materials science, engineering, and processing,
2) cell biology, 3) chemistry and materials synthesis. These and related fields will no doubt
advance spontaneously as breakthrough developments in fields such as polymer synthesis, drug
delivery, protein characterization, gene therapy, and stem cells continue at a frenetic rate.
However, the interplay is essential in designing scaffolds that facilitate premeditated tissue
regeneration responses. Cell biology and materials synthesis must be studied simultaneously to
characterize cell-biomaterial interactions, which will ultimately serve as a basis for the design
and synthesis of smart biomaterials. Materials synthesis and materials processing must move
forward synergistically in order to develop materials processing strategies that are not only
compatible with appropriate biomaterials, but are also able to accommodate technical and
economic factors as well. Lastly, materials science and cell biology must be implemented in
unison to study and eventually engineer the spatial and temporal microenvironments on a precise
level is critical for inducing the desired cellular response, which is especially important in the
field of tissue engineering and organ regeneration. One key thrust of the mutual development
lies in the ability to create materials and systems on the nanometer length scale. The limitations
of traditional photolithography have driven the implementation of other nanofabrication
processes including nanoimprint lithography. Nanoimprint lithography processes are able to
create reproducible features less than 30 nm.[ 329] Features on this length scale could be
potentially utilized to fabricate synthetic basement membrane structures, which are known to
contain features on a similar length scale. [210' 211] Artificial cell substrates could be used to
precisely interact with the filopodia and lamelopodia of cells, which could potentially be used to
control cell functions such as migration and differentiation.
II. The Role of Biomimicry in Engineering Cell-Biomaterial
Interactions
The current tissue engineering paradigm mandates that the driving force for scaffold design and
fabrication is the desire to create a biomimetic system. This rudimentary albeit currently
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appropriate pursuit often manifests itself into designing biomimetic materials, processes, and
cell-scaffold constructs that try to mimic properties of the tissue microenvironment such as cell
phenotype, microarchitecture, mechanical properties, surface topography, and chemical cues.
Biomimetic strategies for scaffold fabrication provide challenges that drive the overall
improvement of microfabrication techniques for scaffold development and tissue engineering in
general. These improvements may come in the form of newfound materials with improved
tissue response or ease of processing, novel methods for controlling cell-cell or cell-biomaterial
interactions, or new methods for the facile fabrication biomaterials into functional scaffolds that
can promote regenerative processes across all hierarchal levels from proteins and cells to tissues
and organs.
Ill. Microfabrication as a Tool for Basic Science and Tissue
Engineering
The primary role of microfabrication in scaffold development and tissue engineering is to
function as a tool that can aid and assist in advancing individual fields of science and engineering
that are either directly or indirectly related to tissue and organ regeneration. Furthermore,
microfabrication techniques for biomaterials must also be viewed as a unifying medium for
creating platforms for interdisciplinary research. For the most part, the instrumental role of
microfabrication in tissue and organ regeneration has been permanently established only recently.
However, the role of microfabrication technology in tissue engineering will become more
prominent as it becomes more and more economically viable, ubiquitous, accessible to other
scientific fields, and it continues to gain traction as a tool for both the fundamental and applied
biological sciences.
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Appendix I
A. Oxygen-in-PGS Diffusion Length Scales
A simple order of magnitude calculation of the diffusion length can be calculated from:
L = 4 DoPGs t Eqn. 19
where the time for diffusion, t, is considered to be 351 sec and the diffusivity of oxygen in PGS,
Do,_-PG, was measured to be 3.42 x 10-12 m2/sec. The resulting length-scale, L, was calculated
to be 69.3 microns. A more detailed calculation was used to determine the feasibility of
supplying oxygen to a confluent monolayer of cells across a PGS membrane via diffusion.
Using the oxygen consumption parameters of endothelial cells outlined in Appendix B, the
steady-state oxygen consumption per unit area, cells, was calculated to be 4.45 x 10-8 mol/m2 -
sec via:
( cells = N .rh Eqn. 20
This consumption was matched with the one-dimensional solution-diffusion model of flux as
governed by the following equation:
(C• - Chyp)
dff = DO,-PGs So2 -PGs Eqn. 21
Applying the appropriate values for C,, Chyp DoPGs, and So,-PGs as defined in the text and
combining Eqns. 20 and 21 leads to the calculation for a maximum membrane thickness, 6, of
232 microns. The variation in transport parameters from 24 oC to 37 oC was considered to be
negligible for this calculation as in other polymer systems.[133]
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B. Determination of Optimal Perfusion Rate
A one-dimensional solution-diffusion-reaction[134] model can be used to determine the maximum
thickness of a PGS layer that ensures adequate oxygen supply to a cell monolayer through
diffusion alone. Assuming an infinite atmospheric supply of oxygen (21%) and standard
hepatocyte cell oxygen uptake rates,t 14' 15] the maximum thickness of the layer was calculated by
flux matching of diffusion and oxygen consumption. This calculation suggest that PGS
membranes have a maximum allowable thickness of approximately 232 microns to avoid
hypoxic oxygen concentrations (< 1%). [135] Therefore, oxygen transport to the microfluidic
layers can be assumed to be negligible.
Because the diffusive limitations of solid PGS result in a coupling of oxygen supply and fluid
maximum shear stress within the device microenvironment, the perfusion rate of 280 pL/hr was
chosen to simultaneously maximize the reactor volume exchange frequency while maintaining
physiologically relevant shear stresses on the cells throughout the device. Using a lumped
parameter model with previously outlined parameters, the required reactor volume exchange
frequency was calculated to be approximately 52 hr-i. Therefore our selection of perfusion rate
satisfied the reactor exchange and shear stress requirements.
The volume and the total microchannel surface area of the microfluidic vascular networks were
calculated on a per microfluidic layer using the feature dimensions on the mask and final etch
depth of the silicon master. Each vascular network has a volume, V, of approximately 1.232 uL
and a total microchannel surface area, Achannel, , of 0.0324 cm 2, excluding the inlet and outlet
regions. Assuming a confluent cell density, N , of 5.71 x 104 cells/cm 2 and a cellular
consumption rate, rih, of approximately 75 x 10-'18 mol/cell-sec, the total oxygen demand of a
single vascular network with confluent HepG2 cells, M , can be calculated as:
M = N - Apchannel • h Eqn. 22
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The lumped oxygen consumption rate was calculated to be 5.71 x 10-13 mol/sec. Assuming that
the liquid contains atmospheric concentrations of oxygen, C., at 37 oC of 2.14 x 10-7 mol/cm 3,
the time required reactor volume exchange, r, is calculated from:
c, -v
M= Eqn. 23
For these selected parameters, r was calculated to be 26.1 sec, which requires a corresponding
ideal volumetric flow rate of 170 pL/hr. The selected flow rate of 140 uL/hr was rationalized to
be sufficient by virtue of the Michaelis-Menten kinetic nature of oxygen uptake within
hepatocytes and working under the assumption that that there would be sporadic regions of non-
confluence . This result can be scaled linearly with the total number of vascular networks within
each device, which results in the total flow rate of 280 jtL/hr.
C. Computational Fluid Mechanic Simulation of Hepatocyte Reactor
A two-dimensional model of incompressible flow within the hepatocyte reactor was performed
using FEMLAB 3.0a (Figure 46). Symmetry arguments were used to reduce the complexity of
the model and the appropriate boundary conditions were applied. Volumetric flow rate and
neutral/outflow boundary conditions were imposed on the inlet and outlet respectively. The
resulting flow distribution within the device revealed high flow rates on the periphery of the
network with low flow rates within the network of posts, which can protect the cells from the
potential shear forces associated with high perfusion rates. In this study, cells were evenly
distributed throughout the device, which suggests the shear forces associated with the selected
perfusion rate was not sufficient to incite cell detachment or death.
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Figure 46. Finite Element Simulation of Flow in Hepatocyte Networks.
Velocity profiles within the device reveal high flow rates within the microchannels on the periphery of the
device and low flow rates within the network of posts. This network can therefore protect cells from shear
forces associated with high flow rates under rapid perfusion conditions. Scale bar represents 2 mm.
D. Shear Stress Calculations
A uniform hexagonal channel network was used as an initial starting point and modified to its
final form by implementing an iterative algorithm that consists of the following steps: 1) Define
channel dimensions; 2) Calculate the maximum shear stresses in microchannels, which occurs at
the midpoint along the top and bottom of the channel boundaries; 3) Compare maximum shear
stress values across device; 4) Rationally alter channel dimensions until constant shear profiles
are achieved. It should be noted that the term "shear stress" for the purposes of this analysis
refers to the maximum shear stress within the microchannel.
Theoretical fluidic resistances were predicted using the Navier-Stokes solution for flow in a
rectangular-duct. The resistances and connectivity of each segment are assembled into a matrix,
M, and incorporated in the following equation:
M -i = Eqn. 24
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where tJ is a vector describing the pressures in each segment and J is a vector describing the
appropriate boundary conditions. The pressure drops across segments were used in the
calculation of volumetric flow rate, Q, which in turn as used to determine the wall shear stress in
each microchannel, r,, by solving the approximating the system as a rectangular duct.[1361
The model that was used to design the constant shear network assumed a rectangular cross-
sectional geometry and a height of 40 microns. The actual duct cross-sectional geometry was
trapezoidal due to a sucrose accumulation effect. This effect is supported by the asymmetric
microchannel geometry of the segment at the bottom of the image shown in Figure 47. After the
sucrose spin-coating step, relatively more of the highly viscous sucrose-in-water solution
accumulates within the regions that are surrounded with microfabricated structures that then
regions at the periphery of the microchannel network. The variable accumulation of sucrose
leads to variable trapezoidal deviations on the eventual replica molded PGS layer. The potential
effect of the deviation between the theoretical rectangular duct and the realized trapezoidal duct
was analyzed by examining the flow of water within a long conduit 100 microns in width and 40
microns in height using FEMLAB 3.0a. This deviation in ideal channel geometry (Figure 47)
led to an approximate increase in volumetric flow rate of 7%, which might affect the constant
maximum shear stress properties throughout the device. This increase in flow rate can be
attributed to the increase in cross-sectional area and therefore a lower fluidic resistance.
However, these deviations can be compensated for in future designs of constant maximum shear
stress networks using PGS microfabricated in the previously described manner.
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Figure 47. Finite Element Simulation Comparision of Flow in Different Microchannel Geometries.
The cross-sectional flow profiles demonstrate the effect of the trapezoidal shape in comparison to the ideal
situation of the rectangular duct. The increase in maximum velocity in the case of the trapezoidal duct can be
attributed to the increase in a cross-sectional area and an overall decrease in the fluidic resistance of the
element. Simulations were performed with FEMLAB 3.0a using low-density mesh. Although the solutions
converged, the low-density mesh causes non-ideal artifacts within the resulting velocity profile. Scale bars in
a and b both represent 50 microns.
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Appendix 2
A. Physicochemical Characterization of Silk Fibroin Films
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Figure 48. Physical Properties of Methanol Treated Silk Fibroin Films.
a) FT-IR on silk films cast from regenerated aqueous silk fibroin solution. Silk films, as cast, exhibit peaks
for amide II (1656.6 cm4" ) and amide 11 (1541.5 cm" 1) of random or silk I structure in addition to other peaks
at 1456.4 cm1 , and 1243.0 cm "'. Silk films treated with aqueous methanol solutions exhibited a shift to silk II
structure as observed in peak shifts in amide I (1616.3 cm~') and amide II (1515.6 cm-i) functionalities.
Additional peaks were observed at 1445.3 cm "', 1231.6 cm7'. b) Hydrated, water-stable silk fibroin films
exhibit relatively high stiffness and toughness with a significant region of plastic deformation, as shown by
this representative tensile stress versus engineering strain curve. c) Representative tensile stress versus
engineering strain curves of silk fibroin films compared to PGS films.
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Figure 49. Surface Roughness Analysis of Silk Fibroin Films.
a) An image of surface topography was taken using a Wyko operated in VSI mode. b) Statistical analysis
including mean surface roughness (Ra), root-mean-squared (RMS) surface roughness (Rq), averaged peak-
to-valley distance (Rz), and maximum peak-to-valley distance (Rt) was taken in PSI mode across four
different regions at 10X magnification.
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Figure 50. Optical Transmission Spectrum of Silk Fibroin Films.
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B. Characterization of Hepatocyte Performance on Silk Fibroin in
Static and Perfused Microfluidic Culture
Silk Fibroin PLGA
O)
LI,
LU
L/)
Figure 51. Morphology of HepG2 Cultured on Biomaterials.
HepG2 cells cultured on silk fibroin substrates appeared healthy and spread. HepG2 cells cultured on PLGA
exhibited spheroid morphologies as observed through both phase contrast and SEM imaging. These
morphologies are similar to that of hepatocytes cultured on PLGA substrates as observed by others. Scale
bars in phase and SEM micrographs represent 100 and 10 microns, respectively.
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Figure 52. Albumin Synthesis Rates of Seeded HepG2s.
a) Albumin secretion of HepG2 in static culture for 24 h on silk fibroin films was comparable to that of other
biomaterial standards including tissue culture polystyrene and PLGA. b) Furthermore, the albumin
secretion rate of HepG2s cultured in silk fibroin microfluidic devices was similar to those cultured on silk
fibroin films in static culture. The increase in albumin secretion across day 3 through 5 is likely attributed to
an increase in the growth rate of cells within the device.
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Table 14. Summary of FT-IR Peaks for 2DAHP-1G and 2DAHP-1T APS Polymers.
a. 2DAHP-1G Peaks of Interest
Wave# (cm-1) Narrow/Broad Corresponding Functional Group
1737 Narrow Ester (C=O stretch)
1648 Narrow Primary Amine (NH2 scissors)
Primary Amides (NH 2 scissors)
Secondary Amides (N-H in-plane
1563 Narrow bend)
Carboxylic Acids (O-H in plane
1467 Narrow bend)
1407 Narrow Primary Amides (C-N stretch)
1250 Narrow Secondary Amides (C-N stretch)
721 Narrow Secondary Amine (N-H wag)
743-628 Broad Primary Amine (NH2 wag)
b. 2DAHP-1T Peaks of Interest
Wave# (cm-1) Narrow/Broad Corresponding Functional Group
1738 Narrow Ester (C=O stretch)
1650 Narrow Primary Amine (NH2 scissors)
Primary Amides (NH2 scissors)
Secondary Amides (N-H in-plane
1557 Narrow bend)
1411 Narrow Primary Amides (C-N stretch)
1251 Narrow Secondary Amides (C-N stretch)
722 Narrow Secondary Amine (N-H wag)
750-618 Broad Primary Amine (NH 2 wag)
Table 15. Physical Properties of APS Polymer Networks.
The mass density, sol content (by mass), and water uptake (by volume) are shown across polymer and curing
time.
Formulation Curing Time (h) Density (g/cm3) Sol Content Water Uptake
2DAHP-1G 24 1.101 16.08% 14.2%
2DAH P-1G 48 1.096 6.91% 17.6%
2DAHP-1T 24 1.114 8.71% 19.8%
2DAHP-1T 48 1.110 3.51% 15.8%
Table 16. Contact Angle and Glass Transition Temperature of APS Elastomers.
Formulation Curing Time (h) Contact Angle (deg) T, (0C)
2DAHP-1G 24 93.3 33.7
2DAHP-1 G 48 92.6 38.1
2DAHP-1T 24 91.5 45.4
2DAHP-1T 48 93.7 48.0
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Table 17. Theoretical Calculation of Glass Transition Temperature Depression.
The effective T, of APS polymers in the hydrated state was calculated from Eqn. 6. The polymer was selected
as component 1 and water was selected as component 2. It was assumed that ACp was constant with
temperature. The values of xt and x 2 are mass fractions.
Polymer (1) Curing Time (h) ACp (J/g-OC) Tg (OC) x, x2  Tg1,2 (OC) ATg•,2 (OC)
2DAHP-1G 24 0.489 33.68 0.864 0.136 -55.22 -88.90
2DAHP-1G 48 0.618 40.29 0.833 0.167 -61.79 -102.08
2DAHP-1T 24 0.584 45.37 0.819 0.181 -78.68 -124.05
2DAHP-1T 48 1.070 48.02 0.852 0.148 -42.85 -90.87
Diluent (2)
Watera -- 1.940 -139.0 --- --- --
aValues obtained from previous work.[1' 4
1
Table 18. Tabulated Values of CD68+ Fractions of Cell Populations in Proximity to APS Implant Sites.
Polymer Location I wk 2 wks 20 wks
2DAHP-1G Fibrous Capsule 36.5 ± 3.6 24.8 ± 6.4 29.1 ± 6.0
Surrounding Tissue 29.6 ± 8.2 22.9 ± 5.2 32.2 ± 8.6
2DAHP-1T Fibrous Capsule 54.8 ± 5.9 41.8 ± 6.6 15.7 ± 8.1
Surrounding Tissue 48.3 ± 3.2 14.9 ± 8.0 25.4 ± 9.1
1 wk 2 wks 12 wks
PLGA Fibrous Capsule 80.9 ± 6.8 63.2 ± 8.5 59.1 ± 4.8
Surrounding Tissue 60.4 + 11.4 57.8 ± 4.4 57.7 ± 6.1
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Figure 53. FT-IR Spectra of 2DAHP-1G and 2DAHP-1T APS Polymers.
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Figure 54. DSC Thermograms of 2DAHP-1G and 2DAHP-1T APS Polymers.
224
Temperature ("C)
I I I I I i ]
a 100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
2 3 4 5 6
Degradation Time (wk)
b 100%
90%
80%
70%
9 60%0
50%
r 40%
30%
20%
10%
0%
C 100%
90%
80%
70%
60%
50%
2 40%
30%
20%
10%
0%
2 3 4 5 6
Degradation Time (wk)
2 3 4
Degradation Time (wk)
Figure 55. In vitro Mass Loss Kinetics of 1DAHP-2G.
In vitro degradation of 1DAHP-2G cured for 48 h (m) and 96 h (A) at 37 OC in (a) 3M sodium acetate buffer,
(b) 10 U/mL bovine cholesterol esterse in DPBS, and (c) 10 U/mL protease XIV in DPBS.
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Figure 56. In vitro Mass Loss Kinetics of 1DAHP-1G.
In vitro degradation of 1DAHP-1G cured for 24 h (m) and 48 h (A) at 37 TC in (a) 3M sodium acetate buffer,
(b) 10 U/mL bovine cholesterol esterse in DPBS, and (c) 10 U/mL protease XIV in DPBS.
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Figure 57. In vitro Mass Loss Kinetics of 2DAHP-1G.
In vitro degradation of 2DAHP-1G cured for 24 h (n) and 48 h (A) at 37 oC in (a) 3M sodium acetate buffer,
(b) 10 U/mL bovine cholesterol esterse in DPBS, and (c) 10 U/mL protease XIV in DPBS.
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Figure 58. In vitro Mass Loss Kinetics of 2DAHP-1T.
In vitro degradation of 2DAHP-1T cured for 24 h (m) and 48 h (A) at 37 OC in (a) 3M sodium acetate buffer,
(b) 10 U/mL bovine cholesterol esterse in DPBS, and (c) 10 U/mL protease XIV in DPBS.
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Figure 59. Effects of in vivo Degradation on Bulk Phase Morphology.
SEM micrographs were taken of the bulk phase of 2DAHP-1G and 2DAHP-1T formulations after 28 wks
post implantation. Examination of the bulk phases of 2DAHP-1G and 2DAHP-1T formulation explants
suggests there was no pore formation on the length scale of microns or hundreds of nanometers. This
morphology can be contrasted with the morphology of PLGA seen at 2 wks Figure 23. The textures observed
in the 2DAHP-1G sample are artifacts from sample preparation. Scale bars represent 1 micron.
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Figure 60. Demonstration of Calculation of Gross Morphological Parameters.
Using phase contrast images (a) as a guide, the perimeter of each cell is traced as shown by the solid line.
Digital zoom was used to increase the magnification and, in turn, the accuracy of the measurements. This
measurement provides the perimeter and cell area parameters for each sample. In addition to these
measurements, the angle, 0 between the longitudinal axis of the cell and the axis of the nanotopography is
measured as shown by the dashed lines on a different cell for clarity. b) These measurements are shown in
further detail on a schematic of a cell. c) The orientation of GTCs (represented here by stars) was
determined by measuring the angle between a line drawn from the center of the nucleus to the complex and
the longitudinal axis of the nucleus. Scale bar in (a) represents 100 microns; (b) and (c) are schematics not
drawn to scale.
Figure 61. Nanofabricated Line-Grating PDMS Substrates.
a) Silicon masters were fabricated using traditional photolithographic techniques with target feature
dimensions of 1200 ± 200 nm period and a feature height of 600 ± 150 nm. Line-grating geometry was chosen
as the most effective geometry to induce alignment and elongation, characteristic fingerprints of the contact
guidance response to nanotopography. b) PDMS substrates replica molded from these substrates exhibited
high feature fidelity. These substrates were autoclaved and treated with oxygen plasma to produce
hydrophilic surfaces. The surfaces were then immediately treated with a 2.5 jtg/mL fibronectin solution for 3
h at 37 oC.
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Figure 62. Projected Cell Areas of hESCs.
a) Cells cultured on flat substrates had large projected cell areas than those cultured on nanotopographic
substrates (b). The addition of actin disrupting agents reduces the projected area of cells cultured on flat and
nanotopographic alike.
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Figure 63. Effect of Cytochalasin D and Latrunculin B on Cells Cultured on Flat Substrates.
a) Morphological characterization of cells cultured on flat substrates in the presence of cyto D and latr B
resulted in increased circularity as confirmed by one-way ANOVA (*** < p 0.001). b) Increased cell densities
at time points 24 h, and 48 h as confirmed by two-way ANOVA (*** < p 0.01) in combination with increased
BrdU uptake at 24 h as confirmed by one-way ANOVA (*** < p 0.001) (c) suggests that treatment with
actindisrupting agents leads to increased proliferation relative to cells cultured on flat substrates in the
absence of ADAs. d) Metabolic activity, as measured by XTT cleavage assay, increased for cells cultured on
flat substrates in the presence of both cyto D (di) and latr B (dii) treatment at 24 h when compared to no drug
as assessed by Student's t-tests (*** p < 0.001, *** p < 0.001 for cyto D and latr B, respectively).
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Appendix 6
Figure 64. Characterization of Linear Nanotopographic Substrates.
a) Patterned photoresist exhibited uniformity across a wide spatial domain. Reactive ion etching followed by
resist strip leads to well defined silicon molds with sub-micron line grating. b) The width and depth of
features was verified through SEM of wafer cross-sections. c) Replica molded PDMS exhibited features with
high fidelity. Scale bars represent 1 micron.
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Figure 65. Light Micrographs of BrdU Incorporation Assay at 2 d.
Scale bars represent 100 microns.
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Figure 66. Migration and Effective Displacement of EPCs is Enhanced by Nanotopography.
EPCs cultured on nanotopographical features exhibited both increased (a) migration velocity (*** p < 0.001)
as well as (b) overall displacement (*** p < 0.001) relative to those cultured on flat substrates.
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Figure 67. The Expression of Endothelial Markers is Maintained in EPCs Cultured on Both Flat and
Nanotopographic Substrates.
EPCs maintained the expression of endothelial cell-specific markers including von Willebrand factor, VEGF-
2 receptor, and lectin receptor. The formation of supercellular band structures is also evident. Scale bars
represent 50 microns.
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Figure 68. Non-contact Optical Profiling of Microfabricated PGS Substrates.
Topographic structures were characterized using optical profiling of the three substrates (G1, G2, and G3
shown in A, B, and C respectively). The large deviations in feature size can be attributed to a combination of
inaccuracies in photolithography and etching in addition to non-uniformities imparted by the sucrose coating.
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Figure 69. Phase Imaging of Live Cells on Microfabricated PGS Substrates at 15 h.
Bovine aortic endothelial cells were cultured for 15 h on patterns G1-G3 and flat controls (a, b, c, and d
respectively). Images such as these were used to calculate the physical characteristics of the cell including
relative angle, perimeter, and area. These parameters were then used to calculate the cell alignment
distribution, alignment frequency, and circularity (Figure 38b, c, and d respectively). Scale bars represent
100 microns.
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Figure 70. Effect of Hydration on Ordering of Features in Nanofabricated Elastomeric Poly(ester amide)
Substrates.
a) Pillars maintain long range order in hydrated nanofabricated 2DAHP-1G elastomeric poly(ester amide)
substrates. b) However, the pillars collapse on each other and form clusters upon dehydration of the
substrate. This is likely due to attraction from van der Waals forces (Chapter 11). Scale bars represent 10
microns.
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Figure 71. Arrangement of Nanotopographical Features of Substrates During Hepatocyte Adhesion.
The features of nanotopographic substrates remained ordered as they appeared in the hydrated condition.
Furthermore the hepatocyte appeared to have no impact on the spacing of the features. This suggests that
the adhesive forces exerted by the cells are not significant enough to deflect the posts an appreciable amount.
Scale bars represent 10 microns.
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